{
  "type": "FeatureCollection",
  "features": [
    {
      "type": "Feature",
      "id": "12",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.586183,
            7.153048
          ],
          [
            7.538383,
            7.16156
          ],
          [
            1.008697,
            8.32279
          ],
          [
            0.960873,
            8.331283
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "1",
        "dest": "2",
        "label": "Progesterone Receptor Signaling Mechanisms. -- The biology of progesterone receptor in the normal mammary gland and in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "13",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.587839,
            7.153043
          ],
          [
            7.691471,
            7.156203
          ],
          [
            13.543195,
            7.334577
          ],
          [
            13.65212,
            7.337896
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "1",
        "dest": "3",
        "label": "Progesterone Receptor Signaling Mechanisms. -- Revisiting progesterone receptor (PR) actions in breast cancer: Insights into PR repressive functions.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "24",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.960275,
            8.331282
          ],
          [
            0.89739,
            8.322397
          ],
          [
            -8.030617,
            7.059017
          ],
          [
            -8.093282,
            7.050137
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "2",
        "dest": "4",
        "label": "The biology of progesterone receptor in the normal mammary gland and in breast cancer. -- Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "25",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.963277,
            8.331364
          ],
          [
            1.13533,
            8.333595
          ],
          [
            9.571062,
            8.442938
          ],
          [
            9.759807,
            8.445385
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "2",
        "dest": "5",
        "label": "The biology of progesterone receptor in the normal mammary gland and in breast cancer. -- Interplay between progesterone and prolactin in mammary development and implications for breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "27",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.960816,
            8.331377
          ],
          [
            1.003063,
            8.340955
          ],
          [
            7.481288,
            9.806806
          ],
          [
            7.523595,
            9.816359
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "2",
        "dest": "7",
        "label": "The biology of progesterone receptor in the normal mammary gland and in breast cancer. -- From the ranks of mammary progesterone mediators, RANKL takes the spotlight.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "210",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.961443,
            8.331376
          ],
          [
            1.050259,
            8.336366
          ],
          [
            8.200989,
            8.73789
          ],
          [
            8.289803,
            8.742875
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "2",
        "dest": "10",
        "label": "The biology of progesterone receptor in the normal mammary gland and in breast cancer. -- Progesterone/RANKL is a major regulatory axis in the human breast.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "214",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.960739,
            8.331377
          ],
          [
            0.998021,
            8.344869
          ],
          [
            9.016643,
            11.234848
          ],
          [
            9.053839,
            11.248192
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "2",
        "dest": "14",
        "label": "The biology of progesterone receptor in the normal mammary gland and in breast cancer. -- Progesterone receptor A stability is mediated by glycogen synthase kinase-3\u03b2 in the Brca1-deficient mammary gland.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "231",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.960665,
            8.331377
          ],
          [
            0.981604,
            8.348834
          ],
          [
            6.785625,
            13.152229
          ],
          [
            6.806525,
            13.169378
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "2",
        "dest": "31",
        "label": "The biology of progesterone receptor in the normal mammary gland and in breast cancer. -- Progesterone signalling in breast cancer: a neglected hormone coming into the limelight.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "48",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.093851,
            7.050043
          ],
          [
            -8.146091,
            7.039695
          ],
          [
            -16.809329,
            5.320781
          ],
          [
            -16.861676,
            5.310378
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "4",
        "dest": "8",
        "label": "Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells. -- Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "419",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.093533,
            7.050042
          ],
          [
            -8.06779,
            7.034602
          ],
          [
            -1.878126,
            3.30994
          ],
          [
            -1.852437,
            3.294441
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "4",
        "dest": "19",
        "label": "Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells. -- Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "420",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.093455,
            7.050042
          ],
          [
            -8.054665,
            7.038463
          ],
          [
            -0.933189,
            4.908142
          ],
          [
            -0.894504,
            4.896549
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "4",
        "dest": "20",
        "label": "Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells. -- Signal transducer and activator of transcription 5a mediates mammary ductal branching and proliferation in the nulliparous mouse.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "422",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.093603,
            7.050042
          ],
          [
            -8.089586,
            7.032426
          ],
          [
            -6.976062,
            2.129533
          ],
          [
            -6.972052,
            2.111827
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "4",
        "dest": "22",
        "label": "Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells. -- A role for site-specific phosphorylation of mouse progesterone receptor at serine 191 in vivo.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "56",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.763212,
            8.445379
          ],
          [
            9.805779,
            8.434801
          ],
          [
            17.011703,
            6.640117
          ],
          [
            17.054145,
            6.629525
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "5",
        "dest": "6",
        "label": "Interplay between progesterone and prolactin in mammary development and implications for breast cancer. -- Progesterone regulation of stem and progenitor cells in normal and malignant breast.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "527",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.763363,
            8.445473
          ],
          [
            9.823697,
            8.453837
          ],
          [
            17.896376,
            9.571225
          ],
          [
            17.956487,
            9.579532
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "5",
        "dest": "27",
        "label": "Interplay between progesterone and prolactin in mammary development and implications for breast cancer. -- The pivotal role of insulin-like growth factor I in normal mammary development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "533",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.763168,
            8.445474
          ],
          [
            9.798468,
            8.457086
          ],
          [
            16.279346,
            10.582669
          ],
          [
            16.314551,
            10.594177
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "5",
        "dest": "33",
        "label": "Interplay between progesterone and prolactin in mammary development and implications for breast cancer. -- Hormonal regulation of the immune microenvironment in the mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "1059",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.290861,
            8.742968
          ],
          [
            8.334568,
            8.752096
          ],
          [
            14.764182,
            10.092235
          ],
          [
            14.807938,
            10.101337
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "10",
        "dest": "59",
        "label": "Progesterone/RANKL is a major regulatory axis in the human breast. -- Comment on \"Progesterone/RANKL is a major regulatory axis in the human breast\".",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "1060",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.290751,
            8.742969
          ],
          [
            8.321026,
            8.755564
          ],
          [
            14.35497,
            11.256539
          ],
          [
            14.385169,
            11.269005
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "10",
        "dest": "60",
        "label": "Progesterone/RANKL is a major regulatory axis in the human breast. -- RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "1478",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.054124,
            11.248286
          ],
          [
            9.088996,
            11.258817
          ],
          [
            14.961752,
            13.02663
          ],
          [
            14.996521,
            13.03706
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "14",
        "dest": "78",
        "label": "Progesterone receptor A stability is mediated by glycogen synthase kinase-3\u03b2 in the Brca1-deficient mammary gland. -- Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "1479",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.05407,
            11.248285
          ],
          [
            9.084244,
            11.262188
          ],
          [
            15.841427,
            14.357128
          ],
          [
            15.871534,
            14.370829
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "14",
        "dest": "79",
        "label": "Progesterone receptor A stability is mediated by glycogen synthase kinase-3\u03b2 in the Brca1-deficient mammary gland. -- BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "1482",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.054054,
            11.248286
          ],
          [
            9.083686,
            11.264724
          ],
          [
            16.77503,
            15.49583
          ],
          [
            16.804605,
            15.511949
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "14",
        "dest": "82",
        "label": "Progesterone receptor A stability is mediated by glycogen synthase kinase-3\u03b2 in the Brca1-deficient mammary gland. -- Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1484",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.054037,
            11.248285
          ],
          [
            9.076606,
            11.263652
          ],
          [
            14.667904,
            15.042851
          ],
          [
            14.690428,
            15.057952
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "14",
        "dest": "84",
        "label": "Progesterone receptor A stability is mediated by glycogen synthase kinase-3\u03b2 in the Brca1-deficient mammary gland. -- Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "31196",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.80687,
            13.169471
          ],
          [
            6.856906,
            13.177503
          ],
          [
            13.416702,
            14.228172
          ],
          [
            13.466748,
            14.23617
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "31",
        "dest": "196",
        "label": "Progesterone signalling in breast cancer: a neglected hormone coming into the limelight. -- Harmful effect of ER\u03b2 on BCRP-mediated drug resistance and cell proliferation in ER\u03b1/PR-negative breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "89",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.861924,
            5.310379
          ],
          [
            -16.866118,
            5.332024
          ],
          [
            -18.266472,
            12.497297
          ],
          [
            -18.27066,
            12.518488
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "9",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "811",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.861978,
            5.310281
          ],
          [
            -16.882148,
            5.29435
          ],
          [
            -21.731983,
            1.45473
          ],
          [
            -21.752112,
            1.438769
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "11",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- Paracrine-rescued lobulogenesis in chimeric outgrowths comprising progesterone-receptor-null mammary epithelium and redirected wild-type testicular cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "812",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.862093,
            5.310283
          ],
          [
            -16.90769,
            5.298126
          ],
          [
            -25.674023,
            2.956971
          ],
          [
            -25.719503,
            2.944809
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "12",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "813",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.861922,
            5.310283
          ],
          [
            -16.864962,
            5.289516
          ],
          [
            -17.859856,
            -1.526484
          ],
          [
            -17.862893,
            -1.5473
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "13",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "815",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.861933,
            5.310283
          ],
          [
            -16.86963,
            5.289892
          ],
          [
            -19.338518,
            -1.271184
          ],
          [
            -19.346203,
            -1.291626
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "15",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "821",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.861913,
            5.310283
          ],
          [
            -16.861155,
            5.291498
          ],
          [
            -16.63573,
            -0.311596
          ],
          [
            -16.634973,
            -0.33043
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "21",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- Research resource: progesterone receptor targetome underlying mammary gland branching morphogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "849",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.861891,
            5.310282
          ],
          [
            -16.851895,
            5.289566
          ],
          [
            -13.645501,
            -1.37605
          ],
          [
            -13.635521,
            -1.396817
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "49",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1923",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.852347,
            3.294344
          ],
          [
            -1.847311,
            3.268897
          ],
          [
            0.114638,
            -6.644499
          ],
          [
            0.119668,
            -6.669783
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "23",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1926",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.852338,
            3.294344
          ],
          [
            -1.843224,
            3.271117
          ],
          [
            1.39825,
            -4.995389
          ],
          [
            1.407351,
            -5.018532
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "26",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- Progesterone receptor A-regulated gene expression in mammary organoid cultures.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "19104",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.852334,
            3.294345
          ],
          [
            -1.842577,
            3.273651
          ],
          [
            1.349827,
            -3.504375
          ],
          [
            1.359569,
            -3.525033
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "104",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "19105",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.852317,
            3.294344
          ],
          [
            -1.833778,
            3.271861
          ],
          [
            4.619617,
            -4.560582
          ],
          [
            4.63813,
            -4.582998
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "105",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- Collaborative interaction of Oct-2 with Oct-1 in transactivation of lactogenic hormones-induced \u03b2-casein gene expression in mammary epithelial cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "19107",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.852254,
            3.294345
          ],
          [
            -1.821575,
            3.280103
          ],
          [
            5.04863,
            0.087291
          ],
          [
            5.079241,
            0.073058
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "107",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "19111",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.851962,
            3.294345
          ],
          [
            -1.793227,
            3.287318
          ],
          [
            4.79141,
            2.499243
          ],
          [
            4.850086,
            2.492218
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "111",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- A composite intronic element directs dynamic binding of the progesterone receptor and GATA-2.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "19114",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.851958,
            3.294345
          ],
          [
            -1.787478,
            3.286676
          ],
          [
            6.064301,
            2.352379
          ],
          [
            6.128757,
            2.344707
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "114",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- Cytokine and progesterone receptor interplay in the regulation of MUC1 gene expression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "2048",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.894085,
            4.896454
          ],
          [
            -0.843525,
            4.887287
          ],
          [
            6.527349,
            3.549671
          ],
          [
            6.57796,
            3.540479
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "20",
        "dest": "48",
        "label": "Signal transducer and activator of transcription 5a mediates mammary ductal branching and proliferation in the nulliparous mouse. -- Strain-specific differences in the mechanisms of progesterone regulation of murine mammary gland development.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "635",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.054456,
            6.62943
          ],
          [
            17.087876,
            6.61638
          ],
          [
            23.915713,
            3.943907
          ],
          [
            23.949052,
            3.930832
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "6",
        "dest": "35",
        "label": "Progesterone regulation of stem and progenitor cells in normal and malignant breast. -- Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "640",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.054561,
            6.629431
          ],
          [
            17.099064,
            6.620237
          ],
          [
            23.645723,
            5.266007
          ],
          [
            23.690275,
            5.25678
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "6",
        "dest": "40",
        "label": "Progesterone regulation of stem and progenitor cells in normal and malignant breast. -- Growth hormone is secreted by normal breast epithelium upon progesterone stimulation and increases proliferation of stem/progenitor cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "27158",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.959209,
            9.579592
          ],
          [
            18.11729,
            9.580501
          ],
          [
            26.083208,
            9.626312
          ],
          [
            26.289817,
            9.6275
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "27",
        "dest": "158",
        "label": "The pivotal role of insulin-like growth factor I in normal mammary development. -- Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "27159",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.957124,
            9.579625
          ],
          [
            18.013859,
            9.588519
          ],
          [
            26.10402,
            10.85423
          ],
          [
            26.160558,
            10.863057
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "27",
        "dest": "159",
        "label": "The pivotal role of insulin-like growth factor I in normal mammary development. -- On the possible role of mammary-derived growth hormone in human breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "27161",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.956971,
            9.579625
          ],
          [
            17.995663,
            9.591983
          ],
          [
            25.707176,
            12.045201
          ],
          [
            25.746241,
            12.057576
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "27",
        "dest": "161",
        "label": "The pivotal role of insulin-like growth factor I in normal mammary development. -- Critical questions in mammary gland development, lactational biology and breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "33202",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.31518,
            10.594271
          ],
          [
            16.379329,
            10.600443
          ],
          [
            22.775662,
            11.21515
          ],
          [
            22.839686,
            11.221297
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "33",
        "dest": "202",
        "label": "Hormonal regulation of the immune microenvironment in the mammary gland. -- Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "33203",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.314782,
            10.594271
          ],
          [
            16.340565,
            10.608057
          ],
          [
            22.036064,
            13.636696
          ],
          [
            22.061788,
            13.650294
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "33",
        "dest": "203",
        "label": "Hormonal regulation of the immune microenvironment in the mammary gland. -- Mammary gland involution as an immunotherapeutic target for postpartum breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "33204",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.314817,
            10.594271
          ],
          [
            16.346357,
            10.606407
          ],
          [
            22.482514,
            12.957552
          ],
          [
            22.513974,
            12.969553
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "33",
        "dest": "204",
        "label": "Hormonal regulation of the immune microenvironment in the mammary gland. -- Hormonal regulation of the cytokine microenvironment in the mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "33205",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.314951,
            10.594271
          ],
          [
            16.362507,
            10.602925
          ],
          [
            22.998126,
            11.807924
          ],
          [
            23.045713,
            11.816547
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "33",
        "dest": "205",
        "label": "Hormonal regulation of the immune microenvironment in the mammary gland. -- Stromal fibroblasts and the immune microenvironment: partners in mammary gland biology and pathology?",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "60337",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.385439,
            11.2691
          ],
          [
            14.421858,
            11.280085
          ],
          [
            20.819751,
            13.203164
          ],
          [
            20.856067,
            13.214039
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "60",
        "dest": "337",
        "label": "RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase. -- The expression of syndecan-1, syndecan-4 and decorin in healthy human breast tissue during the menstrual cycle.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "60338",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.385405,
            11.269099
          ],
          [
            14.416848,
            11.281141
          ],
          [
            20.533913,
            13.613567
          ],
          [
            20.565648,
            13.625611
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "60",
        "dest": "338",
        "label": "RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase. -- Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "60339",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.385372,
            11.2691
          ],
          [
            14.411166,
            11.282783
          ],
          [
            20.033166,
            14.248207
          ],
          [
            20.058901,
            14.261698
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "60",
        "dest": "339",
        "label": "RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase. -- Differences in expression of proliferation-associated genes and RANKL across the menstrual cycle in estrogen receptor-positive primary breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "78459",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.996776,
            13.037153
          ],
          [
            15.02527,
            13.050381
          ],
          [
            21.153888,
            15.877965
          ],
          [
            21.182317,
            15.890995
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "78",
        "dest": "459",
        "label": "Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression. -- Prepubertal physical activity up-regulates estrogen receptor beta, BRCA1 and p53 mRNA expression in the rat mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "78460",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.996842,
            13.037154
          ],
          [
            15.034801,
            13.047816
          ],
          [
            21.562452,
            14.874316
          ],
          [
            21.600301,
            14.884863
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "78",
        "dest": "460",
        "label": "Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression. -- Prepubertal exposure to cow's milk reduces susceptibility to carcinogen-induced mammary tumorigenesis in rats.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "78461",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.996793,
            13.037154
          ],
          [
            15.027882,
            13.049562
          ],
          [
            21.223997,
            15.509417
          ],
          [
            21.255007,
            15.521659
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "78",
        "dest": "461",
        "label": "Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression. -- Prepubertal octylphenol exposure up-regulate BRCA1 expression, down-regulate ERalpha expression and reduce rat mammary tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "78462",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.996756,
            13.037154
          ],
          [
            15.020928,
            13.051259
          ],
          [
            20.509361,
            16.231509
          ],
          [
            20.53348,
            16.245379
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "78",
        "dest": "462",
        "label": "Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression. -- Prepubertal genistein exposure affects erbB2/Akt signal and reduces rat mammary tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "78463",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.996866,
            13.037153
          ],
          [
            15.035761,
            13.046586
          ],
          [
            21.028117,
            14.495483
          ],
          [
            21.067251,
            14.504915
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "78",
        "dest": "463",
        "label": "Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression. -- Lack of ABCG2 shortens latency of BRCA1-deficient mammary tumors and this is not affected by genistein or resveratrol.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "78464",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.996755,
            13.037154
          ],
          [
            15.019721,
            13.050691
          ],
          [
            20.025179,
            15.982362
          ],
          [
            20.048092,
            15.99569
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "78",
        "dest": "464",
        "label": "Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression. -- Segregated responses of mammary gland development and vaginal opening to prepubertal genistein exposure in Bscl2(-/-) female mice with lipodystrophy.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "79466",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.87174,
            14.370921
          ],
          [
            15.899906,
            14.383327
          ],
          [
            21.583037,
            16.871687
          ],
          [
            21.611134,
            16.883912
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "79",
        "dest": "466",
        "label": "BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. -- A novel mechanism whereby BRCA1/1a/1b fine tunes the dynamic complex interplay between SUMO-dependent/independent activities of Ubc9 on E2-induced ERalpha activation/repression and degradation in breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "79467",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.871751,
            14.370922
          ],
          [
            15.905314,
            14.384491
          ],
          [
            23.22064,
            17.321067
          ],
          [
            23.254127,
            17.334408
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "79",
        "dest": "467",
        "label": "BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. -- UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "79468",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.871746,
            14.370921
          ],
          [
            15.902304,
            14.383599
          ],
          [
            22.224564,
            16.990347
          ],
          [
            22.255049,
            17.002833
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "79",
        "dest": "468",
        "label": "BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. -- Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "79469",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.871746,
            14.370922
          ],
          [
            15.902225,
            14.383792
          ],
          [
            22.208271,
            17.029762
          ],
          [
            22.238678,
            17.042435
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "79",
        "dest": "469",
        "label": "BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. -- BRCA1, hormone, and tissue-specific tumor suppression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "79470",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.871747,
            14.370922
          ],
          [
            15.902609,
            14.383742
          ],
          [
            22.287827,
            17.01954
          ],
          [
            22.318615,
            17.032164
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "79",
        "dest": "470",
        "label": "BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. -- Mechanism of BRCA1-mediated inhibition of progesterone receptor transcriptional activity.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "79471",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.871735,
            14.370921
          ],
          [
            15.897684,
            14.382803
          ],
          [
            20.945793,
            16.681839
          ],
          [
            20.971982,
            16.693698
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "79",
        "dest": "471",
        "label": "BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. -- TUSC4 functions as a tumor suppressor by regulating BRCA1 stability.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "82488",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.804769,
            15.512041
          ],
          [
            16.828067,
            15.525683
          ],
          [
            22.045563,
            18.556514
          ],
          [
            22.06881,
            18.569906
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "488",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- HIF-1\u03b1 overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "82489",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.804841,
            15.512041
          ],
          [
            16.843346,
            15.523709
          ],
          [
            24.245895,
            17.754084
          ],
          [
            24.28475,
            17.765721
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "489",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "82490",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.804779,
            15.512042
          ],
          [
            16.833399,
            15.527034
          ],
          [
            23.817791,
            19.150862
          ],
          [
            23.846353,
            19.16553
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "490",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "82491",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.804852,
            15.512041
          ],
          [
            16.842028,
            15.522689
          ],
          [
            23.303282,
            17.364652
          ],
          [
            23.340352,
            17.375169
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "491",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- Expression microarray identifies the unliganded glucocorticoid receptor as a regulator of gene expression in mammary epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "82492",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.804754,
            15.512041
          ],
          [
            16.827099,
            15.52821
          ],
          [
            22.720738,
            19.745077
          ],
          [
            22.74304,
            19.760841
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "492",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "82493",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.804794,
            15.512042
          ],
          [
            16.833727,
            15.524899
          ],
          [
            22.896728,
            18.200629
          ],
          [
            22.925592,
            18.213275
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "493",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- The unliganded glucocorticoid receptor positively regulates the tumor suppressor gene BRCA1 through GABP beta.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "82494",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.804754,
            15.512042
          ],
          [
            16.825458,
            15.527265
          ],
          [
            21.877777,
            19.206084
          ],
          [
            21.898746,
            19.221193
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "494",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- Glucocorticoid receptor repression mediated by BRCA1 inactivation in ovarian cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "84502",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.690517,
            15.058045
          ],
          [
            14.699202,
            15.076853
          ],
          [
            17.329975,
            20.689169
          ],
          [
            17.338646,
            20.70736
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "84",
        "dest": "502",
        "label": "Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis. -- Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "84503",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.690549,
            15.058044
          ],
          [
            14.708782,
            15.073618
          ],
          [
            19.367205,
            19.012732
          ],
          [
            19.385402,
            19.027951
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "84",
        "dest": "503",
        "label": "Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis. -- Regulation of glycogen synthase kinase-3 by thymosin beta-4 is associated with gastric cancer cell migration.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "84504",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.69053,
            15.058044
          ],
          [
            14.703034,
            15.075002
          ],
          [
            18.169042,
            19.718859
          ],
          [
            18.181523,
            19.735361
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "84",
        "dest": "504",
        "label": "Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis. -- Myc is required for \u03b2-catenin-mediated mammary stem cell amplification and tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "84505",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.690576,
            15.058044
          ],
          [
            14.715855,
            15.072557
          ],
          [
            20.705616,
            18.481596
          ],
          [
            20.730841,
            18.49582
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "84",
        "dest": "505",
        "label": "Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis. -- Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "84506",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.690506,
            15.058045
          ],
          [
            14.694561,
            15.076402
          ],
          [
            15.878762,
            20.36307
          ],
          [
            15.88281,
            20.38086
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "84",
        "dest": "506",
        "label": "Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis. -- Metastasis-associated protein 1 short form stimulates Wnt1 pathway in mammary epithelial and cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "947",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.270634,
            12.518583
          ],
          [
            -18.256268,
            12.537947
          ],
          [
            -13.822565,
            18.434782
          ],
          [
            -13.808223,
            18.453569
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "9",
        "dest": "47",
        "label": "The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer. -- Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "950",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.270678,
            12.518583
          ],
          [
            -18.27441,
            12.538052
          ],
          [
            -19.426196,
            18.466445
          ],
          [
            -19.429922,
            18.48533
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "9",
        "dest": "50",
        "label": "The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer. -- Epimorphin is a novel regulator of the progesterone receptor isoform-a.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "951",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.270689,
            12.518583
          ],
          [
            -18.278463,
            12.536541
          ],
          [
            -20.509031,
            17.63149
          ],
          [
            -20.516791,
            17.648992
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "9",
        "dest": "51",
        "label": "The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer. -- Estrogen and progesterone receptors have distinct roles in the establishment of the hyperplastic phenotype in PR-A transgenic mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "952",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.270711,
            12.518582
          ],
          [
            -18.287506,
            12.53741
          ],
          [
            -23.375028,
            18.168381
          ],
          [
            -23.391796,
            18.186675
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "9",
        "dest": "52",
        "label": "The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer. -- Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "953",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.270756,
            12.518488
          ],
          [
            -18.298979,
            12.503141
          ],
          [
            -25.186585,
            8.732996
          ],
          [
            -25.214751,
            8.717489
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "9",
        "dest": "53",
        "label": "The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer. -- Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1241",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.719705,
            2.944809
          ],
          [
            -25.728428,
            2.961965
          ],
          [
            -28.067046,
            7.546576
          ],
          [
            -28.075896,
            7.563852
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "41",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- High hopes for RANKL: will the mouse model live up to its promise?",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "1242",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.719774,
            2.944809
          ],
          [
            -25.744908,
            2.957767
          ],
          [
            -30.816222,
            5.568236
          ],
          [
            -30.841294,
            5.581118
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "42",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- A local basis for progesterone action during mammary tumorigenesis - no longer RANK and file.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "1244",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.719704,
            2.94481
          ],
          [
            -25.729948,
            2.96551
          ],
          [
            -29.01557,
            9.570472
          ],
          [
            -29.025798,
            9.590879
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "44",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1245",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.719715,
            2.944809
          ],
          [
            -25.733452,
            2.963796
          ],
          [
            -29.818736,
            8.586807
          ],
          [
            -29.83245,
            8.605574
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "45",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- RANKL inhibition: a promising novel strategy for breast cancer treatment.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1246",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.719734,
            2.94481
          ],
          [
            -25.740699,
            2.9636
          ],
          [
            -31.863848,
            8.429911
          ],
          [
            -31.884776,
            8.448491
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "46",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1269",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.719929,
            2.944809
          ],
          [
            -25.771137,
            2.954562
          ],
          [
            -33.698051,
            4.46318
          ],
          [
            -33.749335,
            4.472932
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "69",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1270",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.719711,
            2.944713
          ],
          [
            -25.733006,
            2.924118
          ],
          [
            -29.997426,
            -3.686732
          ],
          [
            -30.010701,
            -3.707279
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "70",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1376",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.862914,
            -1.547397
          ],
          [
            -17.869019,
            -1.568202
          ],
          [
            -19.827443,
            -8.215968
          ],
          [
            -19.833539,
            -8.236535
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "13",
        "dest": "76",
        "label": "Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. -- Hormone action in the mammary gland.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1585",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -19.346235,
            -1.291722
          ],
          [
            -19.3519,
            -1.310425
          ],
          [
            -21.006474,
            -6.758892
          ],
          [
            -21.012129,
            -6.777438
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "15",
        "dest": "85",
        "label": "The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse. -- Wnt4 is not sufficient to induce lobuloalveolar mammary development.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "49235",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.635551,
            -1.396914
          ],
          [
            -13.654528,
            -1.414212
          ],
          [
            -18.742354,
            -6.041962
          ],
          [
            -18.761296,
            -6.059137
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "235",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "49278",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.635572,
            -1.396913
          ],
          [
            -13.658074,
            -1.411366
          ],
          [
            -18.767439,
            -4.688893
          ],
          [
            -18.789892,
            -4.703271
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "278",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "49279",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.635509,
            -1.396913
          ],
          [
            -13.640196,
            -1.41702
          ],
          [
            -15.114687,
            -7.720608
          ],
          [
            -15.119366,
            -7.740506
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "279",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "49280",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.635534,
            -1.396913
          ],
          [
            -13.648767,
            -1.414317
          ],
          [
            -17.25567,
            -6.147639
          ],
          [
            -17.268879,
            -6.164915
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "280",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Conditional deletion of \u03b2-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "49281",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.63552,
            -1.396913
          ],
          [
            -13.64484,
            -1.41611
          ],
          [
            -16.467762,
            -7.213852
          ],
          [
            -16.477066,
            -7.232871
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "281",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- MMTV-Wnt1 and -DeltaN89beta-catenin induce canonical signaling in distinct progenitors and differentially activate Hedgehog signaling within mammary tumors.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "49282",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.635475,
            -1.396913
          ],
          [
            -13.626503,
            -1.416194
          ],
          [
            -10.90872,
            -7.239029
          ],
          [
            -10.899763,
            -7.25813
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "282",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Regulation of transgenes in three-dimensional cultures of primary mouse mammary cells demonstrates oncogene dependence and identifies cells that survive deinduction.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "49283",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.635486,
            -1.396914
          ],
          [
            -13.631164,
            -1.415855
          ],
          [
            -12.368701,
            -6.932934
          ],
          [
            -12.364386,
            -6.95171
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "283",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Corneal morphogenesis during development and diseases.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "49284",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.635498,
            -1.396914
          ],
          [
            -13.635935,
            -1.417968
          ],
          [
            -13.778774,
            -8.279641
          ],
          [
            -13.77921,
            -8.300449
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "284",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Targeted overexpression of EZH2 in the mammary gland disrupts ductal morphogenesis and causes epithelial hyperplasia.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "49285",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.635516,
            -1.396914
          ],
          [
            -13.642263,
            -1.414397
          ],
          [
            -15.481415,
            -6.169564
          ],
          [
            -15.48815,
            -6.18692
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "285",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- A bioluminescence reporter mouse that monitors expression of constitutively active \u03b2-catenin.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "49286",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.635499,
            -1.396913
          ],
          [
            -13.636309,
            -1.415828
          ],
          [
            -13.877069,
            -7.025161
          ],
          [
            -13.877877,
            -7.043908
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "286",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- In vivo and in vitro models for the therapeutic targeting of Wnt signaling using a Tet-O\u0394N89\u03b2-catenin system.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "23125",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.119686,
            -6.669881
          ],
          [
            0.124136,
            -6.693923
          ],
          [
            1.77884,
            -15.51781
          ],
          [
            1.783283,
            -15.541102
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "23",
        "dest": "125",
        "label": "A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells. -- ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "26156",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.407389,
            -5.018629
          ],
          [
            1.415707,
            -5.039768
          ],
          [
            4.192747,
            -12.041665
          ],
          [
            4.201053,
            -12.062387
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "26",
        "dest": "156",
        "label": "Progesterone receptor A-regulated gene expression in mammary organoid cultures. -- Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "26157",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.407407,
            -5.018629
          ],
          [
            1.420961,
            -5.035982
          ],
          [
            5.11526,
            -9.743356
          ],
          [
            5.128789,
            -9.760493
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "26",
        "dest": "157",
        "label": "Progesterone receptor A-regulated gene expression in mammary organoid cultures. -- A potential role of progestin-induced laminin-5/\u03b16-integrin signaling in the formation of side branches in the mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "104631",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.359619,
            -3.525129
          ],
          [
            1.369253,
            -3.542446
          ],
          [
            3.952037,
            -8.168376
          ],
          [
            3.961653,
            -8.185518
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "104",
        "dest": "631",
        "label": "Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements. -- The chromatin landscape of the casein gene locus.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "104632",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.359636,
            -3.525129
          ],
          [
            1.374225,
            -3.541369
          ],
          [
            4.988693,
            -7.5526
          ],
          [
            5.003254,
            -7.568697
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "104",
        "dest": "632",
        "label": "Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements. -- Lactogenic hormone stimulation and epigenetic control of L-amino acid oxidase expression in lactating mammary glands.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "104633",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.359659,
            -3.525128
          ],
          [
            1.379842,
            -3.539275
          ],
          [
            5.899472,
            -6.70031
          ],
          [
            5.91961,
            -6.714356
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "104",
        "dest": "633",
        "label": "Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements. -- A functional study of proximal goat \u03b2-casein promoter and intron 1 in immortalized goat mammary epithelial cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "105106",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.638276,
            -4.583094
          ],
          [
            4.666797,
            -4.595819
          ],
          [
            10.421662,
            -7.157881
          ],
          [
            10.450113,
            -7.170516
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "105",
        "dest": "106",
        "label": "Collaborative interaction of Oct-2 with Oct-1 in transactivation of lactogenic hormones-induced \u03b2-casein gene expression in mammary epithelial cells. -- Interactions of the ubiquitous octamer-binding transcription factor-1 with both the signal transducer and activator of transcription 5 and the glucocorticoid receptor mediate prolactin and glucocorticoid-induced \u03b2-casein gene expression in mammary epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "105110",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.638202,
            -4.583094
          ],
          [
            4.649931,
            -4.600379
          ],
          [
            7.847022,
            -9.290907
          ],
          [
            7.85873,
            -9.307989
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "105",
        "dest": "110",
        "label": "Collaborative interaction of Oct-2 with Oct-1 in transactivation of lactogenic hormones-induced \u03b2-casein gene expression in mammary epithelial cells. -- Oct-1 functions as a transactivator in the hormonal induction of beta-casein gene expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "105634",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.638198,
            -4.583094
          ],
          [
            4.65278,
            -4.60731
          ],
          [
            10.20161,
            -13.723599
          ],
          [
            10.216173,
            -13.747167
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "105",
        "dest": "634",
        "label": "Collaborative interaction of Oct-2 with Oct-1 in transactivation of lactogenic hormones-induced \u03b2-casein gene expression in mammary epithelial cells. -- Gap junctions mediate STAT5-independent \u03b2-casein expression in CID-9 mammary epithelial cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "107639",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.079421,
            0.072962
          ],
          [
            5.103106,
            0.058223
          ],
          [
            10.556942,
            -3.33358
          ],
          [
            10.580577,
            -3.348262
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "639",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107640",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.07949,
            0.072962
          ],
          [
            5.113728,
            0.061706
          ],
          [
            11.128472,
            -1.915182
          ],
          [
            11.162613,
            -1.926399
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "640",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Increased AKT or MEK1/2 activity influences progesterone receptor levels and localization in endometriosis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107641",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.07935,
            0.072962
          ],
          [
            5.081907,
            0.054972
          ],
          [
            5.802935,
            -5.011606
          ],
          [
            5.805488,
            -5.029495
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "641",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Mutational analysis of progesterone receptor functional domains in stable cell lines delineates sets of genes regulated by different mechanisms.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107642",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.079357,
            0.072961
          ],
          [
            5.084606,
            0.054092
          ],
          [
            6.61774,
            -5.448993
          ],
          [
            6.62298,
            -5.467745
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "642",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Forkhead transcription factor FOXO1 is a direct target of progestin to inhibit endometrial epithelial cell growth.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107643",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.079403,
            0.072962
          ],
          [
            5.099039,
            0.057086
          ],
          [
            9.963787,
            -3.873067
          ],
          [
            9.983384,
            -3.888874
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "643",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- The PRB-dependent FOXO1/IGFBP-1 axis is essential for progestin to inhibit endometrial epithelial growth.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107644",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.079368,
            0.072962
          ],
          [
            5.088631,
            0.054859
          ],
          [
            7.746695,
            -5.13263
          ],
          [
            7.756105,
            -5.150944
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "644",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107646",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.079386,
            0.07296
          ],
          [
            5.094474,
            0.055545
          ],
          [
            9.073989,
            -4.533168
          ],
          [
            9.089048,
            -4.550496
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "646",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Influence of AKT on progesterone action in endometrial diseases.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107647",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.079445,
            0.072962
          ],
          [
            5.10781,
            0.059672
          ],
          [
            11.051736,
            -2.724404
          ],
          [
            11.080034,
            -2.737648
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "647",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "111656",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.850541,
            2.492122
          ],
          [
            4.870475,
            2.476196
          ],
          [
            9.80901,
            -1.472225
          ],
          [
            9.828904,
            -1.488129
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "111",
        "dest": "656",
        "label": "A composite intronic element directs dynamic binding of the progesterone receptor and GATA-2. -- Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "111658",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.850576,
            2.492122
          ],
          [
            4.87783,
            2.478344
          ],
          [
            10.73972,
            -0.487088
          ],
          [
            10.766911,
            -0.500847
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "111",
        "dest": "658",
        "label": "A composite intronic element directs dynamic binding of the progesterone receptor and GATA-2. -- Progesterone induces expression of the prolactin receptor gene through cooperative action of Sp1 and C/EBP.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "114662",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.129509,
            2.344612
          ],
          [
            6.185576,
            2.337087
          ],
          [
            12.887363,
            1.437346
          ],
          [
            12.943402,
            1.429821
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "114",
        "dest": "662",
        "label": "Cytokine and progesterone receptor interplay in the regulation of MUC1 gene expression. -- Peroxisome proliferator-activated receptor gamma activation inhibits progesterone-stimulated human MUC1 expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "114663",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.129301,
            2.344612
          ],
          [
            6.164272,
            2.333109
          ],
          [
            12.51331,
            0.243718
          ],
          [
            12.548186,
            0.232237
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "114",
        "dest": "663",
        "label": "Cytokine and progesterone receptor interplay in the regulation of MUC1 gene expression. -- Expression of human MUC1 during early pregnancy in the human MUC1 transgenic mouse model.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "114664",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.129247,
            2.344612
          ],
          [
            6.157345,
            2.330113
          ],
          [
            12.627089,
            -1.010353
          ],
          [
            12.655521,
            -1.025034
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "114",
        "dest": "664",
        "label": "Cytokine and progesterone receptor interplay in the regulation of MUC1 gene expression. -- MUC1 protein expression in tumor cells regulates transcription of proinflammatory cytokines by forming a complex with nuclear factor-\u03baB p65 and binding to cytokine promoters: importance of extracellular domain.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "48123",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.578498,
            3.540384
          ],
          [
            6.630558,
            3.531469
          ],
          [
            14.021561,
            2.265022
          ],
          [
            14.073664,
            2.25609
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "48",
        "dest": "123",
        "label": "Strain-specific differences in the mechanisms of progesterone regulation of murine mammary gland development. -- Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "48277",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            6.581618,
            3.540419
          ],
          [
            6.760563,
            3.539761
          ],
          [
            13.951628,
            3.513317
          ],
          [
            14.16243,
            3.512542
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "48",
        "dest": "277",
        "label": "Strain-specific differences in the mechanisms of progesterone regulation of murine mammary gland development. -- Perfluorooctanoic acid effects on steroid hormone and growth factor levels mediate stimulation of peripubertal mammary gland development in C57BL/6 mice.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "35216",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.949312,
            3.930736
          ],
          [
            23.984869,
            3.918279
          ],
          [
            30.902546,
            1.491861
          ],
          [
            30.938012,
            1.479411
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "35",
        "dest": "216",
        "label": "Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary gland. -- In vivo expansion of the mammary stem/ progenitor cell population by xanthosine infusion.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "35217",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.94921,
            3.930736
          ],
          [
            23.962071,
            3.913094
          ],
          [
            27.467532,
            -0.903618
          ],
          [
            27.480369,
            -0.921266
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "35",
        "dest": "217",
        "label": "Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary gland. -- Immortalized, pre-malignant epithelial cell populations contain long-lived, label-retaining cells that asymmetrically divide and retain their template DNA.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "35218",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.949261,
            3.930737
          ],
          [
            23.974843,
            3.916773
          ],
          [
            29.626087,
            0.827824
          ],
          [
            29.651612,
            0.813861
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "35",
        "dest": "218",
        "label": "Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary gland. -- Putative rabbit conjunctival epithelial stem/progenitor cells preferentially reside in palpebral conjunctiva.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "35220",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.949195,
            3.930737
          ],
          [
            23.956551,
            3.913463
          ],
          [
            25.961705,
            -0.802736
          ],
          [
            25.969048,
            -0.820017
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "35",
        "dest": "220",
        "label": "Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary gland. -- Xanthosine administration does not affect the proportion of epithelial stem cells in bovine mammary tissue, but has a latent negative effect on cell proliferation.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "35221",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.949232,
            3.930735
          ],
          [
            23.968184,
            3.914397
          ],
          [
            28.663556,
            -0.139747
          ],
          [
            28.68247,
            -0.15609
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "35",
        "dest": "221",
        "label": "Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary gland. -- In vitro expansion of the mammary stem/progenitor cell population by xanthosine treatment.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "40247",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            23.690693,
            5.25678
          ],
          [
            23.731037,
            5.2668
          ],
          [
            30.191166,
            6.868885
          ],
          [
            30.231778,
            6.87894
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "40",
        "dest": "247",
        "label": "Growth hormone is secreted by normal breast epithelium upon progesterone stimulation and increases proliferation of stem/progenitor cells. -- Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "158910",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.293977,
            9.627476
          ],
          [
            26.316045,
            9.6126
          ],
          [
            31.544934,
            6.071471
          ],
          [
            31.566955,
            6.056499
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "158",
        "dest": "910",
        "label": "Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. -- Parity-induced decrease in systemic growth hormone alters mammary gland signaling: a potential role in pregnancy protection from breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "158911",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.294022,
            9.627476
          ],
          [
            26.32433,
            9.614987
          ],
          [
            32.364971,
            7.117486
          ],
          [
            32.395203,
            7.104948
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "158",
        "dest": "911",
        "label": "Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. -- Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "158912",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.294137,
            9.627476
          ],
          [
            26.338789,
            9.618383
          ],
          [
            32.877725,
            8.284267
          ],
          [
            32.922424,
            8.27513
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "158",
        "dest": "912",
        "label": "Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. -- Growth hormone potentiates 17\u03b2-estradiol-dependent breast cancer cell proliferation independently of IGF-I receptor signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "158913",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.296576,
            9.627477
          ],
          [
            26.447666,
            9.624835
          ],
          [
            32.96545,
            9.510884
          ],
          [
            33.116499,
            9.508242
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "158",
        "dest": "913",
        "label": "Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. -- Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "159914",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.161359,
            10.863057
          ],
          [
            26.235053,
            10.856222
          ],
          [
            34.38421,
            10.099475
          ],
          [
            34.457822,
            10.092631
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "159",
        "dest": "914",
        "label": "On the possible role of mammary-derived growth hormone in human breast cancer. -- Androgens and the breast.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "161919",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.746662,
            12.057577
          ],
          [
            25.798001,
            12.048753
          ],
          [
            33.118746,
            10.787672
          ],
          [
            33.169907,
            10.77884
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "161",
        "dest": "919",
        "label": "Critical questions in mammary gland development, lactational biology and breast cancer. -- Key signalling nodes in mammary gland development and cancer: Myc.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "161920",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.748606,
            12.057577
          ],
          [
            25.886739,
            12.054691
          ],
          [
            32.438476,
            11.917785
          ],
          [
            32.571424,
            11.915006
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "161",
        "dest": "920",
        "label": "Critical questions in mammary gland development, lactational biology and breast cancer. -- The role of activin in mammary gland development and oncogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "161921",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.746707,
            12.05767
          ],
          [
            25.796391,
            12.064961
          ],
          [
            31.670302,
            12.925591
          ],
          [
            31.719956,
            12.932854
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "161",
        "dest": "921",
        "label": "Critical questions in mammary gland development, lactational biology and breast cancer. -- TGF\u03b2 biology in breast: 15 years on.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "161922",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.746515,
            12.05767
          ],
          [
            25.776585,
            12.068853
          ],
          [
            31.235513,
            14.091007
          ],
          [
            31.265833,
            14.102191
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "161",
        "dest": "922",
        "label": "Critical questions in mammary gland development, lactational biology and breast cancer. -- On mammary gland growth factors: roles in normal development and in cancer.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "161923",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.747751,
            12.057577
          ],
          [
            25.868347,
            12.053477
          ],
          [
            33.964713,
            11.778097
          ],
          [
            34.085282,
            11.773994
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "161",
        "dest": "923",
        "label": "Critical questions in mammary gland development, lactational biology and breast cancer. -- Does cancer start in the womb? altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "161924",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.746752,
            12.05767
          ],
          [
            25.806189,
            12.065315
          ],
          [
            33.182118,
            13.012274
          ],
          [
            33.241543,
            13.019889
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "161",
        "dest": "924",
        "label": "Critical questions in mammary gland development, lactational biology and breast cancer. -- Lactation and neonatal nutrition: defining and refining the critical questions.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "4780",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.808195,
            18.45366
          ],
          [
            -13.811403,
            18.473678
          ],
          [
            -14.882348,
            25.01367
          ],
          [
            -14.885551,
            25.032765
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "47",
        "dest": "80",
        "label": "Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development. -- Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "47271",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.808226,
            18.45366
          ],
          [
            -13.822117,
            18.469963
          ],
          [
            -17.608077,
            22.851982
          ],
          [
            -17.622172,
            22.868054
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "47",
        "dest": "271",
        "label": "Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development. -- The estrogen-responsive Agr2 gene regulates mammary epithelial proliferation and facilitates lobuloalveolar development.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "47274",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.808199,
            18.453661
          ],
          [
            -13.812403,
            18.471676
          ],
          [
            -15.040307,
            23.646141
          ],
          [
            -15.044504,
            23.663508
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "47",
        "dest": "274",
        "label": "Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development. -- Impaired mouse mammary gland growth and development is mediated by melatonin and its MT1G protein-coupled receptor via repression of ER\u03b1, Akt1, and Stat5.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "47275",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.808282,
            18.453661
          ],
          [
            -13.835049,
            18.466806
          ],
          [
            -19.592174,
            21.269574
          ],
          [
            -19.618879,
            21.282458
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "47",
        "dest": "275",
        "label": "Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development. -- ER\u03b1 phosphorylation at Y537 by Src triggers E6-AP-ER\u03b1 binding, ER\u03b1 ubiquitylation, promoter occupancy, and target gene expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "47276",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.808413,
            18.45366
          ],
          [
            -13.851887,
            18.46236
          ],
          [
            -20.189897,
            19.72586
          ],
          [
            -20.233416,
            19.734502
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "47",
        "dest": "276",
        "label": "Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development. -- Canid progesterone receptors lack activation function 3 domain-dependent activity.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "50287",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -19.429977,
            18.485422
          ],
          [
            -19.44669,
            18.502307
          ],
          [
            -24.0796,
            23.114196
          ],
          [
            -24.096283,
            23.130541
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "50",
        "dest": "287",
        "label": "Epimorphin is a novel regulator of the progesterone receptor isoform-a. -- MiR-126-3p regulates progesterone receptors and involves development and lactation of mouse mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "50288",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -19.429962,
            18.485422
          ],
          [
            -19.441239,
            18.502521
          ],
          [
            -22.567318,
            23.171745
          ],
          [
            -22.578575,
            23.188289
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "50",
        "dest": "288",
        "label": "Epimorphin is a novel regulator of the progesterone receptor isoform-a. -- Uterine progesterone receptor expression, conceptus development, and ovarian function in pigs treated with RU 486 during early pregnancy.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "5156",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -20.516854,
            17.649085
          ],
          [
            -20.531689,
            17.665674
          ],
          [
            -24.444684,
            21.984297
          ],
          [
            -24.459491,
            22.000409
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "51",
        "dest": "56",
        "label": "Estrogen and progesterone receptors have distinct roles in the establishment of the hyperplastic phenotype in PR-A transgenic mice. -- Overexpression of progesterone receptor A isoform in mice leads to endometrial hyperproliferation, hyperplasia and atypia.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "52289",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.3919,
            18.186767
          ],
          [
            -23.413145,
            18.202727
          ],
          [
            -28.841131,
            22.229677
          ],
          [
            -28.862334,
            22.245197
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "289",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Estrogen-dependent and estrogen-independent mechanisms contribute to AIB1-mediated tumor formation.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "52290",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.391886,
            18.186766
          ],
          [
            -23.410569,
            18.204793
          ],
          [
            -28.867418,
            23.383673
          ],
          [
            -28.88607,
            23.401058
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "290",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "52291",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.391866,
            18.186765
          ],
          [
            -23.402628,
            18.203737
          ],
          [
            -26.437161,
            22.918946
          ],
          [
            -26.447903,
            22.935371
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "291",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "52292",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.391983,
            18.186765
          ],
          [
            -23.424781,
            18.196926
          ],
          [
            -29.00583,
            19.917213
          ],
          [
            -29.038872,
            19.927344
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "292",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERalpha transgenic mice.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "52293",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.391925,
            18.186765
          ],
          [
            -23.417594,
            18.199969
          ],
          [
            -29.087983,
            21.091105
          ],
          [
            -29.11394,
            21.104218
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "293",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "52294",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.392167,
            18.186765
          ],
          [
            -23.445961,
            18.19411
          ],
          [
            -30.070985,
            19.096244
          ],
          [
            -30.124763,
            19.103547
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "294",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "52295",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.392948,
            18.186675
          ],
          [
            -23.491436,
            18.182684
          ],
          [
            -30.110488,
            17.91424
          ],
          [
            -30.208956,
            17.910243
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "295",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Comparison of increased aromatase versus ER\u03b1 in the generation of mammary hyperplasia and cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "53296",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.214805,
            8.717488
          ],
          [
            -25.201916,
            8.735845
          ],
          [
            -21.43762,
            14.051189
          ],
          [
            -21.424754,
            14.069174
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "296",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "53297",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.214828,
            8.717489
          ],
          [
            -25.210944,
            8.73731
          ],
          [
            -24.012088,
            14.793241
          ],
          [
            -24.00821,
            14.812597
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "297",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Cyclin D1 determines estrogen signaling in the mammary gland in vivo.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "53298",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.214817,
            8.717489
          ],
          [
            -25.206918,
            8.735767
          ],
          [
            -22.940371,
            13.936483
          ],
          [
            -22.932485,
            13.954399
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "298",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "53299",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.21485,
            8.717489
          ],
          [
            -25.219727,
            8.737184
          ],
          [
            -26.724867,
            14.755164
          ],
          [
            -26.729736,
            14.774401
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "299",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "53300",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.214839,
            8.717488
          ],
          [
            -25.215308,
            8.736188
          ],
          [
            -25.354825,
            14.2474
          ],
          [
            -25.355294,
            14.265705
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "300",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Estrogen regulation of thrombospondin-1 in human breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "53301",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.214862,
            8.717489
          ],
          [
            -25.224969,
            8.737488
          ],
          [
            -28.404487,
            14.963568
          ],
          [
            -28.414578,
            14.983083
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "301",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "53303",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.21489,
            8.717489
          ],
          [
            -25.232605,
            8.733654
          ],
          [
            -29.758765,
            12.837545
          ],
          [
            -29.776445,
            12.853459
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "303",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Differential expression of decorin, EGFR and cyclin D1 during mammary gland carcinogenesis in TA2 mice with spontaneous breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "53304",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.214918,
            8.717488
          ],
          [
            -25.239042,
            8.731817
          ],
          [
            -30.716572,
            11.969247
          ],
          [
            -30.740643,
            11.983396
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "304",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- A model of spontaneous mouse mammary tumor for human estrogen receptor- and progesterone receptor-negative breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "53305",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.214861,
            8.717488
          ],
          [
            -25.22357,
            8.735476
          ],
          [
            -27.722719,
            13.854416
          ],
          [
            -27.731414,
            13.872054
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "305",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Cyclin D1 regulates hepatic estrogen and androgen metabolism.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "53306",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.214906,
            8.717489
          ],
          [
            -25.238832,
            8.734237
          ],
          [
            -31.549465,
            13.121406
          ],
          [
            -31.573345,
            13.137877
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "306",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "53307",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.214874,
            8.717489
          ],
          [
            -25.228817,
            8.735845
          ],
          [
            -29.229572,
            13.958512
          ],
          [
            -29.24349,
            13.976502
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "307",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Examining the role of cyclin D1 in breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "44249",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -29.025855,
            9.590973
          ],
          [
            -29.038831,
            9.609145
          ],
          [
            -32.828743,
            14.867464
          ],
          [
            -32.841696,
            14.885246
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "44",
        "dest": "249",
        "label": "Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. -- Progestin effects on cell proliferation pathways in the postmenopausal mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "44251",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -29.025872,
            9.590975
          ],
          [
            -29.04295,
            9.607444
          ],
          [
            -33.406439,
            13.785322
          ],
          [
            -33.423484,
            13.801511
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "44",
        "dest": "251",
        "label": "Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. -- Cell adhesion signaling regulates RANK expression in osteoclast precursors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "44252",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -29.025887,
            9.590974
          ],
          [
            -29.048435,
            9.607188
          ],
          [
            -34.901129,
            13.785898
          ],
          [
            -34.923634,
            13.801837
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "44",
        "dest": "252",
        "label": "Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. -- Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "44253",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -29.025909,
            9.590973
          ],
          [
            -29.051435,
            9.604688
          ],
          [
            -34.690178,
            12.619222
          ],
          [
            -34.71599,
            12.632946
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "44",
        "dest": "253",
        "label": "Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. -- Receptor activator of NF-\u03baB ligand promotes proliferation of a putative mammary stem cell unique to the lactating epithelium.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "45257",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -29.832551,
            8.605668
          ],
          [
            -29.856104,
            8.622456
          ],
          [
            -36.170662,
            13.09183
          ],
          [
            -36.194172,
            13.108337
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "45",
        "dest": "257",
        "label": "RANKL inhibition: a promising novel strategy for breast cancer treatment. -- Central control of fever and female body temperature by RANKL/RANK.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "45258",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -29.83257,
            8.605669
          ],
          [
            -29.856971,
            8.619281
          ],
          [
            -35.105282,
            11.534492
          ],
          [
            -35.129627,
            11.547951
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "45",
        "dest": "258",
        "label": "RANKL inhibition: a promising novel strategy for breast cancer treatment. -- RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "4661",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -31.884881,
            8.448586
          ],
          [
            -31.904854,
            8.466913
          ],
          [
            -37.738262,
            13.774923
          ],
          [
            -37.758201,
            13.792888
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "61",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Role of the RANK/RANKL pathway in breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "46259",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -31.884895,
            8.448586
          ],
          [
            -31.906886,
            8.464814
          ],
          [
            -37.525755,
            12.585207
          ],
          [
            -37.547703,
            12.601188
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "259",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- [The role of RANK/RANKL/osteoprotegerin (OPG) triad in cancer-induced bone diseases: physiopathology and clinical implications].",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "46260",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -31.88549,
            8.448585
          ],
          [
            -31.970508,
            8.454612
          ],
          [
            -40.244194,
            9.040688
          ],
          [
            -40.329282,
            9.046711
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "260",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Receptor activator of nuclear factor-kappa B ligand (RANKL) stimulates bone-associated tumors through functional RANK expressed on bone-associated cancer cells?",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "46261",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -31.884918,
            8.448491
          ],
          [
            -31.910614,
            8.434638
          ],
          [
            -37.587235,
            5.363648
          ],
          [
            -37.612874,
            5.349736
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "261",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- RANK signalling in bone lesions with osteoclast-like giant cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "46262",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -31.884974,
            8.448492
          ],
          [
            -31.919674,
            8.437177
          ],
          [
            -38.219217,
            6.37796
          ],
          [
            -38.254206,
            6.366498
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "262",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "46264",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -31.885042,
            8.448586
          ],
          [
            -31.93245,
            8.459099
          ],
          [
            -39.916365,
            10.225207
          ],
          [
            -39.963876,
            10.235689
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "264",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "46265",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -31.884959,
            8.448586
          ],
          [
            -31.919459,
            8.461412
          ],
          [
            -38.880784,
            11.039608
          ],
          [
            -38.9152,
            11.052303
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "265",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Clinical development of anti-RANKL therapies for treatment and prevention of bone metastasis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "46266",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -31.884891,
            8.44849
          ],
          [
            -31.904252,
            8.432902
          ],
          [
            -36.559684,
            4.66939
          ],
          [
            -36.579006,
            4.653717
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "266",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- The RANKL/RANK system as a therapeutic target for bone invasion by oral             squamous cell carcinoma (Review).",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "46267",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -31.884918,
            8.448586
          ],
          [
            -31.910409,
            8.462338
          ],
          [
            -37.466429,
            11.446672
          ],
          [
            -37.491862,
            11.460267
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "267",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Targeting RANKL in breast cancer: bone metastasis and beyond.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "46268",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -31.885037,
            8.448586
          ],
          [
            -31.92719,
            8.458183
          ],
          [
            -38.391139,
            9.926799
          ],
          [
            -38.433156,
            9.936325
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "268",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Multifunctional properties of RANKL/RANK in cell differentiation, proliferation and metastasis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "46269",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -31.885173,
            8.448492
          ],
          [
            -31.9401,
            8.440966
          ],
          [
            -38.578845,
            7.530377
          ],
          [
            -38.633748,
            7.522838
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "269",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Manipulation of receptor oligomerization as a strategy to inhibit signaling by TNF superfamily members.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "46270",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -31.885829,
            8.448585
          ],
          [
            -31.979479,
            8.452971
          ],
          [
            -38.625917,
            8.764068
          ],
          [
            -38.719621,
            8.768452
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "270",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Inhibitory effect of metformin on bone metastasis of cancer via OPG/RANKL/RANK system.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "69336",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -33.750095,
            4.472932
          ],
          [
            -33.823578,
            4.466108
          ],
          [
            -41.813363,
            3.723839
          ],
          [
            -41.886754,
            3.717018
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "336",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- Activation of NF-\u03baB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "69395",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -33.750384,
            4.473026
          ],
          [
            -33.838739,
            4.478245
          ],
          [
            -41.228028,
            4.914575
          ],
          [
            -41.316422,
            4.919793
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "395",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "69396",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -33.749697,
            4.472932
          ],
          [
            -33.781215,
            4.459571
          ],
          [
            -40.472058,
            1.618965
          ],
          [
            -40.503503,
            1.605601
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "396",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "69397",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -33.749641,
            4.472931
          ],
          [
            -33.769463,
            4.455916
          ],
          [
            -38.997536,
            -0.041174
          ],
          [
            -39.01732,
            -0.058208
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "397",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "69398",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -33.749622,
            4.472931
          ],
          [
            -33.76373,
            4.454589
          ],
          [
            -37.811884,
            -0.819878
          ],
          [
            -37.825968,
            -0.838242
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "398",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "69399",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -33.749651,
            4.472932
          ],
          [
            -33.769689,
            4.458569
          ],
          [
            -38.319487,
            1.191837
          ],
          [
            -38.339481,
            1.177465
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "399",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- RANKL Signaling and ErbB Receptors in Breast Carcinogenesis.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "69400",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -33.749664,
            4.472931
          ],
          [
            -33.776106,
            4.456687
          ],
          [
            -40.427938,
            0.36243
          ],
          [
            -40.454328,
            0.346169
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "400",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4\u207a T cells to T-regulatory cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "7077",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.010882,
            -3.707375
          ],
          [
            -30.0512,
            -3.72013
          ],
          [
            -38.186325,
            -6.289134
          ],
          [
            -38.226544,
            -6.301807
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "77",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "70358",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.010846,
            -3.707375
          ],
          [
            -30.041149,
            -3.719933
          ],
          [
            -36.080722,
            -6.218449
          ],
          [
            -36.11095,
            -6.230928
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "358",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- RAR\u03b11 control of mammary gland ductal morphogenesis and wnt1-tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70401",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.010802,
            -3.707375
          ],
          [
            -30.032885,
            -3.722349
          ],
          [
            -35.265591,
            -7.260958
          ],
          [
            -35.287629,
            -7.275811
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "401",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- ERBB2 overexpression suppresses stress-induced autophagy and renders ERBB2-induced mammary tumorigenesis independent of monoallelic Becn1 loss.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70402",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.010736,
            -3.707376
          ],
          [
            -30.012596,
            -3.728789
          ],
          [
            -30.633661,
            -10.830724
          ],
          [
            -30.635519,
            -10.851768
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "402",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "70403",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.010777,
            -3.707375
          ],
          [
            -30.026592,
            -3.724139
          ],
          [
            -34.197995,
            -8.130396
          ],
          [
            -34.21378,
            -8.146995
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "403",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Transcriptomic profiling of progesterone in the male fathead minnow (Pimephales promelas) testis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70404",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.010749,
            -3.707375
          ],
          [
            -30.01769,
            -3.725722
          ],
          [
            -32.044673,
            -9.060214
          ],
          [
            -32.051725,
            -9.078662
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "404",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- IGF1R inhibition in mammary epithelia promotes canonical Wnt signaling and Wnt1-driven tumors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70405",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.010762,
            -3.707376
          ],
          [
            -30.022768,
            -3.726348
          ],
          [
            -33.529125,
            -9.241487
          ],
          [
            -33.541109,
            -9.26022
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "405",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "70406",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.010716,
            -3.707376
          ],
          [
            -30.004051,
            -3.728091
          ],
          [
            -27.866225,
            -10.332762
          ],
          [
            -27.85957,
            -10.353152
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "406",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Regulation of the MIR155 host gene in physiological and pathological processes.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "70407",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.010705,
            -3.707375
          ],
          [
            -29.999422,
            -3.727123
          ],
          [
            -26.450307,
            -9.905361
          ],
          [
            -26.438827,
            -9.925199
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "407",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Hypoxia-inducible factor 1\u03b1 promotes primary tumor growth and tumor-initiating cell activity in breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "70408",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.010726,
            -3.707375
          ],
          [
            -30.008416,
            -3.727177
          ],
          [
            -29.281614,
            -9.922237
          ],
          [
            -29.279263,
            -9.942127
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "408",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "70409",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.010736,
            -3.707375
          ],
          [
            -30.012664,
            -3.7262
          ],
          [
            -30.585783,
            -9.298123
          ],
          [
            -30.587707,
            -9.316708
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "409",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Dietary suppression of the mammary CD29(hi)CD24(+) epithelial subpopulation and its cytokine/chemokine transcriptional signatures modifies mammary tumor risk in MMTV-Wnt1 transgenic mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70410",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.010715,
            -3.707375
          ],
          [
            -30.00438,
            -3.725885
          ],
          [
            -28.154095,
            -9.10759
          ],
          [
            -28.147771,
            -9.125874
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "410",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70411",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.0107,
            -3.707376
          ],
          [
            -29.999,
            -3.725184
          ],
          [
            -26.755703,
            -8.641783
          ],
          [
            -26.744024,
            -8.659395
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "411",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70412",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.01068,
            -3.707376
          ],
          [
            -29.993164,
            -3.723886
          ],
          [
            -25.517796,
            -7.928295
          ],
          [
            -25.500314,
            -7.944649
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "412",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Pea3 transcription factors and wnt1-induced mouse mammary neoplasia.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "76446",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -19.833559,
            -8.23663
          ],
          [
            -19.836117,
            -8.255311
          ],
          [
            -20.596752,
            -13.76322
          ],
          [
            -20.599305,
            -13.781523
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "76",
        "dest": "446",
        "label": "Hormone action in the mammary gland. -- Remodeling of the lymphatic vasculature during mouse mammary gland morphogenesis is mediated via epithelial-derived lymphangiogenic stimuli.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "27963",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -15.119396,
            -7.740601
          ],
          [
            -15.126891,
            -7.760019
          ],
          [
            -17.440287,
            -13.699721
          ],
          [
            -17.44777,
            -13.718729
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "279",
        "dest": "63",
        "label": "Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution. -- Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "125113",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.783301,
            -15.541197
          ],
          [
            1.78688,
            -15.56054
          ],
          [
            2.891349,
            -21.434047
          ],
          [
            2.894922,
            -21.452705
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "125",
        "dest": "113",
        "label": "ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells. -- The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "125126",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.783248,
            -15.541197
          ],
          [
            1.768707,
            -15.556995
          ],
          [
            -1.833928,
            -19.430607
          ],
          [
            -1.84844,
            -19.446039
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "125",
        "dest": "126",
        "label": "ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells. -- Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "125727",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.783297,
            -15.541196
          ],
          [
            1.785595,
            -15.565495
          ],
          [
            2.680839,
            -24.776554
          ],
          [
            2.683134,
            -24.799423
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "125",
        "dest": "727",
        "label": "ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells. -- Differential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "156898",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.201053,
            -12.06248
          ],
          [
            4.193939,
            -12.080467
          ],
          [
            2.116114,
            -17.275278
          ],
          [
            2.108886,
            -17.293124
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "898",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Extensive expression of craniofacial related homeobox genes in canine mammary sarcomas.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156899",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.201055,
            -12.06248
          ],
          [
            4.194609,
            -12.080664
          ],
          [
            2.311877,
            -17.331779
          ],
          [
            2.305442,
            -17.349499
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "899",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Distinct gene-expression profiles characterize mammary tumors developed in transgenic mice expressing constitutively active and C-terminally truncated variants of STAT5.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156900",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.201064,
            -12.062481
          ],
          [
            4.198116,
            -12.080991
          ],
          [
            3.337024,
            -17.425044
          ],
          [
            3.334081,
            -17.443073
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "900",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Transcriptomic profile of two canine mammary cancer cell lines with different proliferative and anti-apoptotic potential.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156901",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.201094,
            -12.06248
          ],
          [
            4.2098,
            -12.080013
          ],
          [
            6.664653,
            -16.972553
          ],
          [
            6.673344,
            -16.989671
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "901",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Evaluation of molecular markers in canine mammary tumors: correlation with histological grading.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156902",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.201073,
            -12.062481
          ],
          [
            4.201623,
            -12.080894
          ],
          [
            4.362441,
            -17.397473
          ],
          [
            4.362991,
            -17.41541
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "902",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Comparison of cellular and tissue transcriptional profiles in canine mammary tumor.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156903",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.201088,
            -12.062481
          ],
          [
            4.207412,
            -12.080201
          ],
          [
            5.990557,
            -17.02448
          ],
          [
            5.996869,
            -17.041776
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "903",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Transcriptomic \"portraits\" of canine mammary cancer cell lines with various phenotypes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156904",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.201084,
            -12.062481
          ],
          [
            4.20658,
            -12.082268
          ],
          [
            5.935311,
            -18.222938
          ],
          [
            5.940797,
            -18.242126
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "904",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "156905",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.201106,
            -12.06248
          ],
          [
            4.214938,
            -12.080892
          ],
          [
            8.328331,
            -17.492465
          ],
          [
            8.342139,
            -17.510391
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "905",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Histological and immunohistochemical identification of atypical ductal mammary hyperplasia as a preneoplastic marker in dogs.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156906",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.2011,
            -12.06248
          ],
          [
            4.212103,
            -12.080387
          ],
          [
            7.369171,
            -17.162513
          ],
          [
            7.380155,
            -17.179978
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "906",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Gene expression pattern in canine mammary osteosarcoma.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "157907",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.128839,
            -9.760588
          ],
          [
            5.133636,
            -9.779111
          ],
          [
            6.534652,
            -15.13735
          ],
          [
            6.53944,
            -15.155462
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "157",
        "dest": "907",
        "label": "A potential role of progestin-induced laminin-5/\u03b16-integrin signaling in the formation of side branches in the mammary gland. -- Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "157908",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.128853,
            -9.760588
          ],
          [
            5.138908,
            -9.778468
          ],
          [
            7.974322,
            -14.775678
          ],
          [
            7.98436,
            -14.793188
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "157",
        "dest": "908",
        "label": "A potential role of progestin-induced laminin-5/\u03b16-integrin signaling in the formation of side branches in the mammary gland. -- Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "157909",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.128871,
            -9.760588
          ],
          [
            5.144508,
            -9.777282
          ],
          [
            9.26886,
            -14.147231
          ],
          [
            9.284467,
            -14.163626
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "157",
        "dest": "909",
        "label": "A potential role of progestin-induced laminin-5/\u03b16-integrin signaling in the formation of side branches in the mammary gland. -- Progesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "106635",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.450212,
            -7.170611
          ],
          [
            10.447352,
            -7.18936
          ],
          [
            9.612255,
            -12.623999
          ],
          [
            9.609401,
            -12.642406
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "106",
        "dest": "635",
        "label": "Interactions of the ubiquitous octamer-binding transcription factor-1 with both the signal transducer and activator of transcription 5 and the glucocorticoid receptor mediate prolactin and glucocorticoid-induced \u03b2-casein gene expression in mammary epithelial cells. -- Bovine prolactin elevates hTF expression directed by a tissue-specific goat \u03b2-casein promoter through prolactin receptor-mediated STAT5a activation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "106636",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.45023,
            -7.170611
          ],
          [
            10.45451,
            -7.189357
          ],
          [
            11.704429,
            -12.623402
          ],
          [
            11.708701,
            -12.641808
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "106",
        "dest": "636",
        "label": "Interactions of the ubiquitous octamer-binding transcription factor-1 with both the signal transducer and activator of transcription 5 and the glucocorticoid receptor mediate prolactin and glucocorticoid-induced \u03b2-casein gene expression in mammary epithelial cells. -- Regulatory roles of Oct proteins in the mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "106637",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.450259,
            -7.170611
          ],
          [
            10.464415,
            -7.187813
          ],
          [
            14.259654,
            -11.771161
          ],
          [
            14.273784,
            -11.788102
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "106",
        "dest": "637",
        "label": "Interactions of the ubiquitous octamer-binding transcription factor-1 with both the signal transducer and activator of transcription 5 and the glucocorticoid receptor mediate prolactin and glucocorticoid-induced \u03b2-casein gene expression in mammary epithelial cells. -- Dynamic trafficking of STAT5 depends on an unconventional nuclear localization signal.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "106638",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.450243,
            -7.170611
          ],
          [
            10.458783,
            -7.187675
          ],
          [
            12.748168,
            -11.734548
          ],
          [
            12.756831,
            -11.751631
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "106",
        "dest": "638",
        "label": "Interactions of the ubiquitous octamer-binding transcription factor-1 with both the signal transducer and activator of transcription 5 and the glucocorticoid receptor mediate prolactin and glucocorticoid-induced \u03b2-casein gene expression in mammary epithelial cells. -- Buffalo alpha S1-casein gene 5'-flanking region and its interspecies comparison.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "634108",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.216457,
            -13.74726
          ],
          [
            10.267721,
            -13.756489
          ],
          [
            18.019047,
            -15.147723
          ],
          [
            18.070378,
            -15.156907
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "634",
        "dest": "108",
        "label": "Gap junctions mediate STAT5-independent \u03b2-casein expression in CID-9 mammary epithelial cells. -- Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "634109",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.216265,
            -13.74726
          ],
          [
            10.235483,
            -13.761338
          ],
          [
            14.599013,
            -16.934338
          ],
          [
            14.618188,
            -16.948172
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "634",
        "dest": "109",
        "label": "Gap junctions mediate STAT5-independent \u03b2-casein expression in CID-9 mammary epithelial cells. -- Analysis of mammary specific gene locus regulation in differentiated cells derived by somatic cell fusion.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "123715",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.073979,
            2.255995
          ],
          [
            14.087654,
            2.238762
          ],
          [
            17.815109,
            -2.460757
          ],
          [
            17.828759,
            -2.477956
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "123",
        "dest": "715",
        "label": "Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary gland. -- Amphiregulin mediates progesterone-induced mammary ductal development during puberty.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "123716",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.073997,
            2.255994
          ],
          [
            14.093771,
            2.238906
          ],
          [
            19.309168,
            -2.270376
          ],
          [
            19.328904,
            -2.28743
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "123",
        "dest": "716",
        "label": "Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary gland. -- Pubertal exposure to high fat diet causes mouse strain-dependent alterations in mammary gland development and estrogen responsiveness.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "80199",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -14.885507,
            25.032852
          ],
          [
            -14.868132,
            25.047967
          ],
          [
            -10.428827,
            28.846581
          ],
          [
            -10.411486,
            28.861164
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "199",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "80272",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -14.885603,
            25.032852
          ],
          [
            -14.901303,
            25.048225
          ],
          [
            -19.042376,
            29.033335
          ],
          [
            -19.058046,
            29.048142
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "272",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- A role for KAI1 in promotion of cell proliferation and mammary gland hyperplasia by the gp78 ubiquitin ligase.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "80273",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -14.886,
            25.032851
          ],
          [
            -14.948456,
            25.038904
          ],
          [
            -21.605409,
            25.682365
          ],
          [
            -21.667979,
            25.688397
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "273",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- E3 ubiquitin protein ligase, E6-associated protein (E6-AP) regulates PI3K-Akt signaling and prostate cell growth.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "80472",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -14.885675,
            25.032764
          ],
          [
            -14.916459,
            25.021329
          ],
          [
            -20.977695,
            22.749493
          ],
          [
            -21.008401,
            22.737884
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "472",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- Downregulation of Smurf2, a tumor-suppressive ubiquitin ligase, in triple-negative breast cancers: involvement of the RB-microRNA axis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "80473",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -14.885622,
            25.032851
          ],
          [
            -14.907036,
            25.047251
          ],
          [
            -20.293986,
            28.614318
          ],
          [
            -20.315357,
            28.628243
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "473",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "80474",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -14.88627,
            25.032765
          ],
          [
            -14.969764,
            25.027739
          ],
          [
            -22.362806,
            24.581907
          ],
          [
            -22.446282,
            24.576864
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "474",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "80475",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -14.885547,
            25.032851
          ],
          [
            -14.881227,
            25.049709
          ],
          [
            -13.619678,
            29.869825
          ],
          [
            -13.615366,
            29.885932
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "475",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- The effects of diet induced obesity on breast cancer associated pathways in mice deficient in SFRP1.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "80476",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -14.885572,
            25.032852
          ],
          [
            -14.891359,
            25.05072
          ],
          [
            -16.677537,
            30.434885
          ],
          [
            -16.683315,
            30.451861
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "476",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- UBE3A/E6-AP regulates cell proliferation by promoting proteasomal degradation of p27.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "80477",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -14.885532,
            25.032851
          ],
          [
            -14.875974,
            25.049152
          ],
          [
            -12.180675,
            29.55562
          ],
          [
            -12.171134,
            29.571242
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "477",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- Latent transforming growth factor binding protein 4 (LTBP4) is downregulated in mouse and human DCIS and mammary carcinomas.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "80478",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -14.885585,
            25.032852
          ],
          [
            -14.895656,
            25.049286
          ],
          [
            -17.735629,
            29.591843
          ],
          [
            -17.745682,
            29.607587
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "478",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- Post-transcriptional mechanisms contribute to the suppression of the ErbB3 negative regulator protein Nrdp1 in mammary tumors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "56315",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.459546,
            22.0005
          ],
          [
            -24.464664,
            22.017945
          ],
          [
            -25.959266,
            27.015993
          ],
          [
            -25.964374,
            27.032727
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "56",
        "dest": "315",
        "label": "Overexpression of progesterone receptor A isoform in mice leads to endometrial hyperproliferation, hyperplasia and atypia. -- Progesterone receptor expression and proliferative activity in uterine tumours of pet rabbits.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "56316",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.459562,
            22.0005
          ],
          [
            -24.470148,
            22.017129
          ],
          [
            -27.455368,
            26.624335
          ],
          [
            -27.465935,
            26.64034
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "56",
        "dest": "316",
        "label": "Overexpression of progesterone receptor A isoform in mice leads to endometrial hyperproliferation, hyperplasia and atypia. -- Analysis of PTEN, estrogen receptor \u03b1 and progesterone receptor expression in endometrial hyperplasia using tissue microarray.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "56317",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.459583,
            22.000501
          ],
          [
            -24.476501,
            22.016232
          ],
          [
            -28.79897,
            25.9756
          ],
          [
            -28.815854,
            25.990823
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "56",
        "dest": "317",
        "label": "Overexpression of progesterone receptor A isoform in mice leads to endometrial hyperproliferation, hyperplasia and atypia. -- Endometrial progesterone resistance and PCOS.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "290146",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -28.886179,
            23.401147
          ],
          [
            -28.908933,
            23.417156
          ],
          [
            -35.215913,
            27.776809
          ],
          [
            -35.23901,
            27.792476
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "290",
        "dest": "146",
        "label": "Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer. -- Epithelial progesterone receptor exhibits pleiotropic roles in uterine development and function.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "290150",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -28.886396,
            23.401147
          ],
          [
            -28.9384,
            23.40926
          ],
          [
            -36.257646,
            24.546123
          ],
          [
            -36.30969,
            24.55417
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "290",
        "dest": "150",
        "label": "Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer. -- Epithelial-stromal interaction and progesterone receptors in the mouse uterus.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "295117",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.210167,
            17.910153
          ],
          [
            -30.23823,
            17.89756
          ],
          [
            -36.11903,
            15.239922
          ],
          [
            -36.147027,
            15.227184
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "295",
        "dest": "117",
        "label": "Comparison of increased aromatase versus ER\u03b1 in the generation of mammary hyperplasia and cancer. -- Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "6173",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -37.758579,
            13.79298
          ],
          [
            -37.818683,
            13.801433
          ],
          [
            -46.133949,
            14.96792
          ],
          [
            -46.194089,
            14.976334
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "61",
        "dest": "73",
        "label": "Role of the RANK/RANKL pathway in breast cancer. -- RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "61340",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -37.758346,
            13.79298
          ],
          [
            -37.785115,
            13.80618
          ],
          [
            -43.542739,
            16.626843
          ],
          [
            -43.569446,
            16.639836
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "61",
        "dest": "340",
        "label": "Role of the RANK/RANKL pathway in breast cancer. -- The anti-tumor effect of RANKL inhibition in malignant solid tumors - A systematic review.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "61341",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -37.758653,
            13.79298
          ],
          [
            -37.818066,
            13.799821
          ],
          [
            -44.455753,
            14.562787
          ],
          [
            -44.515104,
            14.569598
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "61",
        "dest": "341",
        "label": "Role of the RANK/RANKL pathway in breast cancer. -- Denosumab for the treatment of bone metastases in advanced breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "61342",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -37.75843,
            13.792888
          ],
          [
            -37.795175,
            13.78335
          ],
          [
            -43.51035,
            12.29536
          ],
          [
            -43.547325,
            12.285704
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "61",
        "dest": "342",
        "label": "Role of the RANK/RANKL pathway in breast cancer. -- The RANK Pathway in Advanced Breast Cancer: Does Src Play a Role?",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "61343",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -37.758411,
            13.79298
          ],
          [
            -37.792866,
            13.802948
          ],
          [
            -43.420677,
            15.425265
          ],
          [
            -43.45537,
            15.435228
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "61",
        "dest": "343",
        "label": "Role of the RANK/RANKL pathway in breast cancer. -- Progestogens and risk of breast cancer: a link between bone and breast?",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "61344",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -37.758972,
            13.792888
          ],
          [
            -37.838514,
            13.787799
          ],
          [
            -44.482204,
            13.362352
          ],
          [
            -44.561679,
            13.357258
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "61",
        "dest": "344",
        "label": "Role of the RANK/RANKL pathway in breast cancer. -- Therapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal Complications.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "25957",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -37.548647,
            12.601189
          ],
          [
            -37.641189,
            12.596324
          ],
          [
            -45.009422,
            12.208674
          ],
          [
            -45.101949,
            12.203803
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "259",
        "dest": "57",
        "label": "[The role of RANK/RANKL/osteoprotegerin (OPG) triad in cancer-induced bone diseases: physiopathology and clinical implications]. -- RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "26058",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -40.330046,
            9.046805
          ],
          [
            -40.36168,
            9.061387
          ],
          [
            -47.645881,
            12.401554
          ],
          [
            -47.677447,
            12.415945
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "260",
        "dest": "58",
        "label": "Receptor activator of nuclear factor-kappa B ligand (RANKL) stimulates bone-associated tumors through functional RANK expressed on bone-associated cancer cells? -- Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "33671",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.887334,
            3.717018
          ],
          [
            -41.911831,
            3.733473
          ],
          [
            -48.270484,
            7.990415
          ],
          [
            -48.294934,
            8.006714
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "336",
        "dest": "71",
        "label": "Activation of NF-\u03baB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines. -- Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "33672",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.887367,
            3.716923
          ],
          [
            -41.915113,
            3.704395
          ],
          [
            -47.444833,
            1.204709
          ],
          [
            -47.472846,
            1.192036
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "336",
        "dest": "72",
        "label": "Activation of NF-\u03baB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines. -- Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "33674",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.887367,
            3.716923
          ],
          [
            -41.919803,
            3.702272
          ],
          [
            -49.495258,
            0.275913
          ],
          [
            -49.528086,
            0.261054
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "336",
        "dest": "74",
        "label": "Activation of NF-\u03baB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines. -- RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "77308",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.226897,
            -6.301807
          ],
          [
            -38.273343,
            -6.291012
          ],
          [
            -46.260565,
            -4.431689
          ],
          [
            -46.306878,
            -4.420893
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "308",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "77447",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.226933,
            -6.301901
          ],
          [
            -38.274993,
            -6.311364
          ],
          [
            -45.541862,
            -7.739963
          ],
          [
            -45.589985,
            -7.749408
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "447",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in mice.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "77448",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.2268,
            -6.301902
          ],
          [
            -38.257373,
            -6.315498
          ],
          [
            -44.832986,
            -9.230251
          ],
          [
            -44.863488,
            -9.243721
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "448",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Altered proliferation and differentiation properties of primary mammary epithelial cells from BRCA1 mutation carriers.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "77449",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.226845,
            -6.301902
          ],
          [
            -38.266861,
            -6.314485
          ],
          [
            -46.242343,
            -8.815495
          ],
          [
            -46.28226,
            -8.827974
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "449",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Tip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "77450",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.226746,
            -6.301903
          ],
          [
            -38.245499,
            -6.319193
          ],
          [
            -43.27306,
            -10.92879
          ],
          [
            -43.291778,
            -10.945838
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "450",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockade.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "77451",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.226729,
            -6.301903
          ],
          [
            -38.239691,
            -6.319438
          ],
          [
            -41.772595,
            -11.071483
          ],
          [
            -41.785533,
            -11.088764
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "451",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "77452",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.226715,
            -6.301902
          ],
          [
            -38.235535,
            -6.320995
          ],
          [
            -40.907015,
            -12.062557
          ],
          [
            -40.91582,
            -12.081311
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "452",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "77453",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.226769,
            -6.301902
          ],
          [
            -38.252525,
            -6.318044
          ],
          [
            -44.833143,
            -10.422434
          ],
          [
            -44.858849,
            -10.438375
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "453",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "77454",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.226705,
            -6.301903
          ],
          [
            -38.231006,
            -6.320698
          ],
          [
            -39.487456,
            -11.772904
          ],
          [
            -39.49175,
            -11.791384
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "454",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "77455",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.226883,
            -6.301806
          ],
          [
            -38.267164,
            -6.291641
          ],
          [
            -44.717447,
            -4.66158
          ],
          [
            -44.757604,
            -4.651419
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "455",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Embryonic mammary signature subsets are activated in Brca1-/- and basal-like breast cancers.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "77456",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.227605,
            -6.301901
          ],
          [
            -38.316761,
            -6.306499
          ],
          [
            -44.919757,
            -6.646923
          ],
          [
            -45.008921,
            -6.651518
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "456",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- New insights into lineage restriction of mammary gland epithelium using parity-identified mammary epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "77457",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.226685,
            -6.301903
          ],
          [
            -38.223305,
            -6.321869
          ],
          [
            -37.179968,
            -12.435654
          ],
          [
            -37.176593,
            -12.455238
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "457",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "77458",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.227179,
            -6.301807
          ],
          [
            -38.296254,
            -6.295118
          ],
          [
            -45.707363,
            -5.576973
          ],
          [
            -45.776569,
            -5.570262
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "458",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "63355",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.447872,
            -13.718821
          ],
          [
            -17.474112,
            -13.733302
          ],
          [
            -23.691579,
            -17.13725
          ],
          [
            -23.718143,
            -17.15167
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "355",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Mammary adipocytes bioactivate 25-hydroxyvitamin D\u2083 and signal via vitamin D\u2083 receptor, modulating mammary epithelial cell growth.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "63356",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.447917,
            -13.718821
          ],
          [
            -17.480386,
            -13.730484
          ],
          [
            -23.649861,
            -15.935506
          ],
          [
            -23.682244,
            -15.94702
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "356",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Age-related changes in the epithelial and stromal compartments of the mammary gland in normocalcemic mice lacking the vitamin D3 receptor.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "63357",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.447848,
            -13.718822
          ],
          [
            -17.467264,
            -13.734278
          ],
          [
            -22.277606,
            -17.529341
          ],
          [
            -22.296983,
            -17.544481
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "357",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Adipose-specific Vdr deletion alters body fat and enhances mammary epithelial density.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "63359",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.44783,
            -13.718822
          ],
          [
            -17.463255,
            -13.736498
          ],
          [
            -21.813023,
            -18.661826
          ],
          [
            -21.828421,
            -18.679033
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "359",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Genomic vitamin D signaling in breast cancer: Insights from animal models and human cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "63360",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.447816,
            -13.718822
          ],
          [
            -17.457946,
            -13.736348
          ],
          [
            -20.314577,
            -18.620522
          ],
          [
            -20.32469,
            -18.637588
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "360",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Adipocyte derived paracrine mediators of mammary ductal morphogenesis controlled by retinoic acid receptors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "63361",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.447793,
            -13.718821
          ],
          [
            -17.44965,
            -13.737099
          ],
          [
            -18.001785,
            -19.102196
          ],
          [
            -18.003638,
            -19.119945
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "361",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Transgenic Expression of Vitamin D Receptor in Gut Epithelial Cells Ameliorates Spontaneous Colitis Caused by Interleukin-10 Deficiency.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "63362",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.447804,
            -13.718822
          ],
          [
            -17.45407,
            -13.737938
          ],
          [
            -19.38795,
            -19.553928
          ],
          [
            -19.394206,
            -19.57244
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "362",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Critical roles of intestinal epithelial vitamin D receptor signaling in controlling gut mucosal inflammation.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "63364",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.447761,
            -13.718822
          ],
          [
            -17.436662,
            -13.737236
          ],
          [
            -14.13592,
            -19.141769
          ],
          [
            -14.12484,
            -19.159646
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "364",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Morphogenesis of the developing mammary gland: stage-dependent impact of adipocytes.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "63365",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.447772,
            -13.718822
          ],
          [
            -17.441508,
            -13.736822
          ],
          [
            -15.611689,
            -18.928305
          ],
          [
            -15.605434,
            -18.945802
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "365",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Active plasma kallikrein localizes to mast cells and regulates epithelial cell apoptosis, adipocyte differentiation, and stromal remodeling during mammary gland involution.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "63366",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.447745,
            -13.718823
          ],
          [
            -17.432541,
            -13.735522
          ],
          [
            -13.422168,
            -18.09455
          ],
          [
            -13.406992,
            -18.110859
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "366",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Mammary ductal growth is impaired in mice lacking leptin-dependent signal transducer and activator of transcription 3 signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "63367",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -17.447783,
            -13.718821
          ],
          [
            -17.445522,
            -13.738134
          ],
          [
            -16.734031,
            -19.724199
          ],
          [
            -16.731773,
            -19.742882
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "367",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Physiological functions of Vitamin D in adipose tissue.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "117677",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -36.147186,
            15.227186
          ],
          [
            -36.16529,
            15.241885
          ],
          [
            -40.39367,
            18.645085
          ],
          [
            -40.411735,
            18.659489
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "117",
        "dest": "677",
        "label": "Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis. -- 7,8-Dihydroxycoumarin exerts antitumor potential on DMBA-induced mammary carcinogenesis by inhibiting ER\u03b1, PR, EGFR, and IGF1R: involvement of MAPK1/2-JNK1/2-Akt pathway.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "117678",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -36.147221,
            15.227185
          ],
          [
            -36.173943,
            15.240494
          ],
          [
            -41.921393,
            18.082291
          ],
          [
            -41.948054,
            18.095372
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "117",
        "dest": "678",
        "label": "Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis. -- Androgen resistance in female mice increases susceptibility to DMBA-induced mammary tumors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "73426",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.194427,
            14.976428
          ],
          [
            -46.198184,
            14.994802
          ],
          [
            -47.29542,
            20.286882
          ],
          [
            -47.29917,
            20.304692
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "426",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- Out-RANKing BRCA1 in Mutation Carriers.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "73427",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.194509,
            14.976426
          ],
          [
            -46.2237,
            14.991027
          ],
          [
            -53.242389,
            18.47064
          ],
          [
            -53.271948,
            18.485156
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "427",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "73428",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.19444,
            14.976426
          ],
          [
            -46.20329,
            14.993997
          ],
          [
            -48.742655,
            19.970233
          ],
          [
            -48.751489,
            19.987297
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "428",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-\u03baB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "73429",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.194508,
            14.976426
          ],
          [
            -46.220686,
            14.989782
          ],
          [
            -51.926331,
            17.87961
          ],
          [
            -51.95245,
            17.892737
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "429",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- Can we prevent BRCA1-associated breast cancer by RANKL inhibition?",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "73430",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.194671,
            14.976426
          ],
          [
            -46.241989,
            14.984996
          ],
          [
            -52.901666,
            16.187582
          ],
          [
            -52.94902,
            16.196108
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "430",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- Persistent Activation of NF-\u03baB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "73431",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.194458,
            14.976427
          ],
          [
            -46.208856,
            14.993142
          ],
          [
            -50.069002,
            19.423118
          ],
          [
            -50.083374,
            19.439406
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "431",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "73432",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.194556,
            14.976426
          ],
          [
            -46.230394,
            14.988323
          ],
          [
            -53.202778,
            17.289675
          ],
          [
            -53.238525,
            17.301403
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "432",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- RANKL/RANK control Brca1 mutation- .",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "73433",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.194477,
            14.976426
          ],
          [
            -46.213034,
            14.990691
          ],
          [
            -50.547276,
            18.2946
          ],
          [
            -50.565794,
            18.30859
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "433",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- NF-\u03baB at the Crossroads of Normal Mammary Gland Biology and the Pathogenesis and Prevention of <i>BRCA1</i>-Mutated Breast Cancer.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "57255",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -45.102899,
            12.203803
          ],
          [
            -45.125806,
            12.218654
          ],
          [
            -50.633681,
            15.763239
          ],
          [
            -50.656541,
            15.777832
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "255",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- RANK as a therapeutic target in cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "57256",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -45.10291,
            12.203803
          ],
          [
            -45.129717,
            12.218828
          ],
          [
            -51.671473,
            15.857568
          ],
          [
            -51.698623,
            15.872545
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "256",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- RANKL/RANK-beyond bones.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "57263",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -45.102963,
            12.203803
          ],
          [
            -45.139407,
            12.21636
          ],
          [
            -52.492793,
            14.737008
          ],
          [
            -52.529147,
            14.749401
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "263",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- RANKL/RANK - from bone physiology to breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "57318",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -45.103102,
            12.203803
          ],
          [
            -45.156417,
            12.212834
          ],
          [
            -52.964026,
            13.531931
          ],
          [
            -53.017398,
            13.540924
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "318",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- The effect of sex hormones on bone metabolism of the otic capsule--an overview.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "57319",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -45.102931,
            12.203803
          ],
          [
            -45.131083,
            12.216418
          ],
          [
            -50.882493,
            14.780363
          ],
          [
            -50.910576,
            14.792813
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "319",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- Physiology and pathophysiology of the RANKL/RANK system.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "57320",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -45.103018,
            12.203803
          ],
          [
            -45.142684,
            12.213516
          ],
          [
            -51.371864,
            13.734274
          ],
          [
            -51.411404,
            13.743897
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "320",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- Polymorphisms in the RANK/RANKL genes and their effect on bone specific prognosis in breast cancer patients.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "57321",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -45.103255,
            12.203803
          ],
          [
            -45.162791,
            12.21028
          ],
          [
            -51.426406,
            12.890835
          ],
          [
            -51.485852,
            12.897285
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "321",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- The RANKL-RANK Story.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58322",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.677632,
            12.415944
          ],
          [
            -47.704269,
            12.400639
          ],
          [
            -54.204729,
            8.641148
          ],
          [
            -54.231311,
            8.625685
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "322",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "58323",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.67767,
            12.415945
          ],
          [
            -47.711523,
            12.402826
          ],
          [
            -54.897855,
            9.604073
          ],
          [
            -54.931629,
            9.59086
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "323",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "58324",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.677987,
            12.416038
          ],
          [
            -47.738082,
            12.422391
          ],
          [
            -53.979517,
            13.081391
          ],
          [
            -54.039706,
            13.087738
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "324",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Expression of receptor activator of nuclear factor kappa-B as a poor prognostic marker in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58325",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.677626,
            12.415945
          ],
          [
            -47.700228,
            12.40201
          ],
          [
            -52.761718,
            9.264252
          ],
          [
            -52.784269,
            9.250201
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "325",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Examination of the mechanisms of osteolysis in patients with metastatic breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58326",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.678116,
            12.416038
          ],
          [
            -47.755069,
            12.422311
          ],
          [
            -55.646291,
            13.064804
          ],
          [
            -55.723352,
            13.07107
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "326",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- RANKL/RANK/MMP-1 molecular triad contributes to the metastatic phenotype of breast and prostate cancer cells in vitro.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "58327",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.6782,
            12.415945
          ],
          [
            -47.762246,
            12.409976
          ],
          [
            -55.965936,
            11.826677
          ],
          [
            -56.050054,
            11.820689
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "327",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "58328",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.678491,
            12.415945
          ],
          [
            -47.771111,
            12.411393
          ],
          [
            -54.670225,
            12.072056
          ],
          [
            -54.762755,
            12.067502
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "328",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58329",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.678252,
            12.416038
          ],
          [
            -47.754991,
            12.4211
          ],
          [
            -54.099145,
            12.839248
          ],
          [
            -54.175811,
            12.844297
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "329",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58330",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.677703,
            12.415945
          ],
          [
            -47.712644,
            12.40527
          ],
          [
            -53.721433,
            10.563403
          ],
          [
            -53.756274,
            10.552689
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "330",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Effects of icariin on the regulation of the OPG-RANKL-RANK system are mediated through the MAPK pathways in IL-1\u03b2-stimulated human SW1353 chondrosarcoma cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58331",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.6776,
            12.415945
          ],
          [
            -47.694288,
            12.40071
          ],
          [
            -51.828363,
            8.601606
          ],
          [
            -51.845521,
            8.585747
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "331",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58332",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.67765,
            12.415945
          ],
          [
            -47.704899,
            12.403297
          ],
          [
            -53.271988,
            9.807162
          ],
          [
            -53.299171,
            9.794431
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "332",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58333",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.677927,
            12.415945
          ],
          [
            -47.734797,
            12.40898
          ],
          [
            -54.199495,
            11.615967
          ],
          [
            -54.25651,
            11.608963
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "333",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Osteoprotegerin in bone metastases: mathematical solution to the puzzle.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58334",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.677772,
            12.415945
          ],
          [
            -47.725178,
            12.406037
          ],
          [
            -55.353712,
            10.806983
          ],
          [
            -55.401203,
            10.797
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "334",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "58335",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.677612,
            12.415944
          ],
          [
            -47.698038,
            12.400314
          ],
          [
            -52.758516,
            8.502059
          ],
          [
            -52.778901,
            8.486262
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "335",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "71250",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -48.296061,
            8.006714
          ],
          [
            -48.390866,
            8.002507
          ],
          [
            -54.836143,
            7.716404
          ],
          [
            -54.930945,
            7.712195
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "250",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "71254",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -48.295339,
            8.006714
          ],
          [
            -48.353675,
            7.998511
          ],
          [
            -56.032442,
            6.917385
          ],
          [
            -56.090791,
            6.90916
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "254",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "71413",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -48.295089,
            8.006713
          ],
          [
            -48.322059,
            7.991328
          ],
          [
            -54.806652,
            4.277788
          ],
          [
            -54.833565,
            4.262327
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "413",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-\u03baB ligand\u2013induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+\u2013nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "71414",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -48.295457,
            8.006808
          ],
          [
            -48.359575,
            8.013461
          ],
          [
            -55.216219,
            8.72428
          ],
          [
            -55.280248,
            8.730911
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "414",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- Met receptor acts uniquely for survival and morphogenesis of EGFR-dependent normal mammary epithelial and cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "71415",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -48.295209,
            8.006714
          ],
          [
            -48.336819,
            7.997131
          ],
          [
            -54.717374,
            6.525134
          ],
          [
            -54.759043,
            6.515506
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "415",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- RANK-Fc inhibits malignancy via inhibiting ERK activation and evoking caspase-3-mediated anoikis in human osteosarcoma cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "71416",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -48.295111,
            8.006714
          ],
          [
            -48.323808,
            7.993849
          ],
          [
            -54.186686,
            5.357954
          ],
          [
            -54.215313,
            5.345051
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "416",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- Survival and differentiation of mammary epithelial cells in mammary gland development require nuclear retention of Id2 due to RANK signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "71417",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -48.295073,
            8.006714
          ],
          [
            -48.316541,
            7.991865
          ],
          [
            -53.403412,
            4.460336
          ],
          [
            -53.424835,
            4.445418
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "417",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- Impact of RANK signalling on survival and chemotherapy response in osteosarcoma.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72418",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.472989,
            1.192036
          ],
          [
            -47.486225,
            1.209537
          ],
          [
            -51.093768,
            5.970144
          ],
          [
            -51.106979,
            5.987522
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "418",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- AMR-Me inhibits PI3K/Akt signaling in hormone-dependent MCF-7 breast cancer cells and inactivates NF-\u03baB in hormone-independent MDA-MB-231 cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72419",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.473098,
            1.192035
          ],
          [
            -47.507961,
            1.203609
          ],
          [
            -53.837241,
            3.303452
          ],
          [
            -53.872009,
            3.314977
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "419",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- Receptor activator of nuclear factor-\u03baB ligand (RANKL) protects against hepatic ischemia/reperfusion injury in mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72420",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.473012,
            1.192036
          ],
          [
            -47.49234,
            1.208211
          ],
          [
            -52.280824,
            5.20925
          ],
          [
            -52.300113,
            5.225329
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "420",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- Suppression of inflammatory cascade is implicated in methyl amooranin-mediated inhibition of experimental mammary carcinogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72421",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.473276,
            1.192035
          ],
          [
            -47.527294,
            1.199968
          ],
          [
            -54.334622,
            2.19946
          ],
          [
            -54.388634,
            2.207388
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "421",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-\u03baB-mediated epithelial-mesenchymal transition.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72422",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.473447,
            1.19194
          ],
          [
            -47.540152,
            1.18555
          ],
          [
            -54.337516,
            0.53434
          ],
          [
            -54.404309,
            0.527941
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "422",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- Garcinol, an acetyltransferase inhibitor, suppresses proliferation of breast cancer cell line MCF-7 promoted by 17\u03b2-estradiol.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72423",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.47296,
            1.192036
          ],
          [
            -47.475651,
            1.211012
          ],
          [
            -48.261723,
            6.739008
          ],
          [
            -48.26441,
            6.757824
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "423",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- Butein, a tetrahydroxychalcone, suppresses cancer-induced osteoclastogenesis through inhibition of receptor activator of nuclear factor-kappaB ligand signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72424",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.472974,
            1.192036
          ],
          [
            -47.480868,
            1.210512
          ],
          [
            -49.745997,
            6.499466
          ],
          [
            -49.753877,
            6.517796
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "424",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- Knockdown of receptor for advanced glycation end products attenuate 17\u03b1-ethinyl-estradiol dependent proliferation and survival of MCF-7 breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72425",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.476492,
            1.192035
          ],
          [
            -47.637562,
            1.194186
          ],
          [
            -53.244069,
            1.269056
          ],
          [
            -53.405209,
            1.271208
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "425",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- Benzoquinone from Fusarium pigment inhibits the proliferation of estrogen receptor-positive MCF-7 cells through the NF-\u03baB pathway via estrogen receptor signaling.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "7481",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -49.528374,
            0.260958
          ],
          [
            -49.573804,
            0.249018
          ],
          [
            -58.156139,
            -2.006127
          ],
          [
            -58.201449,
            -2.018028
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "81",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "74434",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -49.528667,
            0.260958
          ],
          [
            -49.600342,
            0.2538
          ],
          [
            -57.776625,
            -0.562734
          ],
          [
            -57.848486,
            -0.56991
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "434",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "74435",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -49.52839,
            0.260958
          ],
          [
            -49.571822,
            0.250505
          ],
          [
            -56.774385,
            -1.482834
          ],
          [
            -56.817906,
            -1.493305
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "435",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "74436",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -49.528311,
            0.260957
          ],
          [
            -49.562434,
            0.24691
          ],
          [
            -56.999873,
            -2.813612
          ],
          [
            -57.033919,
            -2.82761
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "436",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "74437",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -49.52825,
            0.260957
          ],
          [
            -49.549394,
            0.24329
          ],
          [
            -55.410496,
            -4.648914
          ],
          [
            -55.431602,
            -4.666492
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "437",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "74438",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -49.528273,
            0.260958
          ],
          [
            -49.55376,
            0.245725
          ],
          [
            -55.682113,
            -3.41482
          ],
          [
            -55.707548,
            -3.429994
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "438",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "74439",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -49.528233,
            0.260957
          ],
          [
            -49.544044,
            0.241811
          ],
          [
            -54.246017,
            -5.443835
          ],
          [
            -54.261801,
            -5.462862
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "439",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "74440",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -49.528251,
            0.260955
          ],
          [
            -49.547259,
            0.244517
          ],
          [
            -54.256436,
            -3.825191
          ],
          [
            -54.275406,
            -3.84156
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "440",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- Cigarette smoke induces epithelial to mesenchymal transition and increases the metastatic ability of breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "74441",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -49.529119,
            0.261053
          ],
          [
            -49.62909,
            0.266155
          ],
          [
            -57.789575,
            0.682663
          ],
          [
            -57.88956,
            0.687766
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "441",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "74442",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -49.528227,
            0.260958
          ],
          [
            -49.540911,
            0.243513
          ],
          [
            -53.056754,
            -4.587227
          ],
          [
            -53.06963,
            -4.604878
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "442",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30883",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.307175,
            -4.420894
          ],
          [
            -46.337116,
            -4.43599
          ],
          [
            -53.431641,
            -8.002004
          ],
          [
            -53.461519,
            -8.016966
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "308",
        "dest": "83",
        "label": "c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer. -- BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact?",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "44992",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.282771,
            -8.828067
          ],
          [
            -46.345275,
            -8.836197
          ],
          [
            -54.506694,
            -9.896048
          ],
          [
            -54.569209,
            -9.904153
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "449",
        "dest": "92",
        "label": "Tip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors. -- Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1687",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -53.369053,
            -13.327328
          ],
          [
            -53.339426,
            -13.313537
          ],
          [
            -46.794667,
            -10.249236
          ],
          [
            -46.765107,
            -10.235322
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "16",
        "dest": "87",
        "label": "Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells. -- Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "87100",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.764857,
            -10.235322
          ],
          [
            -46.72488,
            -10.248
          ],
          [
            -38.658591,
            -12.794996
          ],
          [
            -38.618713,
            -12.807529
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "87",
        "dest": "100",
        "label": "Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. -- Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "8786",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.765085,
            -10.235321
          ],
          [
            -46.792745,
            -10.251838
          ],
          [
            -54.088335,
            -14.574121
          ],
          [
            -54.115942,
            -14.590334
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "87",
        "dest": "86",
        "label": "Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. -- Lineage specific methylation of the Elf5 promoter in mammary epithelial cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "8788",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.765151,
            -10.235321
          ],
          [
            -46.802958,
            -10.247649
          ],
          [
            -54.247123,
            -12.664838
          ],
          [
            -54.284834,
            -12.677029
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "87",
        "dest": "88",
        "label": "Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. -- Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "87352",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.765061,
            -10.235322
          ],
          [
            -46.78451,
            -10.252254
          ],
          [
            -51.998655,
            -14.754274
          ],
          [
            -52.018386,
            -14.771153
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "87",
        "dest": "352",
        "label": "Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. -- PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "87514",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.76508,
            -10.235322
          ],
          [
            -46.787614,
            -10.249852
          ],
          [
            -51.976329,
            -13.575979
          ],
          [
            -51.998814,
            -13.5903
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "87",
        "dest": "514",
        "label": "Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. -- Polycomb group gene Ezh2 regulates mammary gland morphogenesis and maintains the luminal progenitor pool.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "100402",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.618374,
            -12.807529
          ],
          [
            -38.573684,
            -12.796621
          ],
          [
            -30.680276,
            -10.862818
          ],
          [
            -30.635712,
            -10.851862
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "402",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "100234",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.619922,
            -12.807529
          ],
          [
            -38.745379,
            -12.803266
          ],
          [
            -47.523899,
            -12.504749
          ],
          [
            -47.649403,
            -12.500479
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "234",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Small molecule antagonists of the Wnt/\u03b2-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "10062",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.618642,
            -12.807623
          ],
          [
            -38.64305,
            -12.822519
          ],
          [
            -44.426691,
            -16.325329
          ],
          [
            -44.451049,
            -16.339959
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "62",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "100101",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.618944,
            -12.807622
          ],
          [
            -38.680444,
            -12.815144
          ],
          [
            -46.197574,
            -13.732783
          ],
          [
            -46.259054,
            -13.740274
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "101",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "100219",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.618816,
            -12.807529
          ],
          [
            -38.665589,
            -12.798929
          ],
          [
            -45.220298,
            -11.590829
          ],
          [
            -45.267106,
            -11.582182
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "219",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Differential gene expression in nuclear label-retaining cells in the developing mouse mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "100389",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.619932,
            -12.80753
          ],
          [
            -38.735145,
            -12.803646
          ],
          [
            -46.08777,
            -12.555697
          ],
          [
            -46.202984,
            -12.55181
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "389",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Pregnancy in the mature adult mouse does not alter the proportion of mammary epithelial stem/progenitor cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "100513",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.6186,
            -12.807623
          ],
          [
            -38.63234,
            -12.825783
          ],
          [
            -42.574988,
            -17.97587
          ],
          [
            -42.588705,
            -17.993554
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "513",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Chromatin effector Pygo2 mediates Wnt-notch crosstalk to suppress luminal/alveolar potential of mammary stem and basal cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "100608",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.618616,
            -12.807623
          ],
          [
            -38.636312,
            -12.823622
          ],
          [
            -43.157645,
            -16.874854
          ],
          [
            -43.175306,
            -16.890524
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "608",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Wnt and Notch pathways have interrelated opposing roles on prostate progenitor cell proliferation and differentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "100609",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.618554,
            -12.807623
          ],
          [
            -38.614332,
            -12.827082
          ],
          [
            -37.311376,
            -18.750897
          ],
          [
            -37.307161,
            -18.769763
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "609",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "100610",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.618586,
            -12.807622
          ],
          [
            -38.627121,
            -12.825437
          ],
          [
            -41.075901,
            -17.878924
          ],
          [
            -41.084421,
            -17.896281
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "610",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Nitric oxide production upregulates Wnt/\u03b2-catenin signaling by inhibiting Dickkopf-1.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "100611",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.618575,
            -12.807623
          ],
          [
            -38.623163,
            -12.827064
          ],
          [
            -40.038919,
            -18.745291
          ],
          [
            -40.043499,
            -18.76414
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "611",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "100612",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.618565,
            -12.807622
          ],
          [
            -38.618737,
            -12.826046
          ],
          [
            -38.669896,
            -18.237721
          ],
          [
            -38.670067,
            -18.255636
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "612",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Tissue-dependent consequences of Apc inactivation on proliferation and differentiation of ciliated cell progenitors via Wnt and notch signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "100613",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.618543,
            -12.807623
          ],
          [
            -38.61033,
            -12.825512
          ],
          [
            -36.253724,
            -17.89977
          ],
          [
            -36.245526,
            -17.917197
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "613",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- How pregnancy at early age protects against breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "100614",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -38.618587,
            -12.807623
          ],
          [
            -38.628132,
            -12.827522
          ],
          [
            -41.630953,
            -18.997688
          ],
          [
            -41.640484,
            -19.016952
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "614",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Wnt signaling in triple negative breast cancer is associated with metastasis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "86363",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.116152,
            -14.590427
          ],
          [
            -54.149365,
            -14.602204
          ],
          [
            -60.460177,
            -16.828047
          ],
          [
            -60.493302,
            -16.839665
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "86",
        "dest": "363",
        "label": "Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. -- Molecular aspects of adipoepithelial transdifferentiation in mouse mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "86507",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.116109,
            -14.590427
          ],
          [
            -54.141536,
            -14.604023
          ],
          [
            -59.683626,
            -17.546028
          ],
          [
            -59.708996,
            -17.559392
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "86",
        "dest": "507",
        "label": "Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. -- The Pea3 Ets transcription factor regulates differentiation of multipotent progenitor cells during mammary gland development.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "86509",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.116121,
            -14.590426
          ],
          [
            -54.146395,
            -14.604442
          ],
          [
            -61.020275,
            -17.762223
          ],
          [
            -61.050482,
            -17.775986
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "86",
        "dest": "509",
        "label": "Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. -- DNA methylation restricts spontaneous multi-lineage differentiation of mesenchymal progenitor cells, but is stable during growth factor-induced terminal differentiation.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "86510",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.116066,
            -14.590428
          ],
          [
            -54.131021,
            -14.606182
          ],
          [
            -57.835914,
            -18.471809
          ],
          [
            -57.850838,
            -18.487218
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "86",
        "dest": "510",
        "label": "Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. -- Transcription factor regulatory networks in mammary epithelial development and tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "86511",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.116084,
            -14.590427
          ],
          [
            -54.136925,
            -14.605918
          ],
          [
            -59.300219,
            -18.407635
          ],
          [
            -59.321018,
            -18.422793
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "86",
        "dest": "511",
        "label": "Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. -- Elf5 regulation in the trophectoderm.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "86512",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.11609,
            -14.590426
          ],
          [
            -54.140266,
            -14.60662
          ],
          [
            -60.517042,
            -18.83267
          ],
          [
            -60.541173,
            -18.848477
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "86",
        "dest": "512",
        "label": "Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. -- The Hippo transducer TAZ interacts with the SWI/SNF complex to regulate breast epithelial lineage commitment.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "8889",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.285062,
            -12.677122
          ],
          [
            -54.313969,
            -12.693194
          ],
          [
            -61.817282,
            -16.82724
          ],
          [
            -61.846134,
            -16.842978
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "88",
        "dest": "89",
        "label": "Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. -- Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "88516",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.285046,
            -12.677121
          ],
          [
            -54.306188,
            -12.691488
          ],
          [
            -59.243925,
            -16.022962
          ],
          [
            -59.265323,
            -16.037287
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "88",
        "dest": "516",
        "label": "Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. -- Insulin, a key regulator of hormone responsive milk protein synthesis during lactogenesis in murine mammary explants.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "88517",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.28506,
            -12.677122
          ],
          [
            -54.310292,
            -12.69159
          ],
          [
            -60.120187,
            -15.999212
          ],
          [
            -60.145364,
            -16.013435
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "88",
        "dest": "517",
        "label": "Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. -- The STAT5-regulated miR-193b locus restrains mammary stem and progenitor cell activity and alveolar differentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "88518",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.28507,
            -12.677122
          ],
          [
            -54.311373,
            -12.690634
          ],
          [
            -59.968696,
            -15.578858
          ],
          [
            -59.994939,
            -15.592167
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "88",
        "dest": "518",
        "label": "Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. -- Protein tyrosine phosphatase 1B restrains mammary alveologenesis and secretory differentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "88519",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.285043,
            -12.677124
          ],
          [
            -54.305796,
            -12.692714
          ],
          [
            -59.295874,
            -16.411132
          ],
          [
            -59.316584,
            -16.426429
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "88",
        "dest": "519",
        "label": "Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. -- Stat5 assumes distinct functions in mammary gland development and mammary tumor formation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "88521",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.285032,
            -12.677122
          ],
          [
            -54.301341,
            -12.691339
          ],
          [
            -58.004485,
            -15.897176
          ],
          [
            -58.020758,
            -15.911159
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "88",
        "dest": "521",
        "label": "Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. -- Elf5, hormones and cell fate.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "62228",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -44.451118,
            -16.340051
          ],
          [
            -44.448281,
            -16.358263
          ],
          [
            -43.604496,
            -21.691772
          ],
          [
            -43.601664,
            -21.709376
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "228",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- Deregulated ephrin-B2 signaling in mammary epithelial cells alters the             stem cell compartment and interferes with the epithelial differentiation pathway.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "62345",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -44.45115,
            -16.340051
          ],
          [
            -44.459882,
            -16.356533
          ],
          [
            -46.840004,
            -20.792937
          ],
          [
            -46.848865,
            -20.809231
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "345",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "62346",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -44.451142,
            -16.340052
          ],
          [
            -44.458808,
            -16.361588
          ],
          [
            -47.127124,
            -23.695523
          ],
          [
            -47.134778,
            -23.716044
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "346",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- FGF ligands of the postnatal mammary stroma regulate distinct aspects of epithelial morphogenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "62347",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -44.451164,
            -16.340052
          ],
          [
            -44.465036,
            -16.357031
          ],
          [
            -48.246133,
            -20.925441
          ],
          [
            -48.259979,
            -20.941937
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "347",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- Preponderance of cells with stem cell characteristics in metastasising mouse mammary tumours induced by deregulated EphB4 and ephrin-B2 expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "62351",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -44.45113,
            -16.340051
          ],
          [
            -44.452774,
            -16.357153
          ],
          [
            -44.916386,
            -21.114914
          ],
          [
            -44.918028,
            -21.131509
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "351",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- Genotoxic exposure during juvenile growth of mammary gland depletes stem cell activity and inhibits Wnt signaling.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "62353",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -44.45115,
            -16.340052
          ],
          [
            -44.461087,
            -16.358844
          ],
          [
            -47.471115,
            -21.959806
          ],
          [
            -47.481035,
            -21.977938
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "353",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- Slug controls stem/progenitor cell growth dynamics during mammary gland morphogenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "62354",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -44.451135,
            -16.340051
          ],
          [
            -44.455207,
            -16.359049
          ],
          [
            -45.736024,
            -22.234005
          ],
          [
            -45.740167,
            -22.252653
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "354",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- Lgr4 regulates mammary gland development and stem cell activity through the pluripotency transcription factor Sox2.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "101348",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.259479,
            -13.740369
          ],
          [
            -46.275199,
            -13.756926
          ],
          [
            -50.291734,
            -17.9455
          ],
          [
            -50.307423,
            -17.961684
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "348",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- CCAAT/enhancer binding protein beta regulates stem cell activity and specifies luminal cell fate in the mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "101350",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.259468,
            -13.740367
          ],
          [
            -46.272422,
            -13.757635
          ],
          [
            -49.863149,
            -18.490065
          ],
          [
            -49.87608,
            -18.506894
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "350",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- The proto-oncogene Myc is essential for mammary stem cell function.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "101444",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.259459,
            -13.740366
          ],
          [
            -46.270595,
            -13.75971
          ],
          [
            -49.773528,
            -19.75502
          ],
          [
            -49.784646,
            -19.773732
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "444",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "101615",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.259484,
            -13.740367
          ],
          [
            -46.277425,
            -13.756793
          ],
          [
            -51.009665,
            -18.045448
          ],
          [
            -51.027573,
            -18.061497
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "615",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Repression of mammary stem/progenitor cells by p53 is mediated by Notch and separable from apoptotic activity.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "101616",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.25949,
            -13.740366
          ],
          [
            -46.277196,
            -13.754757
          ],
          [
            -50.412766,
            -17.089751
          ],
          [
            -50.430435,
            -17.103881
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "616",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Intraepithelial paracrine Hedgehog signaling induces the expansion of ciliated cells that express diverse progenitor cell markers in the basal epithelium of the mouse mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "101617",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.259456,
            -13.740366
          ],
          [
            -46.268291,
            -13.758051
          ],
          [
            -48.803333,
            -18.771216
          ],
          [
            -48.812153,
            -18.788423
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "617",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Stem/progenitor cells in non-lactating versus lactating equine mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "101618",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.259445,
            -13.740366
          ],
          [
            -46.264255,
            -13.757964
          ],
          [
            -47.644353,
            -18.7468
          ],
          [
            -47.649154,
            -18.763925
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "618",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Irradiation of juvenile, but not adult, mammary gland increases stem cell self-renewal and estrogen receptor negative tumors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "101619",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.259442,
            -13.740367
          ],
          [
            -46.263208,
            -13.760241
          ],
          [
            -47.448111,
            -19.917036
          ],
          [
            -47.451872,
            -19.93624
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "619",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Notch3 marks clonogenic mammary luminal progenitor cells in vivo.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "101620",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.259436,
            -13.740367
          ],
          [
            -46.260711,
            -13.758457
          ],
          [
            -46.633109,
            -18.975576
          ],
          [
            -46.634381,
            -18.993158
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "620",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Stem cell research: a novel boulevard towards improved bovine mastitis management.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "101621",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.259427,
            -13.740368
          ],
          [
            -46.257386,
            -13.756696
          ],
          [
            -45.73607,
            -17.887749
          ],
          [
            -45.734034,
            -17.903713
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "621",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Epithelial vimentin plays a functional role in mammary gland development.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "89508",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -61.846266,
            -16.843071
          ],
          [
            -61.862675,
            -16.859274
          ],
          [
            -66.055281,
            -20.950515
          ],
          [
            -66.071659,
            -20.966294
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "89",
        "dest": "508",
        "label": "Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland. -- Transcript profiling of Elf5+/- mammary glands during pregnancy identifies novel targets of Elf5.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "89515",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -61.846252,
            -16.84307
          ],
          [
            -61.860106,
            -16.861541
          ],
          [
            -66.05679,
            -22.365895
          ],
          [
            -66.070622,
            -22.383713
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "89",
        "dest": "515",
        "label": "Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland. -- Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "89522",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -61.846246,
            -16.84307
          ],
          [
            -61.856814,
            -16.860308
          ],
          [
            -64.786236,
            -21.573188
          ],
          [
            -64.796785,
            -21.589906
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "89",
        "dest": "522",
        "label": "Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland. -- Elf5-centered transcription factor hub controls trophoblast stem cell self-renewal and differentiation through stoichiometry-sensitive shifts in target gene networks.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "89523",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -61.846231,
            -16.843069
          ],
          [
            -61.85141,
            -16.860827
          ],
          [
            -63.364035,
            -21.969874
          ],
          [
            -63.369206,
            -21.987051
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "89",
        "dest": "523",
        "label": "Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland. -- ELF5 isoform expression is tissue-specific and significantly altered in cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "1793",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.286772,
            32.418835
          ],
          [
            -1.172023,
            32.422627
          ],
          [
            7.071498,
            32.694581
          ],
          [
            7.18621,
            32.698359
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "17",
        "dest": "93",
        "label": "Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease. -- RUNX2 in mammary gland development and breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1795",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.287919,
            32.418836
          ],
          [
            -1.263816,
            32.434496
          ],
          [
            5.776144,
            36.889379
          ],
          [
            5.800206,
            36.904191
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "17",
        "dest": "95",
        "label": "Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease. -- Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1796",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.28793,
            32.418836
          ],
          [
            -1.268729,
            32.434209
          ],
          [
            4.145653,
            36.662171
          ],
          [
            4.16482,
            36.676752
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "17",
        "dest": "96",
        "label": "Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease. -- Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "1798",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.288063,
            32.418754
          ],
          [
            -1.315793,
            32.404772
          ],
          [
            -8.400865,
            28.762869
          ],
          [
            -8.428541,
            28.748378
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "17",
        "dest": "98",
        "label": "Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease. -- STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1799",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.287944,
            32.418836
          ],
          [
            -1.273782,
            32.43433
          ],
          [
            2.790038,
            36.767919
          ],
          [
            2.804176,
            36.782597
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "17",
        "dest": "99",
        "label": "Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease. -- ER and PR signaling nodes during mammary gland development.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "9355",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.187451,
            32.69844
          ],
          [
            7.200218,
            32.714118
          ],
          [
            10.929121,
            37.17295
          ],
          [
            10.941866,
            37.18777
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "55",
        "label": "RUNX2 in mammary gland development and breast cancer. -- RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "93223",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.188782,
            32.698359
          ],
          [
            7.297753,
            32.695178
          ],
          [
            13.899361,
            32.502222
          ],
          [
            14.008346,
            32.499033
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "223",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Cellular quiescence in mammary stem cells and breast tumor stem cells: got testable hypotheses?",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "93236",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.187584,
            32.698439
          ],
          [
            7.225093,
            32.707439
          ],
          [
            13.607766,
            34.225599
          ],
          [
            13.645553,
            34.234508
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "236",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Mammary development and breast cancer: the role of stem cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "93237",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.187525,
            32.698359
          ],
          [
            7.216651,
            32.687365
          ],
          [
            13.167146,
            30.413236
          ],
          [
            13.196201,
            30.401997
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "237",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Cancer stem cells in the human mammary gland and regulation of their differentiation by estrogen.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "93314",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.187626,
            32.698359
          ],
          [
            7.230029,
            32.690256
          ],
          [
            13.73215,
            31.439065
          ],
          [
            13.774614,
            31.430838
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "314",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Runx2 contributes to the regenerative potential of the mammary epithelium.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "93540",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.187808,
            32.698439
          ],
          [
            7.249581,
            32.704755
          ],
          [
            14.633419,
            33.456508
          ],
          [
            14.69516,
            33.462767
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "540",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Ectopic runx2 expression in mammary epithelial cells disrupts formation of normal acini structure: implications for breast cancer progression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "93541",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.187519,
            32.698439
          ],
          [
            7.21709,
            32.710224
          ],
          [
            13.749512,
            35.274803
          ],
          [
            13.779016,
            35.286209
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "541",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBF\u03b2-dependent expression of the Wnt antagonist, sclerostin.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "93542",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.187587,
            32.698439
          ],
          [
            7.229448,
            32.708405
          ],
          [
            15.046753,
            34.549747
          ],
          [
            15.08874,
            34.55953
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "542",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Noncanonical TGF-\u03b2 signaling during mammary tumorigenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "93543",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.18749,
            32.69844
          ],
          [
            7.212233,
            32.712525
          ],
          [
            13.634836,
            36.291926
          ],
          [
            13.659532,
            36.30539
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "543",
        "label": "RUNX2 in mammary gland development and breast cancer. -- A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "93544",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.187513,
            32.69844
          ],
          [
            7.212971,
            32.709254
          ],
          [
            12.349761,
            34.864184
          ],
          [
            12.375157,
            34.874702
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "544",
        "label": "RUNX2 in mammary gland development and breast cancer. -- A prognosis classifier for breast cancer based on conserved gene regulation between mammary gland development and tumorigenesis: a multiscale statistical model.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "9594",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.800305,
            36.904267
          ],
          [
            5.815889,
            36.920481
          ],
          [
            10.718256,
            41.847362
          ],
          [
            10.733815,
            41.862442
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "94",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "95559",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.800913,
            36.904266
          ],
          [
            5.882492,
            36.909051
          ],
          [
            13.681142,
            37.365025
          ],
          [
            13.762772,
            37.369783
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "559",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "95560",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.800429,
            36.904267
          ],
          [
            5.837688,
            36.913013
          ],
          [
            12.313038,
            38.417813
          ],
          [
            12.350584,
            38.426449
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "560",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Clinical significance of DJ-1 as a secretory molecule: retrospective study of DJ-1 expression at mRNA and protein levels in ductal carcinoma of the breast.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95561",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.80034,
            36.904267
          ],
          [
            5.825074,
            36.917592
          ],
          [
            12.245138,
            40.296807
          ],
          [
            12.269825,
            40.309492
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "561",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "95562",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.800294,
            36.904268
          ],
          [
            5.809465,
            36.918124
          ],
          [
            8.268133,
            40.541201
          ],
          [
            8.277287,
            40.554345
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "562",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Clinicopathological significance of CADM4 expression in invasive ductal carcinoma of the breast.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95563",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.800726,
            36.904267
          ],
          [
            5.862342,
            36.909356
          ],
          [
            12.121475,
            37.424609
          ],
          [
            12.183171,
            37.429671
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "563",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95564",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.800514,
            36.904267
          ],
          [
            5.847142,
            36.911435
          ],
          [
            12.495968,
            37.926654
          ],
          [
            12.542636,
            37.933731
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "564",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Cytoplasmic Skp2 expression is associated with p-Akt1 and predicts poor prognosis in human breast carcinomas.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95565",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.800391,
            36.904267
          ],
          [
            5.830976,
            36.913819
          ],
          [
            11.575589,
            38.686603
          ],
          [
            11.606093,
            38.695903
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "565",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95566",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.800301,
            36.904267
          ],
          [
            5.812507,
            36.918565
          ],
          [
            9.195995,
            40.777347
          ],
          [
            9.20818,
            40.790863
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "566",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95567",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.800366,
            36.904267
          ],
          [
            5.830021,
            36.915949
          ],
          [
            12.563346,
            39.521755
          ],
          [
            12.592936,
            39.533
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "567",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- The impact of caveolin protein expression in tumor stroma on prognosis of breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "95568",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.800347,
            36.904267
          ],
          [
            5.82431,
            36.915955
          ],
          [
            11.265227,
            39.523079
          ],
          [
            11.289137,
            39.534329
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "568",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Increased SOX2 expression in less differentiated breast carcinomas and their lymph node metastases.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95569",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.80032,
            36.904267
          ],
          [
            5.819541,
            36.918354
          ],
          [
            11.147463,
            40.721817
          ],
          [
            11.166649,
            40.735144
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "569",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "95570",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.800316,
            36.904267
          ],
          [
            5.816465,
            36.917172
          ],
          [
            9.942571,
            40.142142
          ],
          [
            9.958689,
            40.154455
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "570",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Testin is a tumor suppressor and prognostic marker in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96571",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.164913,
            36.676831
          ],
          [
            4.178429,
            36.689618
          ],
          [
            7.428132,
            39.701719
          ],
          [
            7.441619,
            39.71396
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "571",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "96572",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.164912,
            36.67683
          ],
          [
            4.179457,
            36.690705
          ],
          [
            8.078947,
            40.319173
          ],
          [
            8.093465,
            40.332339
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "572",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Hypoxic conditions induce a cancer-like phenotype in human breast epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96573",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.164918,
            36.676831
          ],
          [
            4.179234,
            36.68882
          ],
          [
            7.429644,
            39.362142
          ],
          [
            7.443928,
            39.373673
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "573",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Mammary epithelial morphogenesis and early breast cancer. Evidence of involvement of basal components of the RNA Polymerase I transcription machinery.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "96574",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.164883,
            36.67683
          ],
          [
            4.169264,
            36.690963
          ],
          [
            5.363411,
            40.445041
          ],
          [
            5.367784,
            40.458427
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "574",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "96575",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.164883,
            36.67683
          ],
          [
            4.16938,
            36.691276
          ],
          [
            5.437474,
            40.655252
          ],
          [
            5.441964,
            40.668892
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "575",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96576",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.164896,
            36.676829
          ],
          [
            4.173534,
            36.689762
          ],
          [
            6.380412,
            39.922211
          ],
          [
            6.389033,
            39.934554
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "576",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "96577",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.164912,
            36.676829
          ],
          [
            4.179276,
            36.690221
          ],
          [
            7.968011,
            40.140207
          ],
          [
            7.982348,
            40.152948
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "577",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96578",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.164898,
            36.67683
          ],
          [
            4.176386,
            36.693452
          ],
          [
            7.861247,
            41.836695
          ],
          [
            7.872717,
            41.852111
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "578",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Role of deregulated microRNAs in breast cancer progression using FFPE tissue.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "96579",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.164883,
            36.67683
          ],
          [
            4.169842,
            36.692389
          ],
          [
            5.671932,
            41.258618
          ],
          [
            5.676883,
            41.273178
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "579",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96580",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.164888,
            36.676829
          ],
          [
            4.171352,
            36.691393
          ],
          [
            6.02611,
            40.754984
          ],
          [
            6.032562,
            40.768715
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "580",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96581",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.164894,
            36.67683
          ],
          [
            4.173392,
            36.691217
          ],
          [
            6.529053,
            40.574271
          ],
          [
            6.537536,
            40.587872
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "581",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Morphogenesis of the papillary lesions of the breast: phenotypic observation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96582",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.164883,
            36.67683
          ],
          [
            4.169367,
            36.691465
          ],
          [
            5.456019,
            40.774359
          ],
          [
            5.460495,
            40.788154
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "582",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Aberrant activation of NF-\u03baB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96583",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.164906,
            36.676829
          ],
          [
            4.178258,
            36.691349
          ],
          [
            8.009407,
            40.742962
          ],
          [
            8.022735,
            40.756654
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "583",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "9880",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.428696,
            28.748293
          ],
          [
            -8.453771,
            28.734104
          ],
          [
            -14.860458,
            25.047484
          ],
          [
            -14.885484,
            25.032851
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "80",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "98185",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.428542,
            28.748377
          ],
          [
            -8.403859,
            28.761323
          ],
          [
            -2.720463,
            31.698669
          ],
          [
            -2.695835,
            31.711206
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "185",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "98213",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.428604,
            28.748377
          ],
          [
            -8.420268,
            28.767403
          ],
          [
            -5.578984,
            35.041441
          ],
          [
            -5.57066,
            35.059182
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "213",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "9839",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.428687,
            28.748377
          ],
          [
            -8.449931,
            28.762161
          ],
          [
            -13.713098,
            32.119653
          ],
          [
            -13.7343,
            32.132942
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "39",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "98597",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.428567,
            28.748377
          ],
          [
            -8.409855,
            28.762772
          ],
          [
            -3.62883,
            32.373975
          ],
          [
            -3.610155,
            32.387815
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "597",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ER\u03b1(+) tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "98598",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.428585,
            28.748376
          ],
          [
            -8.414013,
            28.764499
          ],
          [
            -4.15816,
            33.363224
          ],
          [
            -4.143354,
            33.378829
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "598",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "98599",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.428614,
            28.748377
          ],
          [
            -8.424605,
            28.76791
          ],
          [
            -7.029005,
            35.335332
          ],
          [
            -7.025002,
            35.35348
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "599",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "98600",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.428631,
            28.748377
          ],
          [
            -8.433039,
            28.769168
          ],
          [
            -10.072108,
            36.199029
          ],
          [
            -10.07651,
            36.218139
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "600",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "98601",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.428622,
            28.748378
          ],
          [
            -8.428543,
            28.765704
          ],
          [
            -8.404607,
            33.876726
          ],
          [
            -8.404528,
            33.893105
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "601",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "98602",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.428642,
            28.748377
          ],
          [
            -8.436405,
            28.765031
          ],
          [
            -10.745075,
            33.595843
          ],
          [
            -10.752825,
            33.611638
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "602",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "98603",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.428665,
            28.748377
          ],
          [
            -8.444035,
            28.763746
          ],
          [
            -12.6334,
            32.866082
          ],
          [
            -12.648742,
            32.880779
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "603",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- AKT3 regulates ErbB2, ErbB3 and estrogen receptor \u03b1 expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "98604",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.428724,
            28.748376
          ],
          [
            -8.457318,
            28.760072
          ],
          [
            -14.527131,
            31.21264
          ],
          [
            -14.556027,
            31.22417
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "604",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- ER\u03b136, a new variant of the ER\u03b1 is expressed in triple negative breast carcinomas and has a specific transcriptomic signature in breast cancer cell lines.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "98605",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.428811,
            28.748377
          ],
          [
            -8.469389,
            28.757335
          ],
          [
            -15.031714,
            30.19585
          ],
          [
            -15.072168,
            30.204654
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "605",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "99606",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.804241,
            36.782673
          ],
          [
            2.813574,
            36.795557
          ],
          [
            5.197961,
            40.015483
          ],
          [
            5.207566,
            40.028163
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "99",
        "dest": "606",
        "label": "ER and PR signaling nodes during mammary gland development. -- Diet and expression of estrogen alpha and progesterone receptors in the normal mammary gland.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "99607",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.804232,
            36.782673
          ],
          [
            2.811491,
            36.797842
          ],
          [
            4.970407,
            41.17387
          ],
          [
            4.977654,
            41.188102
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "99",
        "dest": "607",
        "label": "ER and PR signaling nodes during mammary gland development. -- Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "55313",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.947019,
            37.187779
          ],
          [
            11.166431,
            37.186523
          ],
          [
            18.365847,
            37.145307
          ],
          [
            18.527854,
            37.14438
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "55",
        "dest": "313",
        "label": "RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland. -- Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "94545",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.733947,
            41.862442
          ],
          [
            10.762686,
            41.85168
          ],
          [
            17.288114,
            39.361304
          ],
          [
            17.31679,
            39.350155
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "545",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "94546",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.733972,
            41.862514
          ],
          [
            10.764934,
            41.871814
          ],
          [
            16.788611,
            43.655424
          ],
          [
            16.819494,
            43.664436
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "546",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in\u00a0situ ductal carcinoma (IDC\u00a0+\u00a0DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "94547",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.734107,
            41.862443
          ],
          [
            10.784181,
            41.855522
          ],
          [
            18.183752,
            40.824543
          ],
          [
            18.233883,
            40.817503
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "547",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "94548",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.733928,
            41.862514
          ],
          [
            10.757212,
            41.873568
          ],
          [
            16.118764,
            44.367768
          ],
          [
            16.141999,
            44.378355
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "548",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "94549",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.733904,
            41.862515
          ],
          [
            10.75147,
            41.875128
          ],
          [
            15.239675,
            45.015832
          ],
          [
            15.257207,
            45.02778
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "549",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "94550",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.733994,
            41.862443
          ],
          [
            10.772136,
            41.85297
          ],
          [
            18.467964,
            39.912977
          ],
          [
            18.506481,
            39.903125
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "550",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Expression of androgen receptors in primary breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "94551",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.734866,
            41.862443
          ],
          [
            10.839313,
            41.858816
          ],
          [
            18.97519,
            41.575702
          ],
          [
            19.079714,
            41.572056
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "551",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "94552",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.733888,
            41.862442
          ],
          [
            10.746962,
            41.849382
          ],
          [
            14.310484,
            38.190882
          ],
          [
            14.323534,
            38.177125
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "552",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- HOXB9 expression promoting tumor cell proliferation and angiogenesis is associated with clinical outcomes in breast cancer patients.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "94553",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.733921,
            41.862442
          ],
          [
            10.755549,
            41.851146
          ],
          [
            15.880401,
            39.11849
          ],
          [
            15.901984,
            39.106747
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "553",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Angiogenesis in the progression of breast ductal proliferations.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "94554",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.733901,
            41.862443
          ],
          [
            10.751852,
            41.84943
          ],
          [
            15.727783,
            38.141081
          ],
          [
            15.746005,
            38.127132
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "554",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Prostate-specific membrane antigen as a potential novel vascular target for treatment of glioblastoma multiforme.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "94555",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.734038,
            41.862514
          ],
          [
            10.776267,
            41.870563
          ],
          [
            18.000079,
            43.232596
          ],
          [
            18.042185,
            43.240448
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "555",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Folate hydrolase (prostate-specific membrane [corrected] antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "94556",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.733994,
            41.862442
          ],
          [
            10.768185,
            41.853864
          ],
          [
            16.975516,
            40.27749
          ],
          [
            17.009613,
            40.268726
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "556",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "94557",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.73438,
            41.862513
          ],
          [
            10.806619,
            41.867333
          ],
          [
            18.261497,
            42.362794
          ],
          [
            18.333841,
            42.367583
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "557",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Which threshold for ER positivity? a retrospective study based on 9639 patients.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "94558",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.734749,
            41.862443
          ],
          [
            10.822897,
            41.85898
          ],
          [
            17.38132,
            41.600831
          ],
          [
            17.469481,
            41.597354
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "558",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Significance of syndecan-1 expression in ductal carcinoma in situ of the breast.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "39242",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.734343,
            32.133023
          ],
          [
            -13.726366,
            32.148671
          ],
          [
            -11.437495,
            36.525152
          ],
          [
            -11.429532,
            36.539975
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "39",
        "dest": "242",
        "label": "Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells. -- Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "39243",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.734369,
            32.133023
          ],
          [
            -13.73633,
            32.149006
          ],
          [
            -14.319517,
            36.775024
          ],
          [
            -14.321475,
            36.790117
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "39",
        "dest": "243",
        "label": "Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells. -- Estrogen up-regulates ATBF1 transcription but causes its protein degradation in estrogen receptor-alpha-positive breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "39244",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.734356,
            32.133023
          ],
          [
            -13.731327,
            32.148166
          ],
          [
            -12.891698,
            36.246583
          ],
          [
            -12.888674,
            36.260978
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "39",
        "dest": "244",
        "label": "Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells. -- Progesterone receptor activates Msx2 expression by downregulating TNAP/Akp2 and activating the Bmp pathway in EpH4 mouse mammary epithelial cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "39245",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.734408,
            32.133023
          ],
          [
            -13.749935,
            32.147426
          ],
          [
            -17.845301,
            35.865177
          ],
          [
            -17.860799,
            35.878934
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "39",
        "dest": "245",
        "label": "Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells. -- Atbf1 regulates pubertal mammary gland development likely by inhibiting the pro-proliferative function of estrogen-ER signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "39246",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.734385,
            32.133022
          ],
          [
            -13.742126,
            32.147588
          ],
          [
            -15.852117,
            36.029292
          ],
          [
            -15.859844,
            36.043177
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "39",
        "dest": "246",
        "label": "Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells. -- Cellular localization of ATBF1 protein and its functional implication in breast epithelial cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "599137",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.024979,
            35.353559
          ],
          [
            -7.01887,
            35.371084
          ],
          [
            -4.979092,
            41.005265
          ],
          [
            -4.972992,
            41.021456
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "599",
        "dest": "137",
        "label": "Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures. -- Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "600129",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.076523,
            36.218216
          ],
          [
            -10.07856,
            36.237008
          ],
          [
            -10.819101,
            42.764154
          ],
          [
            -10.821135,
            42.78123
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "600",
        "dest": "129",
        "label": "Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters. -- Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "18100",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.822902,
            -11.445882
          ],
          [
            -46.768126,
            -11.454996
          ],
          [
            -38.673682,
            -12.798451
          ],
          [
            -38.618844,
            -12.807529
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "18",
        "dest": "100",
        "label": "Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk. -- Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1837",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.823249,
            -11.445884
          ],
          [
            -46.846805,
            -11.462335
          ],
          [
            -52.960972,
            -15.696418
          ],
          [
            -52.984482,
            -15.712546
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "18",
        "dest": "37",
        "label": "Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk. -- Progesterone induces adult mammary stem cell expansion.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "18102",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.823231,
            -11.445883
          ],
          [
            -46.83913,
            -11.461069
          ],
          [
            -50.662004,
            -15.086422
          ],
          [
            -50.67787,
            -15.101351
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "18",
        "dest": "102",
        "label": "Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk. -- A mouse model to dissect progesterone signaling in the female reproductive tract and mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "18103",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.823231,
            -11.445884
          ],
          [
            -46.842522,
            -11.464506
          ],
          [
            -52.476837,
            -16.843501
          ],
          [
            -52.496094,
            -16.861655
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "18",
        "dest": "103",
        "label": "Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk. -- Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "3754",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.984628,
            -15.712638
          ],
          [
            -53.012464,
            -15.728987
          ],
          [
            -60.47512,
            -20.06085
          ],
          [
            -60.502904,
            -20.076773
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "37",
        "dest": "54",
        "label": "Progesterone induces adult mammary stem cell expansion. -- Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "37229",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.984608,
            -15.712638
          ],
          [
            -53.006234,
            -15.729945
          ],
          [
            -59.104511,
            -20.546225
          ],
          [
            -59.126099,
            -20.563031
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "37",
        "dest": "229",
        "label": "Progesterone induces adult mammary stem cell expansion. -- Control of mammary stem cell function by steroid hormone signalling.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "37230",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.984627,
            -15.712639
          ],
          [
            -53.009814,
            -15.727846
          ],
          [
            -59.156266,
            -19.402617
          ],
          [
            -59.1814,
            -19.417487
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "37",
        "dest": "230",
        "label": "Progesterone induces adult mammary stem cell expansion. -- Molecular hierarchy of mammary differentiation yields refined markers of mammary stem cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "37231",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.984602,
            -15.71264
          ],
          [
            -53.002381,
            -15.728862
          ],
          [
            -57.544956,
            -19.828045
          ],
          [
            -57.5627,
            -19.843867
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "37",
        "dest": "231",
        "label": "Progesterone induces adult mammary stem cell expansion. -- The WNT-controlled transcriptional regulator LBH is required for mammary stem cell expansion and maintenance of the basal lineage.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "37232",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.984643,
            -15.712639
          ],
          [
            -53.006787,
            -15.723687
          ],
          [
            -56.982799,
            -17.697398
          ],
          [
            -57.004882,
            -17.708302
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "37",
        "dest": "232",
        "label": "Progesterone induces adult mammary stem cell expansion. -- Ovarian steroid hormones: what's hot in the stem cell pool?",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "102622",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -50.677973,
            -15.101443
          ],
          [
            -50.696553,
            -15.117481
          ],
          [
            -55.596847,
            -19.301453
          ],
          [
            -55.615989,
            -19.317604
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "102",
        "dest": "622",
        "label": "A mouse model to dissect progesterone signaling in the female reproductive tract and mammary gland. -- Dual roles for Id4 in the regulation of estrogen signaling in the mammary gland and ovary.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "103623",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.496194,
            -16.861747
          ],
          [
            -52.513104,
            -16.877167
          ],
          [
            -56.833467,
            -20.772805
          ],
          [
            -56.850871,
            -20.78831
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "623",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Pubertal bisphenol A exposure alters murine mammary stem cell function leading to early neoplasia in regenerated glands.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "103624",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.496187,
            -16.861749
          ],
          [
            -52.512935,
            -16.879938
          ],
          [
            -57.404511,
            -22.110789
          ],
          [
            -57.42123,
            -22.128367
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "624",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Chronic oral exposure to bisphenol A results in a nonmonotonic dose response in mammary carcinogenesis and metastasis in MMTV-erbB2 mice.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "103625",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.496166,
            -16.861749
          ],
          [
            -52.50429,
            -16.879314
          ],
          [
            -54.795238,
            -21.761771
          ],
          [
            -54.803348,
            -21.778787
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "625",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Cell proliferation and apoptosis in rat mammary glands following combinational exposure to bisphenol A and genistein.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "103626",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.496162,
            -16.861748
          ],
          [
            -52.503536,
            -16.880656
          ],
          [
            -54.779605,
            -22.61722
          ],
          [
            -54.786968,
            -22.635429
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "626",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Bisphenol A alters the development of the rhesus monkey mammary gland.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "103627",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.496181,
            -16.861749
          ],
          [
            -52.509276,
            -16.878161
          ],
          [
            -55.963232,
            -21.153578
          ],
          [
            -55.976303,
            -21.169542
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "627",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Prenatal exposure to bisphenol A promotes angiogenesis and alters steroid-mediated responses in the mammary glands of cycling rats.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "103628",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.496203,
            -16.861749
          ],
          [
            -52.516967,
            -16.878206
          ],
          [
            -57.993678,
            -21.165321
          ],
          [
            -58.014403,
            -21.181327
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "628",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Low-dose BPA exposure alters the mesenchymal and epithelial transcriptomes of the mouse fetal mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "103629",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.496173,
            -16.861747
          ],
          [
            -52.50806,
            -16.87999
          ],
          [
            -56.108523,
            -22.317009
          ],
          [
            -56.120609,
            -22.334939
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "629",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Prenatal exposure to BPA alters the epigenome of the rat mammary gland and increases the propensity to neoplastic development.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "103630",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.49616,
            -16.861749
          ],
          [
            -52.502361,
            -16.879879
          ],
          [
            -54.313531,
            -22.094322
          ],
          [
            -54.319721,
            -22.111846
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "630",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- The male mammary gland: a target for the xenoestrogen bisphenol A.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "54309",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -60.503026,
            -20.076862
          ],
          [
            -60.519991,
            -20.094201
          ],
          [
            -65.475021,
            -25.07083
          ],
          [
            -65.491957,
            -25.087523
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "54",
        "dest": "309",
        "label": "Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast. -- DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "54310",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -60.503012,
            -20.076863
          ],
          [
            -60.514832,
            -20.094413
          ],
          [
            -63.967073,
            -25.130617
          ],
          [
            -63.978873,
            -25.147505
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "54",
        "dest": "310",
        "label": "Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast. -- Effects of estrogen on the proportion of stem cells in the breast.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "54311",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -60.503,
            -20.076863
          ],
          [
            -60.50982,
            -20.094228
          ],
          [
            -62.466819,
            -24.992167
          ],
          [
            -62.473628,
            -25.008895
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "54",
        "dest": "311",
        "label": "Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast. -- Progesterone stimulates progenitor cells in normal human breast and breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "22966",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -59.126175,
            -20.563121
          ],
          [
            -59.133084,
            -20.58061
          ],
          [
            -61.115433,
            -25.510911
          ],
          [
            -61.122329,
            -25.52774
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "229",
        "dest": "66",
        "label": "Control of mammary stem cell function by steroid hormone signalling. -- Stem cells: Cues from steroid hormones.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "66390",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -61.122376,
            -25.527827
          ],
          [
            -61.133125,
            -25.54395
          ],
          [
            -64.164287,
            -30.000478
          ],
          [
            -64.175018,
            -30.015924
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "66",
        "dest": "390",
        "label": "Stem cells: Cues from steroid hormones. -- A novel role of microRNA146b in promoting mammary alveolar progenitor cell maintenance.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "34565",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.848986,
            -20.809321
          ],
          [
            -46.8744,
            -20.821156
          ],
          [
            -51.939554,
            -23.160865
          ],
          [
            -51.964904,
            -23.172476
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "345",
        "dest": "65",
        "label": "Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation. -- Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "345116",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.848931,
            -20.809322
          ],
          [
            -46.865361,
            -20.827356
          ],
          [
            -51.751306,
            -26.088414
          ],
          [
            -51.767708,
            -26.105711
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "345",
        "dest": "116",
        "label": "Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation. -- Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "34664",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.134813,
            -23.716133
          ],
          [
            -47.144649,
            -23.739804
          ],
          [
            -51.070337,
            -32.813247
          ],
          [
            -51.08016,
            -32.834949
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "346",
        "dest": "64",
        "label": "FGF ligands of the postnatal mammary stroma regulate distinct aspects of epithelial morphogenesis. -- Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "346122",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.134813,
            -23.716133
          ],
          [
            -47.140443,
            -23.729673
          ],
          [
            -48.418686,
            -26.766328
          ],
          [
            -48.424303,
            -26.779502
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "346",
        "dest": "122",
        "label": "FGF ligands of the postnatal mammary stroma regulate distinct aspects of epithelial morphogenesis. -- The transcriptional co-factor RIP140 regulates mammary gland development by promoting the generation of key mitogenic signals.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "113660",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.894934,
            -21.452795
          ],
          [
            2.896343,
            -21.470357
          ],
          [
            3.315126,
            -26.593641
          ],
          [
            3.316532,
            -26.610486
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "113",
        "dest": "660",
        "label": "The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention. -- ALU repeats in promoters are position-dependent co-response elements (coRE) that enhance or repress transcription by dimeric and monomeric progesterone receptors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "113661",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.894948,
            -21.452794
          ],
          [
            2.901466,
            -21.469993
          ],
          [
            4.805279,
            -26.401048
          ],
          [
            4.811786,
            -26.41757
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "113",
        "dest": "661",
        "label": "The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention. -- Acetylation at lysine 183 of progesterone receptor by p300 accelerates DNA binding kinetics and transactivation of direct target genes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "108648",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.070635,
            -15.156999
          ],
          [
            18.070762,
            -15.175277
          ],
          [
            18.108516,
            -20.533665
          ],
          [
            18.108642,
            -20.551369
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "648",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- Prolactin and epidermal growth factor stimulate adipophilin synthesis in HC11 mouse mammary epithelial cells via the PI3-kinase/Akt/mTOR pathway.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "108649",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.070662,
            -15.156999
          ],
          [
            18.081674,
            -15.175291
          ],
          [
            21.356512,
            -20.537633
          ],
          [
            21.367505,
            -20.55535
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "649",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- The bovine mammary gland expresses multiple functional isoforms of serotonin receptors.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "108650",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.070648,
            -15.156999
          ],
          [
            18.075887,
            -15.175145
          ],
          [
            19.605892,
            -20.401606
          ],
          [
            19.611121,
            -20.419197
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "650",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- Short communication: retinoic acid plus prolactin to synergistically increase specific casein gene expression in MAC-T cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "108651",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.070678,
            -15.157
          ],
          [
            18.085878,
            -15.173626
          ],
          [
            22.095094,
            -19.509451
          ],
          [
            22.110265,
            -19.525657
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "651",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- Increased STAT5 signaling in the ring dove brain in response to prolactin administration and spontaneous elevations in prolactin during the breeding cycle.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "108652",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.070701,
            -15.156999
          ],
          [
            18.09194,
            -15.17186
          ],
          [
            23.198691,
            -18.712611
          ],
          [
            23.219886,
            -18.727163
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "652",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- Serotonin regulates \u03b2-casein expression via 5-HT7 receptors in human mammary epithelial MCF-12A cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "108653",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.070662,
            -15.157
          ],
          [
            18.080173,
            -15.173625
          ],
          [
            20.588987,
            -19.509155
          ],
          [
            20.59848,
            -19.52536
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "653",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- Inhibitory effect of fluvoxamine on \u03b2-casein expression via a serotonin-independent mechanism in human mammary epithelial cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "108654",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.070812,
            -15.156998
          ],
          [
            18.109765,
            -15.167029
          ],
          [
            24.536605,
            -16.815372
          ],
          [
            24.575831,
            -16.82539
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "654",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- Serotonin suppresses \u03b2-casein expression via PTP1B activation in human mammary epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "108655",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.070736,
            -15.156998
          ],
          [
            18.097283,
            -15.169031
          ],
          [
            23.324348,
            -17.524306
          ],
          [
            23.350828,
            -17.536164
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "655",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- [Endogenous Serotonin and Milk Production Regulation in the Mammary Gland].",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "24131",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.59201,
            53.08908
          ],
          [
            4.606112,
            53.100393
          ],
          [
            8.725089,
            56.278782
          ],
          [
            8.739167,
            56.289222
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "24",
        "dest": "131",
        "label": "Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a. -- Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "24132",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.591911,
            53.089022
          ],
          [
            4.569803,
            53.078809
          ],
          [
            -1.357261,
            50.252596
          ],
          [
            -1.379328,
            50.241743
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "24",
        "dest": "132",
        "label": "Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a. -- Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "24134",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.59201,
            53.08908
          ],
          [
            4.607296,
            53.101343
          ],
          [
            9.416051,
            56.787956
          ],
          [
            9.431313,
            56.799122
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "24",
        "dest": "134",
        "label": "Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a. -- Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "24139",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.591966,
            53.089079
          ],
          [
            4.588734,
            53.101285
          ],
          [
            3.552161,
            56.84028
          ],
          [
            3.548934,
            56.851379
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "24",
        "dest": "139",
        "label": "Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a. -- Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "24143",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.591986,
            53.08908
          ],
          [
            4.596758,
            53.099759
          ],
          [
            5.919541,
            55.958916
          ],
          [
            5.924304,
            55.968853
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "24",
        "dest": "143",
        "label": "Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a. -- Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "131750",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.741222,
            56.289222
          ],
          [
            8.88771,
            56.287317
          ],
          [
            16.957801,
            56.182225
          ],
          [
            17.104325,
            56.180314
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "131",
        "dest": "750",
        "label": "Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. -- miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "131751",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.739498,
            56.289222
          ],
          [
            8.793105,
            56.284424
          ],
          [
            16.146967,
            55.620434
          ],
          [
            16.200604,
            55.615549
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "131",
        "dest": "751",
        "label": "Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. -- Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "131752",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.739278,
            56.289275
          ],
          [
            8.763506,
            56.297886
          ],
          [
            14.676103,
            58.341951
          ],
          [
            14.700282,
            58.350078
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "131",
        "dest": "752",
        "label": "Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. -- MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Kr\u00fcppel-like factor 4.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "131754",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.739576,
            56.289275
          ],
          [
            8.802973,
            56.293757
          ],
          [
            16.950196,
            56.865449
          ],
          [
            17.013596,
            56.869864
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "131",
        "dest": "754",
        "label": "Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. -- MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "131755",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.739382,
            56.289275
          ],
          [
            8.780487,
            56.295457
          ],
          [
            15.924689,
            57.354764
          ],
          [
            15.965677,
            57.360756
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "131",
        "dest": "755",
        "label": "Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. -- Hyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "131756",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.739314,
            56.289275
          ],
          [
            8.772238,
            56.29713
          ],
          [
            16.145101,
            58.015975
          ],
          [
            16.177951,
            58.023455
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "131",
        "dest": "756",
        "label": "Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. -- Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "132133",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.379384,
            50.241682
          ],
          [
            -1.376646,
            50.227938
          ],
          [
            -0.462576,
            45.416098
          ],
          [
            -0.459843,
            45.401035
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "132",
        "dest": "133",
        "label": "Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties. -- A high-content assay to identify small-molecule modulators of a cancer stem cell population in luminal breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "132135",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.379385,
            50.241743
          ],
          [
            -1.377048,
            50.254666
          ],
          [
            -0.627453,
            54.220645
          ],
          [
            -0.625074,
            54.232671
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "132",
        "dest": "135",
        "label": "Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties. -- Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "132757",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.379402,
            50.241744
          ],
          [
            -1.384105,
            50.254475
          ],
          [
            -2.835805,
            54.022816
          ],
          [
            -2.840501,
            54.034491
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "132",
        "dest": "757",
        "label": "Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties. -- Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "132758",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.379379,
            50.241744
          ],
          [
            -1.375081,
            50.253866
          ],
          [
            -0.119753,
            53.663415
          ],
          [
            -0.115462,
            53.674626
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "132",
        "dest": "758",
        "label": "Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties. -- Progestins induce catalase activities in breast cancer cells through PRB isoform: correlation with cell growth inhibition.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "13443",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.431339,
            56.799176
          ],
          [
            9.427436,
            56.809516
          ],
          [
            8.287328,
            59.709554
          ],
          [
            8.283431,
            59.719062
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "43",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- Signaling inputs to progesterone receptor gene regulation and promoter selectivity.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "134136",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.431409,
            56.799175
          ],
          [
            9.454931,
            56.809622
          ],
          [
            16.450313,
            59.789221
          ],
          [
            16.473796,
            59.798804
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "136",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- miR-221/222 control luminal breast cancer tumor progression by regulating different targets.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134142",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.431357,
            56.799175
          ],
          [
            9.435275,
            56.812549
          ],
          [
            10.926158,
            61.564723
          ],
          [
            10.93007,
            61.576337
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "142",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- miR-129-2 mediates down-regulation of progesterone receptor in response to progesterone in breast cancer cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134753",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.431389,
            56.799175
          ],
          [
            9.446614,
            56.809158
          ],
          [
            13.815412,
            59.565527
          ],
          [
            13.830611,
            59.574746
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "753",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "134764",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.431418,
            56.799175
          ],
          [
            9.455972,
            56.80843
          ],
          [
            16.038471,
            59.208298
          ],
          [
            16.06338,
            59.217076
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "764",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134765",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.431347,
            56.799175
          ],
          [
            9.430423,
            56.810007
          ],
          [
            9.13964,
            60.064938
          ],
          [
            9.1387,
            60.074983
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "765",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "134766",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.431369,
            56.799176
          ],
          [
            9.43944,
            56.809997
          ],
          [
            11.884062,
            59.946636
          ],
          [
            11.892119,
            59.956517
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "766",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "134767",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.431323,
            56.799175
          ],
          [
            9.420739,
            56.809778
          ],
          [
            6.214932,
            59.885693
          ],
          [
            6.204366,
            59.895392
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "767",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134768",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.431409,
            56.799177
          ],
          [
            9.451167,
            56.808228
          ],
          [
            14.34601,
            58.984126
          ],
          [
            14.365728,
            58.992626
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "768",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "134769",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.431339,
            56.799176
          ],
          [
            9.426977,
            56.810729
          ],
          [
            7.99989,
            60.403365
          ],
          [
            7.995535,
            60.41377
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "769",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134770",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.431435,
            56.799175
          ],
          [
            9.458382,
            56.807328
          ],
          [
            15.843458,
            58.689737
          ],
          [
            15.870738,
            58.69757
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "770",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "134771",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.431378,
            56.799175
          ],
          [
            9.442311,
            56.808944
          ],
          [
            12.525115,
            59.46353
          ],
          [
            12.536029,
            59.472578
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "771",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "134772",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.431358,
            56.799176
          ],
          [
            9.434842,
            56.809658
          ],
          [
            10.471038,
            59.799101
          ],
          [
            10.474517,
            59.808714
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "772",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "134773",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.431399,
            56.799175
          ],
          [
            9.450745,
            56.809244
          ],
          [
            15.101074,
            59.636022
          ],
          [
            15.120732,
            59.645467
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "773",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134774",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.431378,
            56.799175
          ],
          [
            9.443648,
            56.810246
          ],
          [
            13.3034,
            60.13338
          ],
          [
            13.31565,
            60.143431
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "774",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134775",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.431352,
            56.799175
          ],
          [
            9.432854,
            56.810896
          ],
          [
            9.934183,
            60.523559
          ],
          [
            9.935683,
            60.534076
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "775",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134776",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.431363,
            56.799176
          ],
          [
            9.437474,
            56.81089
          ],
          [
            11.436762,
            60.450861
          ],
          [
            11.442863,
            60.461394
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "776",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134777",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.431297,
            56.799176
          ],
          [
            9.415124,
            56.807516
          ],
          [
            5.637709,
            58.705168
          ],
          [
            5.62157,
            58.713063
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "777",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- Progestin drives breast cancer growth by inducing p21(CIP1) expression through the assembly of a transcriptional complex among Stat3, progesterone receptor and ErbB-2.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "139804",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            3.548948,
            56.851431
          ],
          [
            3.558342,
            56.862699
          ],
          [
            6.631542,
            60.370599
          ],
          [
            6.641109,
            60.380974
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "804",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "139805",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            3.548952,
            56.851432
          ],
          [
            3.558326,
            56.861462
          ],
          [
            6.201637,
            59.584068
          ],
          [
            6.210994,
            59.593337
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "805",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "139806",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            3.548952,
            56.851432
          ],
          [
            3.558527,
            56.861346
          ],
          [
            6.258407,
            59.553759
          ],
          [
            6.267964,
            59.56293
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "806",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Down-regulation of vitamin D receptor in mammospheres: implications for vitamin D resistance in breast cancer and potential for combination therapy.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "139807",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            3.548941,
            56.851431
          ],
          [
            3.554643,
            56.861569
          ],
          [
            5.219793,
            59.706929
          ],
          [
            5.225485,
            59.716265
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "807",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "139808",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            3.548927,
            56.851432
          ],
          [
            3.54899,
            56.862112
          ],
          [
            3.568146,
            59.959283
          ],
          [
            3.568209,
            59.969045
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "808",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "139809",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            3.548937,
            56.851432
          ],
          [
            3.553067,
            56.862364
          ],
          [
            4.8279,
            60.086404
          ],
          [
            4.832024,
            60.096358
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "809",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "139810",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            3.548933,
            56.851432
          ],
          [
            3.551813,
            56.863225
          ],
          [
            4.513089,
            60.597069
          ],
          [
            4.515964,
            60.607641
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "810",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "139811",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            3.54895,
            56.851432
          ],
          [
            3.557187,
            56.860974
          ],
          [
            5.802396,
            59.37249
          ],
          [
            5.810619,
            59.381364
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "811",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Oxidized LDL triggers pro-oncogenic signaling in human breast mammary epithelial cells partly via stimulation of MiR-21.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "139812",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            3.548934,
            56.851432
          ],
          [
            3.551845,
            56.861636
          ],
          [
            4.38701,
            59.676459
          ],
          [
            4.389916,
            59.685864
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "812",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- The flavonoid apigenin reduces prostate cancer CD44(+) stem cell survival and migration through PI3K/Akt/NF-\u03baB signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "139813",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            3.548926,
            56.851431
          ],
          [
            3.548497,
            56.861786
          ],
          [
            3.420925,
            59.81598
          ],
          [
            3.420497,
            59.825484
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "813",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Generation of breast cancer stem cells by steroid hormones in irradiated human mammary cell lines.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "43248",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.28343,
            59.719111
          ],
          [
            8.286712,
            59.728122
          ],
          [
            9.21212,
            62.173827
          ],
          [
            9.215396,
            62.182154
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "43",
        "dest": "248",
        "label": "Signaling inputs to progesterone receptor gene regulation and promoter selectivity. -- Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "25147",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.018999,
            -31.880683
          ],
          [
            9.014128,
            -31.89966
          ],
          [
            7.318463,
            -38.260089
          ],
          [
            7.313598,
            -38.277612
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "25",
        "dest": "147",
        "label": "Research resource: Genome-wide profiling of progesterone receptor binding in the mouse uterus. -- A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "25148",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.016102,
            -31.880673
          ],
          [
            8.859078,
            -31.882328
          ],
          [
            2.393303,
            -31.950466
          ],
          [
            2.213821,
            -31.952357
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "25",
        "dest": "148",
        "label": "Research resource: Genome-wide profiling of progesterone receptor binding in the mouse uterus. -- Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "25151",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.019007,
            -31.880683
          ],
          [
            9.017836,
            -31.898812
          ],
          [
            8.626988,
            -37.745787
          ],
          [
            8.625819,
            -37.762643
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "25",
        "dest": "151",
        "label": "Research resource: Genome-wide profiling of progesterone receptor binding in the mouse uterus. -- A comprehensive view of nuclear receptor cancer cistromes.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "25152",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.019007,
            -31.880683
          ],
          [
            9.017958,
            -31.897014
          ],
          [
            8.700405,
            -36.707151
          ],
          [
            8.699358,
            -36.722544
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "25",
        "dest": "152",
        "label": "Research resource: Genome-wide profiling of progesterone receptor binding in the mouse uterus. -- Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "25153",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            9.019021,
            -31.880683
          ],
          [
            9.024557,
            -31.899419
          ],
          [
            10.951668,
            -38.182299
          ],
          [
            10.957196,
            -38.199617
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "25",
        "dest": "153",
        "label": "Research resource: Genome-wide profiling of progesterone receptor binding in the mouse uterus. -- Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target genes in the glands of the mouse uterus.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "147842",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.312834,
            -38.277687
          ],
          [
            7.237282,
            -38.281421
          ],
          [
            1.503969,
            -38.564237
          ],
          [
            1.428387,
            -38.567958
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "842",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Growth regulation by estrogen in breast cancer 1 (GREB1) is a novel progesterone-responsive gene required for human endometrial stromal decidualization.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "147843",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.313405,
            -38.277612
          ],
          [
            7.273695,
            -38.269452
          ],
          [
            0.787408,
            -36.924265
          ],
          [
            0.747819,
            -36.91598
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "843",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Acceleration of the glycolytic flux by steroid receptor coactivator-2 is essential for endometrial decidualization.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147844",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.313464,
            -38.277687
          ],
          [
            7.281857,
            -38.287363
          ],
          [
            1.205192,
            -40.123467
          ],
          [
            1.173666,
            -40.132867
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "844",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- The Promyelocytic Leukemia Zinc Finger Transcription Factor Is Critical for Human Endometrial Stromal Cell Decidualization.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147845",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.312915,
            -38.277612
          ],
          [
            7.235565,
            -38.27333
          ],
          [
            0.515047,
            -37.900329
          ],
          [
            0.437729,
            -37.896027
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "845",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- The coregulator, repressor of estrogen receptor activity (REA), is a crucial regulator of the timing and magnitude of uterine decidualization.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147846",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.313349,
            -38.277687
          ],
          [
            7.26751,
            -38.284811
          ],
          [
            0.644181,
            -39.306884
          ],
          [
            0.598299,
            -39.313913
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "846",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Evaluation of human first trimester decidual and telomerase-transformed endometrial stromal cells as model systems of in vitro decidualization.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147847",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.313533,
            -38.277689
          ],
          [
            7.295616,
            -38.2906
          ],
          [
            2.856708,
            -41.417975
          ],
          [
            2.838827,
            -41.430284
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "847",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Evidence for a conserved function of heart and neural crest derivatives expressed transcript 2 in mouse and human decidualization.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147848",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.313508,
            -38.277687
          ],
          [
            7.289542,
            -38.289083
          ],
          [
            1.847765,
            -40.829964
          ],
          [
            1.823851,
            -40.840923
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "848",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- The p160/steroid receptor coactivator family: potent arbiters of uterine physiology and dysfunction.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147849",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.313599,
            -38.277688
          ],
          [
            7.318334,
            -38.29369
          ],
          [
            8.80769,
            -43.150442
          ],
          [
            8.812417,
            -43.165289
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "849",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Perturbing the cellular levels of steroid receptor coactivator-2 impairs murine endometrial function.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147850",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.313555,
            -38.277687
          ],
          [
            7.301641,
            -38.291419
          ],
          [
            4.054332,
            -41.936552
          ],
          [
            4.04244,
            -41.949541
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "850",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Endometrial stromal beta-catenin is required for steroid-dependent mesenchymal-epithelial cross talk and decidualization.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147851",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.313567,
            -38.277688
          ],
          [
            7.304982,
            -38.293013
          ],
          [
            4.704551,
            -42.784591
          ],
          [
            4.695981,
            -42.798895
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "851",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Notch1 mediates uterine stromal differentiation and is critical for complete decidualization in the mouse.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "147852",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.313547,
            -38.277688
          ],
          [
            7.297983,
            -38.292252
          ],
          [
            2.832081,
            -42.349496
          ],
          [
            2.816544,
            -42.363183
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "852",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "147853",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.313577,
            -38.277687
          ],
          [
            7.309361,
            -38.292398
          ],
          [
            6.055651,
            -42.53372
          ],
          [
            6.051365,
            -42.547757
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "853",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Changes in global gene expression during in vitro decidualization of rat endometrial stromal cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147854",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.313589,
            -38.277687
          ],
          [
            7.313904,
            -38.292766
          ],
          [
            7.409513,
            -42.714537
          ],
          [
            7.409828,
            -42.728627
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "854",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147855",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.313566,
            -38.277688
          ],
          [
            7.305975,
            -38.291345
          ],
          [
            5.303828,
            -41.802963
          ],
          [
            5.296252,
            -41.815907
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "855",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- G-protein coupled receptor 64 is required for decidualization of endometrial stromal cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "148727",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.210017,
            -31.952356
          ],
          [
            2.211339,
            -31.933049
          ],
          [
            2.681815,
            -24.820134
          ],
          [
            2.683136,
            -24.79951
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "727",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Differential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "148241",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.210022,
            -31.952438
          ],
          [
            2.213257,
            -31.969089
          ],
          [
            3.193233,
            -36.870238
          ],
          [
            3.196463,
            -36.885911
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "241",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "148465",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.210058,
            -31.952438
          ],
          [
            2.22613,
            -31.967255
          ],
          [
            6.606763,
            -35.915036
          ],
          [
            6.622805,
            -35.929153
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "465",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Non-overlapping progesterone receptor cistromes contribute to cell-specific transcriptional outcomes.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "148856",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.210012,
            -31.952438
          ],
          [
            2.209123,
            -31.968163
          ],
          [
            1.954063,
            -36.366529
          ],
          [
            1.953176,
            -36.381426
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "856",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Progesterone and mifepristone regulate L-type amino acid transporter 2 and 4F2 heavy chain expression in uterine leiomyoma cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "148857",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.210037,
            -31.952438
          ],
          [
            2.218608,
            -31.967703
          ],
          [
            4.59445,
            -36.099118
          ],
          [
            4.603006,
            -36.113629
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "857",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Expression of a mitochondrial progesterone receptor (PR-M) in leiomyomata and association with increased mitochondrial membrane potential.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "148858",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.209998,
            -31.952438
          ],
          [
            2.204179,
            -31.966985
          ],
          [
            0.644259,
            -35.781958
          ],
          [
            0.638356,
            -35.796067
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "858",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- LAT1 regulates growth of uterine leiomyoma smooth muscle cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "148859",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.210024,
            -31.952438
          ],
          [
            2.213471,
            -31.967175
          ],
          [
            3.137627,
            -35.830853
          ],
          [
            3.141068,
            -35.844908
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "859",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "148860",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.21008,
            -31.952439
          ],
          [
            2.230721,
            -31.965472
          ],
          [
            7.051473,
            -34.958006
          ],
          [
            7.072069,
            -34.970568
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "860",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- GSTM1 gene expression correlates to leiomyoma volume regression in response to mifepristone treatment.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "148861",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.210053,
            -31.952438
          ],
          [
            2.222858,
            -31.965887
          ],
          [
            5.395266,
            -35.236024
          ],
          [
            5.408046,
            -35.248944
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "861",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- The T47D cell line is an ideal experimental model to elucidate the progesterone-specific effects of a luminal A subtype of breast cancer.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "148862",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.210032,
            -31.952438
          ],
          [
            2.217469,
            -31.969547
          ],
          [
            4.557131,
            -37.189147
          ],
          [
            4.564557,
            -37.205185
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "862",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Progesterone is essential for maintenance and growth of uterine leiomyoma.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "148863",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.210044,
            -31.952438
          ],
          [
            2.222359,
            -31.96885
          ],
          [
            5.952642,
            -36.801813
          ],
          [
            5.964937,
            -36.817275
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "863",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- The role of progesterone signaling in the pathogenesis of uterine leiomyoma.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "148864",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.210116,
            -31.952437
          ],
          [
            2.236178,
            -31.962785
          ],
          [
            7.246765,
            -33.930285
          ],
          [
            7.27276,
            -33.940378
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "864",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Mifepristone inhibits extracellular matrix formation in uterine\u00a0leiomyoma.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "151876",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.625815,
            -37.76272
          ],
          [
            8.625213,
            -37.777434
          ],
          [
            8.45259,
            -41.877158
          ],
          [
            8.45199,
            -41.890992
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "151",
        "dest": "876",
        "label": "A comprehensive view of nuclear receptor cancer cistromes. -- Genome-wide interplay of nuclear receptors with the epigenome.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "151877",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.625819,
            -37.76272
          ],
          [
            8.626696,
            -37.777647
          ],
          [
            8.883059,
            -42.007224
          ],
          [
            8.883936,
            -42.021231
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "151",
        "dest": "877",
        "label": "A comprehensive view of nuclear receptor cancer cistromes. -- Integrating multiple oestrogen receptor alpha ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "152878",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.69937,
            -36.72262
          ],
          [
            8.705315,
            -36.738897
          ],
          [
            10.612274,
            -41.779023
          ],
          [
            10.61821,
            -41.794142
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "878",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor \u03b1 in luminal breast cancer cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "152879",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.699372,
            -36.722621
          ],
          [
            8.70577,
            -36.737333
          ],
          [
            10.541587,
            -40.840869
          ],
          [
            10.547974,
            -40.854731
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "879",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Binding of estrogen receptor alpha/beta heterodimers to chromatin in MCF-7 cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "152880",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.699365,
            -36.722621
          ],
          [
            8.70358,
            -36.739933
          ],
          [
            10.110829,
            -42.298024
          ],
          [
            10.115038,
            -42.313975
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "880",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "152881",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.699381,
            -36.722621
          ],
          [
            8.708601,
            -36.736603
          ],
          [
            11.22158,
            -40.45179
          ],
          [
            11.230783,
            -40.46504
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "881",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Aryl hydrocarbon receptor modulation of estrogen receptor \u03b1-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "152882",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.699358,
            -36.722621
          ],
          [
            8.700099,
            -36.737568
          ],
          [
            8.912817,
            -40.904739
          ],
          [
            8.913557,
            -40.918808
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "882",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Novel DNA motif binding activity observed in vivo with an estrogen receptor \u03b1 mutant mouse.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "152883",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.699357,
            -36.72262
          ],
          [
            8.699992,
            -36.738288
          ],
          [
            8.895838,
            -41.41882
          ],
          [
            8.896471,
            -41.433454
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "883",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Nucleosome eviction and multiple co-factor binding predict estrogen-receptor-alpha-associated long-range interactions.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "152884",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.699377,
            -36.722621
          ],
          [
            8.708432,
            -36.739193
          ],
          [
            11.612941,
            -41.867245
          ],
          [
            11.621982,
            -41.882618
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "884",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Integrative model of genomic factors for determining binding site selection by estrogen receptor-\u03b1.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "152885",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.699366,
            -36.722621
          ],
          [
            8.703239,
            -36.737526
          ],
          [
            9.81455,
            -40.893318
          ],
          [
            9.818416,
            -40.90735
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "885",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- A carrier-assisted ChIP-seq method for estrogen receptor-chromatin interactions from breast cancer core needle biopsy samples.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "152886",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.699379,
            -36.722621
          ],
          [
            8.708318,
            -36.737611
          ],
          [
            11.319339,
            -40.988981
          ],
          [
            11.328264,
            -41.003074
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "886",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Research resource: Aorta- and liver-specific ER\u03b1-binding patterns and gene regulation by estrogen.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "152887",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.699386,
            -36.72262
          ],
          [
            8.709509,
            -36.735635
          ],
          [
            11.296075,
            -39.987775
          ],
          [
            11.306179,
            -40.000191
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "887",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Genome-Wide Mapping of In Vivo ER\u03b1-Binding Sites in Male Mouse Efferent Ductules.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "153888",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.957229,
            -38.199692
          ],
          [
            10.965159,
            -38.214058
          ],
          [
            13.240667,
            -42.217727
          ],
          [
            13.248583,
            -42.231242
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "153",
        "dest": "888",
        "label": "Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target genes in the glands of the mouse uterus. -- Integrated microarray and ChIP analysis identifies multiple Foxa2 dependent target genes in the notochord.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "153889",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.957267,
            -38.199692
          ],
          [
            10.976614,
            -38.212078
          ],
          [
            15.769793,
            -41.215154
          ],
          [
            15.789101,
            -41.226986
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "153",
        "dest": "889",
        "label": "Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target genes in the glands of the mouse uterus. -- Genome-wide characterization of Foxa2 targets reveals upregulation of floor plate genes and repression of ventrolateral genes in midbrain dopaminergic progenitors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "153890",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.957227,
            -38.199692
          ],
          [
            10.96519,
            -38.215594
          ],
          [
            13.519485,
            -43.134804
          ],
          [
            13.527436,
            -43.149547
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "153",
        "dest": "890",
        "label": "Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target genes in the glands of the mouse uterus. -- Foxa2 is essential for mouse endometrial gland development and fertility.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "153891",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.957245,
            -38.199692
          ],
          [
            10.970542,
            -38.213224
          ],
          [
            14.595031,
            -41.806984
          ],
          [
            14.608305,
            -41.819796
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "153",
        "dest": "891",
        "label": "Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target genes in the glands of the mouse uterus. -- Cell-specific transcriptional profiling reveals candidate mechanisms regulating development and function of uterine epithelia in mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "153892",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.957215,
            -38.199693
          ],
          [
            10.960168,
            -38.215114
          ],
          [
            11.854479,
            -42.734301
          ],
          [
            11.857427,
            -42.74869
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "153",
        "dest": "892",
        "label": "Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target genes in the glands of the mouse uterus. -- Forkhead box a2 (FOXA2) is essential for uterine function and fertility.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "28163",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            30.309678,
            -21.699499
          ],
          [
            30.298851,
            -21.677131
          ],
          [
            26.272642,
            -13.14509
          ],
          [
            26.26183,
            -13.121679
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "28",
        "dest": "163",
        "label": "Distribution of prolactin receptors suggests an intraductal role for prolactin in the mouse and human mammary gland, a finding supported by analysis of signaling in polarized monolayer cultures. -- Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "28164",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            30.309725,
            -21.699589
          ],
          [
            30.320325,
            -21.718866
          ],
          [
            33.788744,
            -27.877335
          ],
          [
            33.799329,
            -27.895647
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "28",
        "dest": "164",
        "label": "Distribution of prolactin receptors suggests an intraductal role for prolactin in the mouse and human mammary gland, a finding supported by analysis of signaling in polarized monolayer cultures. -- Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "28165",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            30.309872,
            -21.699589
          ],
          [
            30.351869,
            -21.710408
          ],
          [
            38.062155,
            -23.682698
          ],
          [
            38.104038,
            -23.693333
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "28",
        "dest": "165",
        "label": "Distribution of prolactin receptors suggests an intraductal role for prolactin in the mouse and human mammary gland, a finding supported by analysis of signaling in polarized monolayer cultures. -- Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "163108",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.261623,
            -13.121678
          ],
          [
            26.216998,
            -13.132814
          ],
          [
            18.11557,
            -15.145838
          ],
          [
            18.070821,
            -15.156906
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "108",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "16391",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.262394,
            -13.121678
          ],
          [
            26.332815,
            -13.127221
          ],
          [
            32.725514,
            -13.629913
          ],
          [
            32.795939,
            -13.635445
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "91",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "163162",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.262402,
            -13.121678
          ],
          [
            26.340199,
            -13.127728
          ],
          [
            34.026532,
            -13.724736
          ],
          [
            34.104173,
            -13.730759
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "162",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "163532",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.261884,
            -13.121678
          ],
          [
            26.290606,
            -13.139134
          ],
          [
            34.389553,
            -18.006285
          ],
          [
            34.418224,
            -18.023301
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "532",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- Prolactin regulates ZNT2 expression through the JAK2/STAT5 signaling pathway in mammary cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "163685",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.261822,
            -13.121679
          ],
          [
            26.267228,
            -13.139837
          ],
          [
            27.818301,
            -18.288025
          ],
          [
            27.823697,
            -18.305697
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "685",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- Scribble is required for pregnancy-induced alveologenesis in the adult mammary gland.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "163935",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.261811,
            -13.121678
          ],
          [
            26.262908,
            -13.140908
          ],
          [
            26.601717,
            -18.99406
          ],
          [
            26.602813,
            -19.012699
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "935",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary             carcinoma cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "163936",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.261834,
            -13.121678
          ],
          [
            26.271998,
            -13.140062
          ],
          [
            29.2948,
            -18.53876
          ],
          [
            29.304947,
            -18.556628
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "936",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- Pten regulates development and lactation in the mammary glands of dairy cows.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "163937",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.26185,
            -13.121679
          ],
          [
            26.277446,
            -13.13918
          ],
          [
            30.600636,
            -17.936919
          ],
          [
            30.616204,
            -17.953985
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "937",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- miR-135a Targets and Regulates Prolactin Receptor Gene in Goat Mammary Epithelial Cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164124",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.799699,
            -27.895731
          ],
          [
            33.852633,
            -27.902183
          ],
          [
            39.977191,
            -28.646076
          ],
          [
            40.030084,
            -28.652478
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "124",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Estradiol, progesterone and prolactin modulate mammary gland morphogenesis in adult female plains vizcacha (Lagostomus maximus).",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164166",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.799372,
            -27.895732
          ],
          [
            33.80738,
            -27.914662
          ],
          [
            36.427369,
            -33.922471
          ],
          [
            36.435365,
            -33.940217
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "166",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Cloning and expression of a unique short form of the porcine prolactin receptor.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164167",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.799415,
            -27.895733
          ],
          [
            33.820203,
            -27.910761
          ],
          [
            39.131569,
            -31.68019
          ],
          [
            39.152316,
            -31.694632
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "167",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Triennial Lactation Symposium: Prolactin: The multifaceted potentiator of mammary growth and function.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164169",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.799441,
            -27.895731
          ],
          [
            33.825102,
            -27.908302
          ],
          [
            39.493752,
            -30.648727
          ],
          [
            39.519354,
            -30.660936
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "169",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Reproductive experience alters prolactin receptor expression in mammary and hepatic tissues in female rats.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164939",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.799501,
            -27.895731
          ],
          [
            33.834567,
            -27.905843
          ],
          [
            40.130638,
            -29.70584
          ],
          [
            40.165607,
            -29.71575
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "939",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Molecular characterization, mRNA expression of prolactin receptor (PRLR) gene during pregnancy, nonpregnancy in the yak (Bos grunniens).",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164940",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.799323,
            -27.895731
          ],
          [
            33.788498,
            -27.910436
          ],
          [
            30.933637,
            -31.717079
          ],
          [
            30.922485,
            -31.731661
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "940",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Effects of metoclopramide-induced hyperprolactinemia on the prolactin receptor of murine endometrium.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "164941",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.799366,
            -27.895732
          ],
          [
            33.804091,
            -27.91242
          ],
          [
            35.18419,
            -32.672478
          ],
          [
            35.188907,
            -32.688345
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "941",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Hormone interactions confer specific proliferative and histomorphogenic responses in the porcine mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164943",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.799394,
            -27.895731
          ],
          [
            33.813741,
            -27.910995
          ],
          [
            37.660122,
            -31.923018
          ],
          [
            37.674442,
            -31.937649
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "943",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Short form 1b human prolactin receptor down-regulates expression of the long form.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164944",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.799339,
            -27.895731
          ],
          [
            33.794062,
            -27.911166
          ],
          [
            32.331231,
            -32.102026
          ],
          [
            32.325874,
            -32.117044
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "944",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- A novel first exon directs hormone-sensitive transcription of the pig prolactin receptor.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "164945",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.799354,
            -27.895732
          ],
          [
            33.799477,
            -27.911617
          ],
          [
            33.833695,
            -32.222121
          ],
          [
            33.833818,
            -32.237299
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "945",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Metoclopramide-induced hyperprolactinemia effects on the pituitary and uterine prolactin receptor expression.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "164946",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.799379,
            -27.895732
          ],
          [
            33.808264,
            -27.911049
          ],
          [
            36.151704,
            -31.872977
          ],
          [
            36.160572,
            -31.887667
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "946",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- The progesterone and estrogen modify the uterine prolactin and prolactin receptor expression of hyperprolactinemic mice.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "164947",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.799415,
            -27.895733
          ],
          [
            33.818093,
            -27.909061
          ],
          [
            38.05897,
            -30.891732
          ],
          [
            38.077607,
            -30.904645
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "947",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Comparative genomics reveals tissue-specific regulation of prolactin receptor gene expression.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "165191",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            38.104254,
            -23.693421
          ],
          [
            38.12001,
            -23.709104
          ],
          [
            42.275916,
            -27.776983
          ],
          [
            42.291643,
            -27.792107
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "191",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- The permissive role of prolactin as a regulator of luteinizing hormone action in the female mouse ovary and extragonadal tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "165948",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            38.104317,
            -23.693421
          ],
          [
            38.133624,
            -23.705414
          ],
          [
            44.121124,
            -26.132042
          ],
          [
            44.15036,
            -26.143772
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "948",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- CD40-modulated dual-specificity phosphatases MAPK phosphatase (MKP)-1 and MKP-3 reciprocally regulate Leishmania major infection.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "165949",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            38.105007,
            -23.69342
          ],
          [
            38.18369,
            -23.6977
          ],
          [
            44.058093,
            -24.016856
          ],
          [
            44.13679,
            -24.021126
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "949",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- Regulation of transcription factors and repression of Sp1 by prolactin signaling through the short isoform of its cognate receptor.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "165950",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            38.104298,
            -23.69342
          ],
          [
            38.133682,
            -23.707904
          ],
          [
            45.413289,
            -27.244682
          ],
          [
            45.442613,
            -27.258715
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "950",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- Prolactin signaling through the short isoform of the mouse prolactin receptor regulates DNA binding of specific transcription factors, often with opposite effects in different reproductive issues.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "165951",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            38.104238,
            -23.69342
          ],
          [
            38.114412,
            -23.708847
          ],
          [
            40.797874,
            -27.711466
          ],
          [
            40.808029,
            -27.726352
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "951",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- Differential roles of MAPK-Erk1/2 and MAPK-p38 in insulin or insulin-like growth factor-I (IGF-I) signaling pathways for progesterone production in human ovarian cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "165952",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            38.104407,
            -23.69342
          ],
          [
            38.145731,
            -23.702595
          ],
          [
            44.635211,
            -25.135243
          ],
          [
            44.676403,
            -25.144285
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "952",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- Generation of mice expressing only the long form of the prolactin receptor reveals that both isoforms of the receptor are required for normal ovarian function.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "165953",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            38.104213,
            -23.693421
          ],
          [
            38.105697,
            -23.710279
          ],
          [
            38.53155,
            -28.453153
          ],
          [
            38.533032,
            -28.469311
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "953",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- Prolactin (PRL) induction of cyclooxygenase 2 (COX2) expression and prostaglandin (PG) production in hamster Leydig cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "165954",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            38.104276,
            -23.69342
          ],
          [
            38.125677,
            -23.707394
          ],
          [
            43.271326,
            -27.022284
          ],
          [
            43.292683,
            -27.03585
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "954",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- Prolactin activation of the long form of its cognate receptor causes increased visceral fat and obesity in males as shown in transgenic mice expressing only this receptor subtype.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "91535",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            32.796593,
            -13.63554
          ],
          [
            32.817462,
            -13.650517
          ],
          [
            37.691767,
            -17.120446
          ],
          [
            37.712593,
            -17.135142
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "91",
        "dest": "535",
        "label": "Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation. -- Expression mechanism of tryptophan hydroxylase 1 in mouse islets during pregnancy.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "91536",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            32.796563,
            -13.635538
          ],
          [
            32.810208,
            -13.652238
          ],
          [
            36.529361,
            -18.155527
          ],
          [
            36.543207,
            -18.172097
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "91",
        "dest": "536",
        "label": "Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation. -- Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "29174",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.302555,
            37.710762
          ],
          [
            -18.312698,
            37.727449
          ],
          [
            -21.699061,
            43.085518
          ],
          [
            -21.709188,
            43.100899
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "29",
        "dest": "174",
        "label": "Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. -- A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "29175",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.302523,
            37.710687
          ],
          [
            -18.298362,
            37.693617
          ],
          [
            -16.880062,
            31.651291
          ],
          [
            -16.875906,
            31.632949
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "29",
        "dest": "175",
        "label": "Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. -- Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "29178",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.30261,
            37.710687
          ],
          [
            -18.3263,
            37.699192
          ],
          [
            -23.781065,
            35.005179
          ],
          [
            -23.805036,
            34.993135
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "29",
        "dest": "178",
        "label": "Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. -- Constitutive activation of JAK2 in mammary epithelium elevates Stat5 signalling, promotes alveologenesis and resistance to cell death, and contributes to tumourigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "29180",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.302737,
            37.710687
          ],
          [
            -18.3448,
            37.702989
          ],
          [
            -24.856052,
            36.5017
          ],
          [
            -24.898178,
            36.493866
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "29",
        "dest": "180",
        "label": "Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. -- CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "29182",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.302568,
            37.710763
          ],
          [
            -18.31561,
            37.724734
          ],
          [
            -21.870312,
            41.433598
          ],
          [
            -21.88333,
            41.446814
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "29",
        "dest": "182",
        "label": "Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. -- Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "29184",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.302589,
            37.710763
          ],
          [
            -18.320549,
            37.72286
          ],
          [
            -22.639001,
            40.573804
          ],
          [
            -22.656924,
            40.585395
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "29",
        "dest": "184",
        "label": "Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. -- A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174176",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.709242,
            43.100969
          ],
          [
            -21.719252,
            43.112559
          ],
          [
            -24.199228,
            45.91629
          ],
          [
            -24.209218,
            45.927311
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "176",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "174177",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.709214,
            43.100968
          ],
          [
            -21.71036,
            43.116059
          ],
          [
            -22.085307,
            47.853377
          ],
          [
            -22.086451,
            47.867224
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "177",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "174977",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.709224,
            43.100969
          ],
          [
            -21.71439,
            43.115396
          ],
          [
            -23.279113,
            47.328726
          ],
          [
            -23.28427,
            47.342096
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "977",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "174978",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.709319,
            43.100899
          ],
          [
            -21.740258,
            43.091006
          ],
          [
            -28.394386,
            40.926177
          ],
          [
            -28.425658,
            40.915829
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "978",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "174979",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.709689,
            43.100899
          ],
          [
            -21.777907,
            43.095963
          ],
          [
            -29.121305,
            42.562287
          ],
          [
            -29.189655,
            42.557298
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "979",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "174980",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.70924,
            43.100898
          ],
          [
            -21.719978,
            43.087605
          ],
          [
            -24.747871,
            39.224479
          ],
          [
            -24.75859,
            39.2104
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "980",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Genetic polymorphisms in RNA binding proteins contribute to breast cancer survival.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174981",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.709202,
            43.100969
          ],
          [
            -21.705403,
            43.115337
          ],
          [
            -20.532928,
            47.388539
          ],
          [
            -20.529135,
            47.401841
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "981",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "174982",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.709234,
            43.100968
          ],
          [
            -21.718863,
            43.115526
          ],
          [
            -24.747831,
            47.522898
          ],
          [
            -24.757444,
            47.53634
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "982",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- The role of tristetraprolin in cancer and inflammation.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "174983",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.709224,
            43.100899
          ],
          [
            -21.714506,
            43.087181
          ],
          [
            -23.285056,
            38.871989
          ],
          [
            -23.290328,
            38.857387
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "983",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Regulation of p21/CIP1/WAF-1 mediated cell-cycle arrest by RNase L and tristetraprolin, and involvement of AU-rich elements.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174984",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.709258,
            43.100899
          ],
          [
            -21.725572,
            43.088665
          ],
          [
            -26.028679,
            39.776959
          ],
          [
            -26.044962,
            39.764107
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "984",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Tristetraprolin down-regulates IL-23 expression in colon cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174985",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.709285,
            43.100898
          ],
          [
            -21.732118,
            43.089937
          ],
          [
            -27.065047,
            40.476175
          ],
          [
            -27.087832,
            40.46478
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "985",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Tristetraprolin is involved in the glucocorticoid-mediated interleukin 8 repression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174986",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.709396,
            43.100898
          ],
          [
            -21.749021,
            43.093342
          ],
          [
            -28.157258,
            41.859005
          ],
          [
            -28.196762,
            41.85132
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "986",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Dysregulation of TTP and HuR plays an important role in cancers.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174987",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.709241,
            43.100969
          ],
          [
            -21.720516,
            43.11403
          ],
          [
            -24.899848,
            46.685837
          ],
          [
            -24.911103,
            46.698087
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "987",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Control of pro-angiogenic cytokine mRNA half-life in cancer: the role of AU-rich elements and associated proteins.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174988",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.709213,
            43.100969
          ],
          [
            -21.709816,
            43.114748
          ],
          [
            -21.886112,
            47.006294
          ],
          [
            -21.886715,
            47.019141
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "988",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "17580",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.875884,
            31.632868
          ],
          [
            -16.870079,
            31.614228
          ],
          [
            -14.891368,
            25.052655
          ],
          [
            -14.885571,
            25.032852
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "80",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "17536",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.876109,
            31.632869
          ],
          [
            -16.923431,
            31.623846
          ],
          [
            -24.892782,
            30.092
          ],
          [
            -24.940207,
            30.082811
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "36",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "175183",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.876157,
            31.632949
          ],
          [
            -16.928884,
            31.641116
          ],
          [
            -24.976095,
            32.879095
          ],
          [
            -25.028894,
            32.887162
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "183",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "175989",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.875925,
            31.63295
          ],
          [
            -16.886308,
            31.648291
          ],
          [
            -19.814063,
            35.870986
          ],
          [
            -19.824428,
            35.885561
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "989",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "175990",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.875998,
            31.63295
          ],
          [
            -16.904006,
            31.6443
          ],
          [
            -22.773202,
            33.991769
          ],
          [
            -22.801143,
            34.002795
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "990",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "175991",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.879902,
            31.632881
          ],
          [
            -17.052988,
            31.631691
          ],
          [
            -22.7803,
            31.59228
          ],
          [
            -22.941679,
            31.591169
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "991",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- The protein tyrosine phosphatase receptor type J is regulated by the pVHL-HIF axis in clear cell renal cell carcinoma.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "175992",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.876187,
            31.632949
          ],
          [
            -16.926519,
            31.639969
          ],
          [
            -23.525072,
            32.555619
          ],
          [
            -23.575414,
            32.562569
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "992",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "175993",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.876161,
            31.632868
          ],
          [
            -16.924095,
            31.625493
          ],
          [
            -23.499858,
            30.608164
          ],
          [
            -23.547819,
            30.600704
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "993",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- The gene desert mammary carcinoma susceptibility locus Mcs1a regulates Nr2f1 modifying mammary epithelial cell differentiation and proliferation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "175994",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.876022,
            31.632868
          ],
          [
            -16.907868,
            31.622348
          ],
          [
            -23.030511,
            29.578126
          ],
          [
            -23.062275,
            29.567409
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "994",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Regulated expression of PTPRJ/CD148 and an antisense long noncoding RNA in macrophages by proinflammatory stimuli.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "175995",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.875971,
            31.632869
          ],
          [
            -16.898875,
            31.620305
          ],
          [
            -22.248277,
            28.640464
          ],
          [
            -22.271132,
            28.627541
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "995",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "175996",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.877708,
            31.632869
          ],
          [
            -17.010001,
            31.629928
          ],
          [
            -24.345178,
            31.466743
          ],
          [
            -24.458439,
            31.464221
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "996",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- FoxM1 regulates mammary luminal cell fate.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "175997",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -16.875947,
            31.632866
          ],
          [
            -16.892861,
            31.618326
          ],
          [
            -21.214336,
            27.830491
          ],
          [
            -21.231216,
            27.815418
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "997",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Mammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "36222",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.94043,
            30.082812
          ],
          [
            -24.944661,
            30.100114
          ],
          [
            -26.250704,
            35.290772
          ],
          [
            -26.254929,
            35.307067
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "36",
        "dest": "222",
        "label": "Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. -- Role of epithelial stem/progenitor cells in mammary cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "36224",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.94044,
            30.082811
          ],
          [
            -24.949054,
            30.100337
          ],
          [
            -27.712171,
            35.556136
          ],
          [
            -27.720772,
            35.572587
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "36",
        "dest": "224",
        "label": "Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. -- Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "36225",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.940453,
            30.082812
          ],
          [
            -24.954094,
            30.09987
          ],
          [
            -29.086122,
            35.127227
          ],
          [
            -29.099741,
            35.143324
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "36",
        "dest": "225",
        "label": "Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. -- Mammary stem cells and the differentiation hierarchy: current status and perspectives.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "36227",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -24.940445,
            30.082812
          ],
          [
            -24.950205,
            30.098608
          ],
          [
            -27.702307,
            34.449401
          ],
          [
            -27.71205,
            34.464428
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "36",
        "dest": "227",
        "label": "Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. -- The mammary cellular hierarchy and breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "222160",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -26.254976,
            35.307145
          ],
          [
            -26.269248,
            35.322101
          ],
          [
            -30.364527,
            39.497457
          ],
          [
            -30.378774,
            39.511574
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "222",
        "dest": "160",
        "label": "Role of epithelial stem/progenitor cells in mammary cancer. -- From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "30185",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.544745,
            36.15524
          ],
          [
            -0.552189,
            36.140264
          ],
          [
            -2.688303,
            31.727036
          ],
          [
            -2.695735,
            31.711288
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "185",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30186",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.54474,
            36.155318
          ],
          [
            -0.550363,
            36.170424
          ],
          [
            -2.192605,
            40.45596
          ],
          [
            -2.198218,
            40.470171
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "186",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30187",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.544762,
            36.155319
          ],
          [
            -0.557423,
            36.169359
          ],
          [
            -3.896958,
            39.783574
          ],
          [
            -3.909595,
            39.796911
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "187",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Form and function: how estrogen and progesterone regulate the mammary epithelial hierarchy.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30188",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.544727,
            36.155318
          ],
          [
            -0.545386,
            36.170638
          ],
          [
            -0.741176,
            40.591945
          ],
          [
            -0.741833,
            40.606329
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "188",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Prolactin-growth factor crosstalk reduces mammary estrogen responsiveness despite elevated ERalpha expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30190",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.544685,
            36.155319
          ],
          [
            -0.530358,
            36.169366
          ],
          [
            3.310568,
            39.843422
          ],
          [
            3.324869,
            39.856755
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "190",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Prolactin activates ER\u03b1 in the absence of ligand in female mammary development and carcinogenesis in vivo.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30192",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.544714,
            36.155319
          ],
          [
            -0.540402,
            36.170641
          ],
          [
            0.719028,
            40.515738
          ],
          [
            0.723333,
            40.530139
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "192",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Hormone-sensing mammary epithelial progenitors: emerging identity and hormonal regulation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30193",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.544665,
            36.155318
          ],
          [
            -0.526,
            36.167413
          ],
          [
            3.833538,
            38.940743
          ],
          [
            3.852163,
            38.95237
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "193",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30194",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.544701,
            36.155318
          ],
          [
            -0.536085,
            36.168821
          ],
          [
            1.736353,
            39.648208
          ],
          [
            1.744953,
            39.661061
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "194",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Obesity reversibly depletes the basal cell population and enhances mammary epithelial cell estrogen receptor alpha expression and progenitor activity.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "30195",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.544701,
            36.155318
          ],
          [
            -0.535183,
            36.170462
          ],
          [
            2.295386,
            40.542531
          ],
          [
            2.305061,
            40.557019
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "195",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Hormone signaling requirements for the conversion of non-mammary mouse cells to mammary cell fate(s) in vivo.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "19568",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.305147,
            40.557094
          ],
          [
            2.324558,
            40.569253
          ],
          [
            6.991853,
            43.428355
          ],
          [
            7.011224,
            43.439953
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "195",
        "dest": "68",
        "label": "Hormone signaling requirements for the conversion of non-mammary mouse cells to mammary cell fate(s) in vivo. -- <i>In vivo</i> reprogramming of non-mammary cells to an epithelial cell fate is independent of amphiregulin signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "68393",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.011532,
            43.440024
          ],
          [
            7.057975,
            43.446471
          ],
          [
            13.622786,
            44.350963
          ],
          [
            13.669265,
            44.357317
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "68",
        "dest": "393",
        "label": "<i>In vivo</i> reprogramming of non-mammary cells to an epithelial cell fate is independent of amphiregulin signaling. -- Amphiregulin mediates self-renewal in an immortal mammary epithelial cell line with stem cell characteristics.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "68394",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.014114,
            43.440024
          ],
          [
            7.160176,
            43.441797
          ],
          [
            12.914186,
            43.511599
          ],
          [
            13.06026,
            43.51337
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "68",
        "dest": "394",
        "label": "<i>In vivo</i> reprogramming of non-mammary cells to an epithelial cell fate is independent of amphiregulin signaling. -- Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "32138",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.310755,
            58.638101
          ],
          [
            2.315313,
            58.628988
          ],
          [
            3.578685,
            56.009811
          ],
          [
            3.583234,
            56.000039
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "32",
        "dest": "138",
        "label": "Role of KLF5 in hormonal signaling and breast cancer development. -- The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "32200",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.310766,
            58.638151
          ],
          [
            2.319556,
            58.647719
          ],
          [
            4.88691,
            61.332014
          ],
          [
            4.895842,
            61.340976
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "32",
        "dest": "200",
        "label": "Role of KLF5 in hormonal signaling and breast cancer development. -- Alpha-actinin 4 and tumorigenesis of breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "32201",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.310752,
            58.638152
          ],
          [
            2.314514,
            58.648219
          ],
          [
            3.433038,
            61.515671
          ],
          [
            3.436793,
            61.524881
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "32",
        "dest": "201",
        "label": "Role of KLF5 in hormonal signaling and breast cancer development. -- Impact of obesity on mammary gland inflammation and local estrogen production.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "138135",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            3.583179,
            55.999985
          ],
          [
            3.563793,
            55.992022
          ],
          [
            -0.60566,
            54.241031
          ],
          [
            -0.625001,
            54.232729
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "135",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "138198",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            3.583242,
            56.00004
          ],
          [
            3.581334,
            56.011254
          ],
          [
            2.992562,
            59.319457
          ],
          [
            2.990657,
            59.329673
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "198",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "138799",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            3.583217,
            56.00004
          ],
          [
            3.571089,
            56.010942
          ],
          [
            -0.102334,
            59.173957
          ],
          [
            -0.114442,
            59.183931
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "799",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- Kr\u00fcppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "138800",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            3.583214,
            56.000039
          ],
          [
            3.570782,
            56.010023
          ],
          [
            0.065375,
            58.723782
          ],
          [
            0.052965,
            58.733034
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "800",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- Kr\u00fcppel-like factor 5 in human breast carcinoma: a potent prognostic factor induced by androgens.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "138801",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            3.583231,
            56.000039
          ],
          [
            3.576661,
            56.011159
          ],
          [
            1.509832,
            59.353114
          ],
          [
            1.503273,
            59.363234
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "801",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "138802",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            3.583246,
            56.000039
          ],
          [
            3.58283,
            56.010086
          ],
          [
            3.465657,
            58.740365
          ],
          [
            3.465242,
            58.749672
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "802",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "138803",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            3.583225,
            56.000039
          ],
          [
            3.575061,
            56.009984
          ],
          [
            1.272941,
            58.713559
          ],
          [
            1.264651,
            58.722938
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "803",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- Kruppel-like factor 5 transcription factor promotes microsomal prostaglandin E2 synthase 1 gene transcription in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "34213",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.558682,
            40.759505
          ],
          [
            -3.564672,
            40.743194
          ],
          [
            -5.564646,
            35.076857
          ],
          [
            -5.570628,
            35.059261
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "213",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "34206",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.558478,
            40.759577
          ],
          [
            -3.513972,
            40.768039
          ],
          [
            4.347119,
            42.245584
          ],
          [
            4.3915,
            42.25383
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "206",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "34207",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.558556,
            40.759578
          ],
          [
            -3.525502,
            40.770313
          ],
          [
            3.776173,
            43.099155
          ],
          [
            3.809151,
            43.109481
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "207",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- A role for the TGFbeta-Par6 polarity pathway in breast cancer progression.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "34209",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.558431,
            40.759577
          ],
          [
            -3.513181,
            40.766458
          ],
          [
            2.996191,
            41.748763
          ],
          [
            3.041483,
            41.755546
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "209",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- Inhibiting breast cancer progression by exploiting TGFbeta signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "34210",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.558613,
            40.759578
          ],
          [
            -3.538226,
            40.773106
          ],
          [
            2.113009,
            44.416406
          ],
          [
            2.133359,
            44.42914
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "210",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "34212",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.558551,
            40.759578
          ],
          [
            -3.528044,
            40.769099
          ],
          [
            2.478893,
            42.617136
          ],
          [
            2.509323,
            42.626363
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "212",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- A role of TGF\u00df1 dependent 14-3-3\u03c3 phosphorylation at Ser69 and Ser74 in the regulation of gene transcription, stemness and radioresistance.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "34214",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.558613,
            40.759579
          ],
          [
            -3.540336,
            40.772115
          ],
          [
            0.987551,
            43.804666
          ],
          [
            1.005791,
            43.816586
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "214",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- Autocrine CSF1R signaling mediates switching between invasion and proliferation downstream of TGF\u03b2 in claudin-low breast tumor cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "34215",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.558591,
            40.759578
          ],
          [
            -3.533786,
            40.771323
          ],
          [
            2.430231,
            43.534756
          ],
          [
            2.454984,
            43.545973
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "215",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- A basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemness.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "38234",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.871189,
            -19.423473
          ],
          [
            -51.858623,
            -19.403239
          ],
          [
            -47.663337,
            -12.521393
          ],
          [
            -47.65079,
            -12.50048
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "38",
        "dest": "234",
        "label": "Wnt and mammary stem cells: hormones cannot fly wingless. -- Small molecule antagonists of the Wnt/\u03b2-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "38233",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.871258,
            -19.423564
          ],
          [
            -51.887318,
            -19.441495
          ],
          [
            -56.663373,
            -24.679701
          ],
          [
            -56.679406,
            -24.696949
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "38",
        "dest": "233",
        "label": "Wnt and mammary stem cells: hormones cannot fly wingless. -- Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "38238",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.871251,
            -19.423564
          ],
          [
            -51.885026,
            -19.441702
          ],
          [
            -56.057601,
            -24.835602
          ],
          [
            -56.071353,
            -24.853027
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "38",
        "dest": "238",
        "label": "Wnt and mammary stem cells: hormones cannot fly wingless. -- Key signaling nodes in mammary gland development and cancer: \u03b2-catenin.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "38239",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.871234,
            -19.423565
          ],
          [
            -51.87869,
            -19.443965
          ],
          [
            -54.368087,
            -26.098479
          ],
          [
            -54.375532,
            -26.117875
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "38",
        "dest": "239",
        "label": "Wnt and mammary stem cells: hormones cannot fly wingless. -- The Wnt receptor, Lrp5, is expressed by mouse mammary stem cells and is required to maintain the basal lineage.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "38240",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.871241,
            -19.423565
          ],
          [
            -51.881404,
            -19.442802
          ],
          [
            -55.078303,
            -25.371963
          ],
          [
            -55.088449,
            -25.390364
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "38",
        "dest": "240",
        "label": "Wnt and mammary stem cells: hormones cannot fly wingless. -- Wnt signaling in stem and cancer stem cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "65380",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.965036,
            -23.172564
          ],
          [
            -51.978773,
            -23.189584
          ],
          [
            -55.920686,
            -27.979151
          ],
          [
            -55.9344,
            -27.995471
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "380",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Lineage enforcement by inductive mesenchyme on adult epithelial stem cells across developmental germ layers.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "65381",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.965035,
            -23.172564
          ],
          [
            -51.979983,
            -23.191118
          ],
          [
            -56.682201,
            -28.8924
          ],
          [
            -56.697125,
            -28.910042
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "381",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Embryonic stem cells are redirected to non-tumorigenic epithelial cell fate by interaction with the mammary microenvironment.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "65382",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.965035,
            -23.172564
          ],
          [
            -51.979146,
            -23.190045
          ],
          [
            -56.175637,
            -28.281985
          ],
          [
            -56.189724,
            -28.298702
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "382",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Peroxisomal membrane channel Pxmp2 in the mammary fat pad is essential for stromal lipid homeostasis and for development of mammary gland epithelium in mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "65383",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.965028,
            -23.172564
          ],
          [
            -51.976055,
            -23.189846
          ],
          [
            -55.196805,
            -28.136649
          ],
          [
            -55.207813,
            -28.153197
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "383",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Human amniotic fluid stem cells have a potential to recover ovarian function in mice with chemotherapy-induced sterility.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "65384",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.965025,
            -23.172565
          ],
          [
            -51.974105,
            -23.188313
          ],
          [
            -54.368991,
            -27.274542
          ],
          [
            -54.378054,
            -27.289739
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "384",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Amniotic fluid stem cell-based models to study the effects of gene mutations and toxicants on male germ cell formation.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "65385",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.965009,
            -23.172564
          ],
          [
            -51.968164,
            -23.187711
          ],
          [
            -52.774366,
            -26.999126
          ],
          [
            -52.777515,
            -27.013778
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "385",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Bovine mammary epithelial cells retain stem-like phenotype in long-term cultures.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "65386",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.965026,
            -23.172564
          ],
          [
            -51.976088,
            -23.19105
          ],
          [
            -55.456119,
            -28.872057
          ],
          [
            -55.467164,
            -28.889638
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "386",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- The potential of amniotic fluid stem cells for cellular therapy and tissue engineering.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "65387",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.965016,
            -23.172564
          ],
          [
            -51.971954,
            -23.190746
          ],
          [
            -54.113114,
            -28.677452
          ],
          [
            -54.120041,
            -28.694775
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "387",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Reconstitution of mammary epithelial morphogenesis by murine embryonic stem cells undergoing hematopoietic stem cell differentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "65388",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.965012,
            -23.172563
          ],
          [
            -51.969712,
            -23.188911
          ],
          [
            -53.294855,
            -27.715069
          ],
          [
            -53.299627,
            -27.731054
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "388",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- The mouse mammary microenvironment redirects mesoderm-derived bone marrow cells to a mammary epithelial progenitor cell fate.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "116674",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.767788,
            -26.105798
          ],
          [
            -51.781594,
            -26.121201
          ],
          [
            -55.4827,
            -30.174557
          ],
          [
            -55.496706,
            -30.1896
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "116",
        "dest": "674",
        "label": "Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. -- The miR-17/92 cluster is targeted by STAT5 but dispensable for mammary development.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "116676",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.767776,
            -26.105799
          ],
          [
            -51.778377,
            -26.123126
          ],
          [
            -54.931075,
            -31.157181
          ],
          [
            -54.941659,
            -31.173666
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "116",
        "dest": "676",
        "label": "Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. -- Basal cell signaling by p63 controls luminal progenitor function and lactation via NRG1.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "64368",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.08023,
            -32.83503
          ],
          [
            -51.098379,
            -32.849045
          ],
          [
            -55.885285,
            -36.467054
          ],
          [
            -55.903399,
            -36.480442
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "368",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- Extracellular matrix composition reveals complex and dynamic stromal-epithelial interactions in the mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "64369",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.080203,
            -32.834949
          ],
          [
            -51.089023,
            -32.820483
          ],
          [
            -53.453558,
            -28.859071
          ],
          [
            -53.462362,
            -28.84402
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "369",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- P190A RhoGAP is required for mammary gland development.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "64370",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.0802,
            -32.83503
          ],
          [
            -51.088463,
            -32.850763
          ],
          [
            -53.545719,
            -37.403125
          ],
          [
            -53.554117,
            -37.418244
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "370",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- The hemopexin domain of MMP3 is responsible for mammary epithelial invasion and morphogenesis through extracellular interaction with HSP90\u03b2.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "64371",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.080177,
            -32.835031
          ],
          [
            -51.079503,
            -32.85155
          ],
          [
            -50.875453,
            -37.710392
          ],
          [
            -50.874781,
            -37.725919
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "371",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- Mast cells contribute to the stromal microenvironment in mammary gland branching morphogenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "64372",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.080212,
            -32.835031
          ],
          [
            -51.093503,
            -32.851051
          ],
          [
            -55.045971,
            -37.484292
          ],
          [
            -55.05924,
            -37.499397
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "372",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- The role of the microenvironment in mammary gland development and cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "64373",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.080189,
            -32.835031
          ],
          [
            -51.08463,
            -32.852269
          ],
          [
            -52.481688,
            -38.104522
          ],
          [
            -52.486122,
            -38.12064
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "373",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "64374",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.080263,
            -32.83503
          ],
          [
            -51.104646,
            -32.846627
          ],
          [
            -56.419094,
            -35.337664
          ],
          [
            -56.443422,
            -35.348897
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "374",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- The metastasis-promoting protein S100A4 regulates mammary branching morphogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "64375",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.080235,
            -32.835031
          ],
          [
            -51.097349,
            -32.847551
          ],
          [
            -54.983173,
            -35.643864
          ],
          [
            -55.000249,
            -35.655946
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "375",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- Transplantation of a mammary stromal cell line into a mammary fat pad: development of the site-specific in vivo analysis system for mammary stromal cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "64376",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.080214,
            -32.835031
          ],
          [
            -51.092692,
            -32.849477
          ],
          [
            -54.383676,
            -36.576152
          ],
          [
            -54.39613,
            -36.589933
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "376",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- Paracrine interactions between primary human macrophages and human fibroblasts enhance murine mammary gland humanization in vivo.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "64377",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.080188,
            -32.83503
          ],
          [
            -51.08374,
            -32.850332
          ],
          [
            -52.102792,
            -37.129667
          ],
          [
            -52.106338,
            -37.144161
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "377",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- Mammary fibroblasts regulate morphogenesis of normal and tumorigenic breast epithelial cells by mechanical and paracrine signals.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "64378",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.080166,
            -32.83503
          ],
          [
            -51.07524,
            -32.850307
          ],
          [
            -49.661665,
            -37.12296
          ],
          [
            -49.656747,
            -37.137431
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "378",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- Mammary ductal elongation and myoepithelial migration are regulated by the composition of the extracellular matrix.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "64379",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.080151,
            -32.83503
          ],
          [
            -51.069854,
            -32.849732
          ],
          [
            -48.215547,
            -36.829477
          ],
          [
            -48.205269,
            -36.843457
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "379",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- SHARPIN regulates collagen architecture and ductal outgrowth in the developing mouse mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "38167",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -56.697176,
            -28.910126
          ],
          [
            -56.703342,
            -28.926808
          ],
          [
            -58.536934,
            -33.764823
          ],
          [
            -58.543089,
            -33.780638
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "381",
        "dest": "67",
        "label": "Embryonic stem cells are redirected to non-tumorigenic epithelial cell fate by interaction with the mammary microenvironment. -- Reprogramming human cancer cells in the mouse mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "67391",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -58.543126,
            -33.780718
          ],
          [
            -58.551824,
            -33.79681
          ],
          [
            -61.186491,
            -38.529142
          ],
          [
            -61.195175,
            -38.544263
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "67",
        "dest": "391",
        "label": "Reprogramming human cancer cells in the mouse mammary gland. -- The normal mammary microenvironment suppresses the tumorigenic phenotype of mouse mammary tumor virus-neu-transformed mammary tumor cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "67392",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -58.543115,
            -33.780719
          ],
          [
            -58.547139,
            -33.796508
          ],
          [
            -59.722368,
            -38.280883
          ],
          [
            -59.726385,
            -38.295769
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "67",
        "dest": "392",
        "label": "Reprogramming human cancer cells in the mouse mammary gland. -- Human breast cancer cells are redirected to mammary epithelial cells upon interaction with the regenerating mammary gland microenvironment in-vivo.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "81211",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -58.20195,
            -2.018122
          ],
          [
            -58.26053,
            -2.026772
          ],
          [
            -66.330738,
            -3.217813
          ],
          [
            -66.389353,
            -3.22646
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "211",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "81479",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -58.20217,
            -2.018028
          ],
          [
            -58.271054,
            -2.011998
          ],
          [
            -64.895067,
            -1.432086
          ],
          [
            -64.963998,
            -1.42605
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "479",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "81480",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -58.20169,
            -2.018123
          ],
          [
            -58.223502,
            -2.03558
          ],
          [
            -64.168816,
            -6.781161
          ],
          [
            -64.190588,
            -6.798474
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "480",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "81481",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -58.20179,
            -2.018122
          ],
          [
            -58.240595,
            -2.029568
          ],
          [
            -65.285193,
            -4.105634
          ],
          [
            -65.324319,
            -4.117152
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "481",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "81482",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -58.201729,
            -2.018123
          ],
          [
            -58.229605,
            -2.031502
          ],
          [
            -64.071078,
            -4.831522
          ],
          [
            -64.098887,
            -4.84483
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "482",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- Cell fate takes a slug in BRCA1-associated breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "81484",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -58.201802,
            -2.018123
          ],
          [
            -58.237796,
            -2.028094
          ],
          [
            -63.890399,
            -3.59298
          ],
          [
            -63.92628,
            -3.602906
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "484",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "81485",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -58.201673,
            -2.018124
          ],
          [
            -58.216941,
            -2.035196
          ],
          [
            -62.244109,
            -6.527372
          ],
          [
            -62.259348,
            -6.544313
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "485",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "81486",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -58.202111,
            -2.018122
          ],
          [
            -58.267152,
            -2.02451
          ],
          [
            -64.894902,
            -2.675309
          ],
          [
            -64.960029,
            -2.681702
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "486",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- BRCA1--conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "81487",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -58.201695,
            -2.018123
          ],
          [
            -58.221448,
            -2.032675
          ],
          [
            -62.706671,
            -5.331587
          ],
          [
            -62.726381,
            -5.346053
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "487",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- BRCA1 mutations and luminal-basal transformation.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "83495",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -53.46171,
            -8.016966
          ],
          [
            -53.490544,
            -8.002803
          ],
          [
            -59.947668,
            -4.820297
          ],
          [
            -59.976438,
            -4.806077
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "495",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "83496",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -53.462079,
            -8.016967
          ],
          [
            -53.529663,
            -8.010163
          ],
          [
            -60.927458,
            -7.26473
          ],
          [
            -60.995186,
            -7.257899
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "496",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- The complex relationship between BRCA1 and ERalpha in hereditary breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "83497",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -53.461679,
            -8.016966
          ],
          [
            -53.482844,
            -8.001678
          ],
          [
            -58.571849,
            -4.311645
          ],
          [
            -58.592971,
            -4.296282
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "497",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive element-like site.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "83498",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -53.461795,
            -8.016967
          ],
          [
            -53.501206,
            -8.006786
          ],
          [
            -59.938629,
            -6.340782
          ],
          [
            -59.978312,
            -6.330493
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "498",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- Disruption of 3D MCF-12A breast cell cultures by estrogens--an in vitro model for ER-mediated changes indicative of hormonal carcinogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "83499",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -53.462548,
            -8.01706
          ],
          [
            -53.553061,
            -8.021595
          ],
          [
            -60.188132,
            -8.353882
          ],
          [
            -60.278639,
            -8.358413
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "499",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- Correlations between BRCA1 defect and environmental factors in the risk of breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "83500",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -53.461762,
            -8.016966
          ],
          [
            -53.500795,
            -8.004428
          ],
          [
            -61.186292,
            -5.529043
          ],
          [
            -61.225226,
            -5.516473
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "500",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "83501",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -53.461717,
            -8.016966
          ],
          [
            -53.488693,
            -8.004595
          ],
          [
            -58.736769,
            -5.591368
          ],
          [
            -58.763676,
            -5.578966
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "501",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- Hormone responsive breast cancer and BRCA1 mutation: mechanism, regulation and iron-mediated effects.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "92189",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.569669,
            -9.904247
          ],
          [
            -54.600405,
            -9.918983
          ],
          [
            -61.77917,
            -13.340508
          ],
          [
            -61.809841,
            -13.355031
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "92",
        "dest": "189",
        "label": "Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression. -- Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "92443",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.569841,
            -9.904246
          ],
          [
            -54.623796,
            -9.913511
          ],
          [
            -62.706918,
            -11.298306
          ],
          [
            -62.76094,
            -11.307539
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "92",
        "dest": "443",
        "label": "Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression. -- Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "92524",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.569623,
            -9.904247
          ],
          [
            -54.587622,
            -9.920146
          ],
          [
            -59.186589,
            -13.953998
          ],
          [
            -59.204553,
            -13.969632
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "92",
        "dest": "524",
        "label": "Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression. -- Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "92525",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.569607,
            -9.904248
          ],
          [
            -54.583442,
            -9.921929
          ],
          [
            -58.418345,
            -14.780656
          ],
          [
            -58.432154,
            -14.797979
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "92",
        "dest": "525",
        "label": "Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression. -- FOXA1 represses the molecular phenotype of basal breast cancer cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "92538",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.569719,
            -9.904247
          ],
          [
            -54.606963,
            -9.916108
          ],
          [
            -61.602323,
            -12.135722
          ],
          [
            -61.639468,
            -12.147462
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "92",
        "dest": "538",
        "label": "Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression. -- MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "92539",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.569868,
            -9.904247
          ],
          [
            -54.620977,
            -9.912245
          ],
          [
            -61.215042,
            -10.942467
          ],
          [
            -61.266155,
            -10.950439
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "92",
        "dest": "539",
        "label": "Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression. -- Loss of ER\u03b1 and FOXA1 expression in a progression model of luminal type breast cancer: insights from PyMT transgenic mouse model.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "75349",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -67.402839,
            -13.577027
          ],
          [
            -67.381307,
            -13.562259
          ],
          [
            -62.204054,
            -9.986822
          ],
          [
            -62.182566,
            -9.97189
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "75",
        "dest": "349",
        "label": "Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis. -- Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "75445",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -67.402952,
            -13.57712
          ],
          [
            -67.418819,
            -13.593441
          ],
          [
            -71.603842,
            -17.855344
          ],
          [
            -71.619679,
            -17.871295
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "75",
        "dest": "445",
        "label": "Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis. -- Lgr6 labels a rare population of mammary gland progenitor cells that are able to originate luminal mammary tumours.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "34992",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -62.177669,
            -9.971801
          ],
          [
            -61.964685,
            -9.969908
          ],
          [
            -54.778366,
            -9.906055
          ],
          [
            -54.574013,
            -9.904239
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "349",
        "dest": "92",
        "label": "Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. -- Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "9092",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -60.688906,
            -14.137481
          ],
          [
            -60.665511,
            -14.12143
          ],
          [
            -54.592987,
            -9.92052
          ],
          [
            -54.569637,
            -9.904247
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "92",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "90526",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -60.689188,
            -14.137573
          ],
          [
            -60.732103,
            -14.146827
          ],
          [
            -67.221093,
            -15.541516
          ],
          [
            -67.264065,
            -15.550721
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "526",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- The BRG1 chromatin remodeler protects against ovarian cysts, uterine tumors, and mammary tumors in a lineage-specific manner.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "90527",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -60.689047,
            -14.137574
          ],
          [
            -60.711736,
            -14.152021
          ],
          [
            -66.010951,
            -17.499365
          ],
          [
            -66.033592,
            -17.513544
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "527",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- Histone demethylase jumonji AT-rich interactive domain 1B (JARID1B) controls mammary gland development by regulating key developmental and lineage specification genes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "90528",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -60.689088,
            -14.137573
          ],
          [
            -60.717526,
            -14.149076
          ],
          [
            -66.058814,
            -16.29872
          ],
          [
            -66.087176,
            -16.310075
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "528",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- Foxa1 is essential for mammary duct formation.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "90529",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -60.689082,
            -14.137573
          ],
          [
            -60.71989,
            -14.150695
          ],
          [
            -67.34597,
            -16.954214
          ],
          [
            -67.377111,
            -16.967297
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "529",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- Runx1 is associated with breast cancer progression in MMTV-PyMT transgenic mice and its depletion in vitro inhibits migration and invasion.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "90530",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -60.689024,
            -14.137575
          ],
          [
            -60.70507,
            -14.152902
          ],
          [
            -64.563119,
            -17.805713
          ],
          [
            -64.579131,
            -17.82073
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "530",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- Distinct luminal-type mammary carcinomas arise from orthotopic Trp53-null mammary transplantation of juvenile versus adult mice.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "90531",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -60.689006,
            -14.137574
          ],
          [
            -60.700832,
            -14.155011
          ],
          [
            -63.978985,
            -18.931438
          ],
          [
            -63.99079,
            -18.948416
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "531",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- RUNX1 prevents oestrogen-mediated AXIN1 suppression and \u03b2-catenin activation in ER-positive breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97312",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.014429,
            57.097186
          ],
          [
            -6.999182,
            57.106436
          ],
          [
            -3.103437,
            59.395324
          ],
          [
            -3.08822,
            59.403977
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "312",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "97584",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.014764,
            57.097184
          ],
          [
            -7.067716,
            57.101889
          ],
          [
            -14.362527,
            57.744308
          ],
          [
            -14.41551,
            57.748933
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "584",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "97585",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.014471,
            57.097132
          ],
          [
            -7.013038,
            57.084813
          ],
          [
            -6.503301,
            52.438121
          ],
          [
            -6.50187,
            52.424316
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "585",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "97586",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.014328,
            57.097132
          ],
          [
            -6.979032,
            57.090913
          ],
          [
            -0.571353,
            55.944478
          ],
          [
            -0.535764,
            55.938013
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "586",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97587",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.014452,
            57.097132
          ],
          [
            -7.005722,
            57.086989
          ],
          [
            -4.456137,
            54.003927
          ],
          [
            -4.447423,
            53.992971
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "587",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- The diverse distribution of risk factors between breast cancer subtypes of ER, PR and HER2: a 10-year retrospective multi-center study in China.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97588",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.017578,
            57.09715
          ],
          [
            -7.189239,
            57.09667
          ],
          [
            -14.423931,
            57.076469
          ],
          [
            -14.609694,
            57.07595
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "588",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "97589",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.014464,
            57.097132
          ],
          [
            -7.010758,
            57.08718
          ],
          [
            -5.965775,
            54.172792
          ],
          [
            -5.962076,
            54.162087
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "589",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Evaluation of BrightGen HR RT-qDx assay to detect nuclear receptors mRNA overexpression in FFPE breast cancer tissue samples for selection of tamoxifen therapy.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "97590",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.014479,
            57.097132
          ],
          [
            -7.016381,
            57.087241
          ],
          [
            -7.562085,
            54.138452
          ],
          [
            -7.563983,
            54.127803
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "590",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Agreement of self-reported hormone receptor status with cancer registry data in young breast cancer patients.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "97591",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.014769,
            57.097132
          ],
          [
            -7.065797,
            57.092656
          ],
          [
            -13.728795,
            56.503465
          ],
          [
            -13.779832,
            56.498916
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "591",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Expression of AIB1 protein as a prognostic factor in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97592",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.014492,
            57.097132
          ],
          [
            -7.021408,
            57.086885
          ],
          [
            -9.078206,
            53.911815
          ],
          [
            -9.08511,
            53.900722
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "592",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Estrogen and progesterone receptors in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97593",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.014524,
            57.097132
          ],
          [
            -7.031841,
            57.088057
          ],
          [
            -11.599571,
            54.615905
          ],
          [
            -11.616856,
            54.606249
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "593",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97594",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.014553,
            57.097132
          ],
          [
            -7.038834,
            57.089053
          ],
          [
            -12.629823,
            55.18141
          ],
          [
            -12.654052,
            55.172936
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "594",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97595",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.014507,
            57.097131
          ],
          [
            -7.025967,
            57.087715
          ],
          [
            -10.048608,
            54.519568
          ],
          [
            -10.060047,
            54.509526
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "595",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Histological and immunohistochemical study of estrogen and progesterone receptors in normal human breast tissue in adult age groups vulnerable to malignancy.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "97596",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.014606,
            57.097132
          ],
          [
            -7.047779,
            57.090587
          ],
          [
            -13.351123,
            55.825822
          ],
          [
            -13.384209,
            55.819072
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "596",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Progesterone receptor targeting with radiolabelled steroids: an approach in predicting breast cancer response to therapy.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "585141",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -6.501864,
            52.424257
          ],
          [
            -6.500344,
            52.409577
          ],
          [
            -5.935097,
            46.607059
          ],
          [
            -5.933579,
            46.590543
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "585",
        "dest": "141",
        "label": "Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers. -- Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "112645",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.515125,
            -36.096476
          ],
          [
            -1.5176,
            -36.111411
          ],
          [
            -2.227725,
            -40.277919
          ],
          [
            -2.230196,
            -40.291995
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "112",
        "dest": "645",
        "label": "Multimodal regulation of E2F1 gene expression by progestins. -- Deep sequencing reveals new aspects of progesterone receptor signaling in breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "112657",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.515115,
            -36.096398
          ],
          [
            -1.513806,
            -36.081189
          ],
          [
            -1.131311,
            -31.51556
          ],
          [
            -1.130004,
            -31.499542
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "112",
        "dest": "657",
        "label": "Multimodal regulation of E2F1 gene expression by progestins. -- Progesterone receptor inhibits proliferation of human breast cancer cells via induction of MAPK phosphatase 1 (MKP-1/DUSP1).",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "112659",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.515112,
            -36.096476
          ],
          [
            -1.512334,
            -36.111408
          ],
          [
            -0.715352,
            -40.277037
          ],
          [
            -0.712579,
            -40.29111
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "112",
        "dest": "659",
        "label": "Multimodal regulation of E2F1 gene expression by progestins. -- The role of the retinoblastoma/E2F1 tumor suppressor pathway in the lesion recognition step of nucleotide excision repair.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "657127",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.129993,
            -31.499459
          ],
          [
            -1.126245,
            -31.479459
          ],
          [
            0.236424,
            -23.938042
          ],
          [
            0.240166,
            -23.916633
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "657",
        "dest": "127",
        "label": "Progesterone receptor inhibits proliferation of human breast cancer cells via induction of MAPK phosphatase 1 (MKP-1/DUSP1). -- Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "115181",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            64.810847,
            -41.639034
          ],
          [
            64.814639,
            -41.653245
          ],
          [
            65.922051,
            -45.669366
          ],
          [
            65.925836,
            -45.682631
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "181",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Trp63 is regulated by STAT5 in mammary tissue and subject to differentiation in cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115520",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            64.810861,
            -41.639033
          ],
          [
            64.819741,
            -41.652621
          ],
          [
            67.367763,
            -45.43277
          ],
          [
            67.376627,
            -45.445507
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "520",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Coregulation of genetic programs by the transcription factors NFIB and STAT5.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115537",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            64.810878,
            -41.639034
          ],
          [
            64.825278,
            -41.651928
          ],
          [
            68.685946,
            -45.015419
          ],
          [
            68.70032,
            -45.027593
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "537",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Loss of EZH2 results in precocious mammary gland development and activation of STAT5-dependent genes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115666",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            64.810902,
            -41.639034
          ],
          [
            64.831624,
            -41.650874
          ],
          [
            69.814057,
            -44.434315
          ],
          [
            69.834736,
            -44.445603
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "666",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Genome-wide chromatin occupancy analysis reveals a role for ASH2 in transcriptional pausing.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115667",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            64.810914,
            -41.639033
          ],
          [
            64.836781,
            -41.651144
          ],
          [
            71.445925,
            -44.670768
          ],
          [
            71.471742,
            -44.68227
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "667",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Chromatin signature of embryonic pluripotency is established during genome activation.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "115668",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            64.810938,
            -41.639033
          ],
          [
            64.838902,
            -41.649049
          ],
          [
            70.698991,
            -43.713354
          ],
          [
            70.726889,
            -43.723017
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "668",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Three distinct patterns of histone H3Y41 phosphorylation mark active genes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115669",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            64.81076,
            -41.638961
          ],
          [
            64.784619,
            -41.626671
          ],
          [
            58.105526,
            -38.410128
          ],
          [
            58.079436,
            -38.397267
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "669",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Sequential activation of genetic programs in mouse mammary epithelium during pregnancy depends on STAT5A/B concentration.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "115670",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            64.811023,
            -41.639033
          ],
          [
            64.850853,
            -41.646742
          ],
          [
            71.292207,
            -42.881242
          ],
          [
            71.331915,
            -42.888777
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "670",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Epigenetic modifications unlock the milk protein gene loci during mouse mammary gland development and differentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115671",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            64.811543,
            -41.639033
          ],
          [
            64.890338,
            -41.642979
          ],
          [
            71.540077,
            -41.975166
          ],
          [
            71.619016,
            -41.979099
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "671",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- FRA2 is a STAT5 target gene regulated by IL-2 in human CD4 T cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115673",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            64.811236,
            -41.638962
          ],
          [
            64.870487,
            -41.6337
          ],
          [
            71.512927,
            -41.041023
          ],
          [
            71.572117,
            -41.035718
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "673",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Differential cytokine sensitivities of STAT5-dependent enhancers rely on Stat5 autoregulation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "669118",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            58.079317,
            -38.397192
          ],
          [
            58.062584,
            -38.382404
          ],
          [
            53.086451,
            -33.852391
          ],
          [
            53.069746,
            -33.836748
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "669",
        "dest": "118",
        "label": "Sequential activation of genetic programs in mouse mammary epithelium during pregnancy depends on STAT5A/B concentration. -- PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "118179",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            53.069692,
            -33.836748
          ],
          [
            53.065066,
            -33.852116
          ],
          [
            51.713914,
            -38.220183
          ],
          [
            51.709296,
            -38.234694
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "179",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Forced activation of Stat5 subjects mammary epithelial cells to DNA damage and preferential induction of the cellular response mechanism during proliferation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "118665",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            53.069674,
            -33.836668
          ],
          [
            53.056247,
            -33.818808
          ],
          [
            48.573483,
            -27.653917
          ],
          [
            48.560076,
            -27.634899
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "665",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "118672",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            53.069705,
            -33.836749
          ],
          [
            53.070142,
            -33.852412
          ],
          [
            53.197885,
            -38.301822
          ],
          [
            53.198322,
            -38.316594
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "672",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- MiR-21 is under control of STAT5 but is dispensable for mammary development and lactation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "118679",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            53.069718,
            -33.836749
          ],
          [
            53.075251,
            -33.852157
          ],
          [
            54.662733,
            -38.156505
          ],
          [
            54.668256,
            -38.171066
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "679",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Prolactin promotes mammary pathogenesis independently from cyclin D1.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "118680",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            53.06973,
            -33.836748
          ],
          [
            53.079961,
            -33.852442
          ],
          [
            56.122572,
            -38.38922
          ],
          [
            56.132786,
            -38.404004
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "680",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "118681",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            53.069744,
            -33.836749
          ],
          [
            53.083772,
            -33.850957
          ],
          [
            56.783723,
            -37.514683
          ],
          [
            56.797724,
            -37.528225
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "681",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Dystroglycan controls signaling of multiple hormones through modulation of STAT5 activity.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "118682",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            53.069835,
            -33.836749
          ],
          [
            53.102515,
            -33.846754
          ],
          [
            59.240714,
            -35.705072
          ],
          [
            59.273308,
            -35.714827
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "682",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Fyn regulates adipogenesis by promoting PIKE-A/STAT5a interaction.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "118683",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            53.069784,
            -33.836748
          ],
          [
            53.093711,
            -33.848565
          ],
          [
            58.451908,
            -36.453204
          ],
          [
            58.475782,
            -36.464622
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "683",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Function of phosphoenolpyruvate carboxykinase in mammary gland epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "118684",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            53.06976,
            -33.836748
          ],
          [
            53.089416,
            -33.850705
          ],
          [
            58.273782,
            -37.451113
          ],
          [
            58.293401,
            -37.464428
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "684",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Phosphoinositide 3-kinase enhancer regulates neuronal dendritogenesis and survival in neocortex.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "665120",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            48.560093,
            -27.634899
          ],
          [
            48.5775,
            -27.650667
          ],
          [
            53.402673,
            -31.930905
          ],
          [
            53.420049,
            -31.945983
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "665",
        "dest": "120",
        "label": "Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1. -- Signal transducer and activator of transcription 5a inhibited by pimozide may regulate survival of goat mammary gland epithelial cells by regulating parathyroid hormone-related protein.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "665168",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            48.559993,
            -27.634814
          ],
          [
            48.538468,
            -27.617465
          ],
          [
            41.894896,
            -22.137592
          ],
          [
            41.873405,
            -22.119482
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "665",
        "dest": "168",
        "label": "Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1. -- Autocrine prolactin induced by the Pten-Akt pathway is required for lactation initiation and provides a direct link between the Akt and Stat5 pathways.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "119140",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            3.108906,
            60.747226
          ],
          [
            3.090749,
            60.741432
          ],
          [
            -0.280667,
            59.647234
          ],
          [
            -0.298775,
            59.641258
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "119",
        "dest": "140",
        "label": "Prolactin signalling in the mouse hypothalamus is primarily mediated by signal transducer and activator of transcription factor 5b but not 5a. -- Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.",
        "weight": "",
        "level": 2
      }
    }
  ]
}